ACADIA Pharmaceuticals Inc.
Einführung
Diese Seite bietet eine umfassende Analyse des bekannten Insiderhandels von Baker Brothers Life Sciences LP. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Es ist für Insider illegal, auf der Grundlage bestimmter, nicht öffentlicher Informationen mit ihren Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden. Trotz dieser Einschränkungen deuten akademische Untersuchungen darauf hin, dass Insider im Allgemeinen dazu neigen, den Markt in ihren eigenen Unternehmen zu übertreffen.
Durchschnittliche Handelsrentabilität
Die durchschnittliche Handelsrentabilität ist die durchschnittliche Rendite aller offenen Marktkäufe, die der Insider in den letzten drei Jahren getätigt hat. Um dies zu berechnen, untersuchen wir jeden ungeplanten Kauf, den der Insider auf dem offenen Markt getätigt hat, mit Ausnahme aller Geschäfte, die als Teil eines 10b5-1-Handelsplans gekennzeichnet waren. Anschließend berechnen wir die durchschnittliche Performance dieser Geschäfte über 3, 6 und 12 Monate, wobei wir für jeden dieser Zeiträume den Durchschnitt bilden, um eine endgültige Performance-Kennzahl für jedes Geschäft zu erhalten. Schließlich berechnen wir den Durchschnitt aller Performance-Metriken, um eine Performance-Metrik für den Insider zu ermitteln. Diese Liste enthält nur Insider, die in den letzten zwei Jahren mindestens drei Geschäfte getätigt haben.
Wenn die Handelsrentabilität dieses Insiders "N/A" ist, hat er entweder in den letzten drei Jahren keine Käufe auf dem freien Markt getätigt, oder die von ihm getätigten Geschäfte sind zu kurz her, um eine zuverlässige Performance-Kennzahl zu berechnen.
Aktualisierungshäufigkeit: Täglich
Unternehmen mit gemeldeten Insiderpositionen
Aus den SEC-Filings geht hervor, dass Baker Brothers Life Sciences LP Beteiligungen an den folgenden Unternehmen gemeldet oder mit ihnen gehandelt hat:
So interpretieren Sie die Diagramme
Die folgenden Diagramme zeigen die Wertentwicklung von Wertpapieren nach jedem offenen, nicht geplanten Handel von Baker Brothers Life Sciences LP. Nicht geplante Geschäfte sind Geschäfte, die nicht im Rahmen eines 10b5-1-Handelsplans getätigt wurden. Die Aktienperformance wird als kumulative prozentuale Veränderung des Aktienkurses dargestellt. Wenn beispielsweise am 1. Januar 2019 ein Insiderhandel getätigt wurde, zeigt das Diagramm die tägliche prozentuale Veränderung des Wertpapiers bis zum heutigen Tag. Wenn der Aktienkurs in dieser Zeit von $10 auf $15 gestiegen ist, beträgt die kumulative prozentuale Veränderung des Aktienkurses 50 %. Eine Kursveränderung von $10 auf $20 würde 100% betragen und eine Kursveränderung von $10 auf $5 wäre -50%.
Letztendlich versuchen wir festzustellen, wie eng die Geschäfte des Insiders mit den (positiven oder negativen) Überschussrenditen des Aktienkurses korrelieren, um zu sehen, ob der Insider seine Geschäfte zeitlich so abstimmt, dass er von Insiderinformationen profitiert. Stellen Sie sich die Situation vor, dass ein Insider dies tun würde. In dieser Situation würden wir entweder (a) positive Renditen nach Käufen oder (b) negative Renditen nach Verkäufen erwarten. Im Falle von (a) würde das KAUF-Diagramm eine Reihe von aufwärts gerichteten Kurven zeigen, die auf positive Renditen nach jeder Kauftransaktion hinweisen. Im Falle von (b) würde das VERKAUFS-Diagramm eine Reihe von abwärts gerichteten Kurven zeigen, die auf negative Renditen nach jeder Verkaufstransaktion hinweisen.
Dies allein reicht jedoch nicht aus, um Schlussfolgerungen zu ziehen. Wenn sich der Aktienkurs des Unternehmens beispielsweise über viele Jahre hinweg in einem nicht-zyklischen Aufwärtstrend befand, dann würden wir erwarten, dass alle Nach-Kauf-Kurven aufwärts gerichtet sind. Ebenso würden nicht-zyklische Rückgänge über viele Jahre hinweg zu abwärts geneigten Nachhandelsdiagrammen führen. Keines dieser Diagramme würde auf Insiderhandel hindeuten.
Der stärkste Indikator wäre eine Situation, in der der Aktienkurs extrem zyklisch war und es sowohl positive Signale im KAUF-Chart als auch negative im VERKAUF-Chart gab. Diese Situation würde stark auf einen Insider hindeuten, der das Timing von Geschäften zu seinem finanziellen Vorteil nutzt.
Insiderkäufe ACAD / ACADIA Pharmaceuticals Inc. - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderverkäufe ACAD / ACADIA Pharmaceuticals Inc. - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
| Handelsdatum | Ticker | Insider | Berichtete Aktien |
Berichteter Preis |
Angepasste Aktien |
Angepasster Preis |
Kostenbasis | Tage bis Min |
Preis bei Min |
Max Verlust Vermieden ($) |
Max. Verlust Vermieden (%) |
|---|---|---|---|---|---|---|---|
| Für diese Insider- und Wertpapierkombination sind keine ungeplanten Open-Market-Trades bekannt |
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderkäufe BCRX / BioCryst Pharmaceuticals, Inc. - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderverkäufe BCRX / BioCryst Pharmaceuticals, Inc. - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
| Handelsdatum | Ticker | Insider | Berichtete Aktien |
Berichteter Preis |
Angepasste Aktien |
Angepasster Preis |
Kostenbasis | Tage bis Min |
Preis bei Min |
Max Verlust Vermieden ($) |
Max. Verlust Vermieden (%) |
|---|---|---|---|---|---|---|---|
| Für diese Insider- und Wertpapierkombination sind keine ungeplanten Open-Market-Trades bekannt |
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderkäufe BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderverkäufe BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
| Handelsdatum | Ticker | Insider | Berichtete Aktien |
Berichteter Preis |
Angepasste Aktien |
Angepasster Preis |
Kostenbasis | Tage bis Min |
Preis bei Min |
Max Verlust Vermieden ($) |
Max. Verlust Vermieden (%) |
|---|---|---|---|---|---|---|---|
| Für diese Insider- und Wertpapierkombination sind keine ungeplanten Open-Market-Trades bekannt |
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderkäufe IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderverkäufe IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
| Handelsdatum | Ticker | Insider | Berichtete Aktien |
Berichteter Preis |
Angepasste Aktien |
Angepasster Preis |
Kostenbasis | Tage bis Min |
Preis bei Min |
Max Verlust Vermieden ($) |
Max. Verlust Vermieden (%) |
|---|---|---|---|---|---|---|---|
| Für diese Insider- und Wertpapierkombination sind keine ungeplanten Open-Market-Trades bekannt |
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderkäufe KNSA / Kiniksa Pharmaceuticals International, plc - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderverkäufe KNSA / Kiniksa Pharmaceuticals International, plc - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
| Handelsdatum | Ticker | Insider | Berichtete Aktien |
Berichteter Preis |
Angepasste Aktien |
Angepasster Preis |
Kostenbasis | Tage bis Min |
Preis bei Min |
Max Verlust Vermieden ($) |
Max. Verlust Vermieden (%) |
|---|---|---|---|---|---|---|---|
| Für diese Insider- und Wertpapierkombination sind keine ungeplanten Open-Market-Trades bekannt |
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderkäufe KOD / Kodiak Sciences Inc. - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderverkäufe KOD / Kodiak Sciences Inc. - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
| Handelsdatum | Ticker | Insider | Berichtete Aktien |
Berichteter Preis |
Angepasste Aktien |
Angepasster Preis |
Kostenbasis | Tage bis Min |
Preis bei Min |
Max Verlust Vermieden ($) |
Max. Verlust Vermieden (%) |
|---|---|---|---|---|---|---|---|
| Für diese Insider- und Wertpapierkombination sind keine ungeplanten Open-Market-Trades bekannt |
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderkäufe KYMR / Kymera Therapeutics, Inc. - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderverkäufe KYMR / Kymera Therapeutics, Inc. - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
| Handelsdatum | Ticker | Insider | Berichtete Aktien |
Berichteter Preis |
Angepasste Aktien |
Angepasster Preis |
Kostenbasis | Tage bis Min |
Preis bei Min |
Max Verlust Vermieden ($) |
Max. Verlust Vermieden (%) |
|---|---|---|---|---|---|---|---|
| Für diese Insider- und Wertpapierkombination sind keine ungeplanten Open-Market-Trades bekannt |
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderkäufe MDGL / Madrigal Pharmaceuticals, Inc. - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderverkäufe MDGL / Madrigal Pharmaceuticals, Inc. - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
| Handelsdatum | Ticker | Insider | Berichtete Aktien |
Berichteter Preis |
Angepasste Aktien |
Angepasster Preis |
Kostenbasis | Tage bis Min |
Preis bei Min |
Max Verlust Vermieden ($) |
Max. Verlust Vermieden (%) |
|---|---|---|---|---|---|---|---|
| Für diese Insider- und Wertpapierkombination sind keine ungeplanten Open-Market-Trades bekannt |
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderkäufe PRLD / Prelude Therapeutics Incorporated - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderverkäufe PRLD / Prelude Therapeutics Incorporated - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
| Handelsdatum | Ticker | Insider | Berichtete Aktien |
Berichteter Preis |
Angepasste Aktien |
Angepasster Preis |
Kostenbasis | Tage bis Min |
Preis bei Min |
Max Verlust Vermieden ($) |
Max. Verlust Vermieden (%) |
|---|---|---|---|---|---|---|---|
| Für diese Insider- und Wertpapierkombination sind keine ungeplanten Open-Market-Trades bekannt |
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderkäufe REPL / Replimune Group, Inc. - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
| Handelsdatum | Ticker | Insider | Berichtete Aktien |
Berichteter Preis |
Angepasste Aktien |
Angepasster Preis |
Kostenbasis | Tage bis Max |
Preis bei Max |
Max Gewinn ($) |
Max Rendite (%) |
|---|---|---|---|---|---|---|---|
| Für diese Insider- und Wertpapierkombination sind keine ungeplanten Open-Market-Trades bekannt |
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderverkäufe REPL / Replimune Group, Inc. - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
| Handelsdatum | Ticker | Insider | Berichtete Aktien |
Berichteter Preis |
Angepasste Aktien |
Angepasster Preis |
Kostenbasis | Tage bis Min |
Preis bei Min |
Max Verlust Vermieden ($) |
Max. Verlust Vermieden (%) |
|---|---|---|---|---|---|---|---|
| Für diese Insider- und Wertpapierkombination sind keine ungeplanten Open-Market-Trades bekannt |
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderkäufe SYRE / Spyre Therapeutics, Inc. - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
| Handelsdatum | Ticker | Insider | Berichtete Aktien |
Berichteter Preis |
Angepasste Aktien |
Angepasster Preis |
Kostenbasis | Tage bis Max |
Preis bei Max |
Max Gewinn ($) |
Max Rendite (%) |
|---|---|---|---|---|---|---|---|
| Für diese Insider- und Wertpapierkombination sind keine ungeplanten Open-Market-Trades bekannt |
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderverkäufe SYRE / Spyre Therapeutics, Inc. - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
| Handelsdatum | Ticker | Insider | Berichtete Aktien |
Berichteter Preis |
Angepasste Aktien |
Angepasster Preis |
Kostenbasis | Tage bis Min |
Preis bei Min |
Max Verlust Vermieden ($) |
Max. Verlust Vermieden (%) |
|---|---|---|---|---|---|---|---|
| Für diese Insider- und Wertpapierkombination sind keine ungeplanten Open-Market-Trades bekannt |
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderkäufe TCRX / TScan Therapeutics, Inc. - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderverkäufe TCRX / TScan Therapeutics, Inc. - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
| Handelsdatum | Ticker | Insider | Berichtete Aktien |
Berichteter Preis |
Angepasste Aktien |
Angepasster Preis |
Kostenbasis | Tage bis Min |
Preis bei Min |
Max Verlust Vermieden ($) |
Max. Verlust Vermieden (%) |
|---|---|---|---|---|---|---|---|
| Für diese Insider- und Wertpapierkombination sind keine ungeplanten Open-Market-Trades bekannt |
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderkäufe VTVT / vTv Therapeutics Inc. - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
| Handelsdatum | Ticker | Insider | Berichtete Aktien |
Berichteter Preis |
Angepasste Aktien |
Angepasster Preis |
Kostenbasis | Tage bis Max |
Preis bei Max |
Max Gewinn ($) |
Max Rendite (%) |
|---|---|---|---|---|---|---|---|
| Für diese Insider- und Wertpapierkombination sind keine ungeplanten Open-Market-Trades bekannt |
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderverkäufe VTVT / vTv Therapeutics Inc. - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
| Handelsdatum | Ticker | Insider | Berichtete Aktien |
Berichteter Preis |
Angepasste Aktien |
Angepasster Preis |
Kostenbasis | Tage bis Min |
Preis bei Min |
Max Verlust Vermieden ($) |
Max. Verlust Vermieden (%) |
|---|---|---|---|---|---|---|---|
| Für diese Insider- und Wertpapierkombination sind keine ungeplanten Open-Market-Trades bekannt |
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderkäufe XOMAO / XOMA Royalty Corporation - Preferred Stock - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderverkäufe XOMAO / XOMA Royalty Corporation - Preferred Stock - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderkäufe ZYME / Zymeworks Inc. - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
| Handelsdatum | Ticker | Insider | Berichtete Aktien |
Berichteter Preis |
Angepasste Aktien |
Angepasster Preis |
Kostenbasis | Tage bis Max |
Preis bei Max |
Max Gewinn ($) |
Max Rendite (%) |
|---|---|---|---|---|---|---|---|
| Für diese Insider- und Wertpapierkombination sind keine ungeplanten Open-Market-Trades bekannt |
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderverkäufe ZYME / Zymeworks Inc. - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in ACAD / ACADIA Pharmaceuticals Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
| Handelsdatum | Ticker | Insider | Berichtete Aktien |
Berichteter Preis |
Angepasste Aktien |
Angepasster Preis |
Kostenbasis | Tage bis Min |
Preis bei Min |
Max Verlust Vermieden ($) |
Max. Verlust Vermieden (%) |
|---|---|---|---|---|---|---|---|
| Für diese Insider- und Wertpapierkombination sind keine ungeplanten Open-Market-Trades bekannt |
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Geschichte des Insiderhandels
Diese Tabelle zeigt die vollständige Liste der von Baker Brothers Life Sciences LP getätigten Insidergeschäfte, die der Securities Exchange Commission (SEC) gemeldet wurden.
| Datum der Einreichung | Tran Datum | Form | Ticker | Wertpapier | Code | Aktien | Verbleibende Aktien | Prozent Änderung |
Aktie Preis |
Tran Wert |
Verbleibender Wert |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-02 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 6.078 | 2.744.894 | 0,22 | ||||
| 2026-06-02 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 6.078 | 143.277 | 4,43 | ||||
| 2026-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18.622 | 39.384.587 | 0,05 | ||||
| 2026-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18.622 | 3.677.357 | 0,51 | ||||
| 2026-05-27 |
|
4 | ONC |
BeOne Medicines Ltd.
Ordinary Shares |
S - Sale | -2.756 | 142.570 | -1,90 | 23,79 | -65.567 | 3.391.812 | |
| 2026-05-27 |
|
4 | ONC |
BeOne Medicines Ltd.
Ordinary Shares |
S - Sale | -2.756 | 142.566 | -1,90 | 23,79 | -65.567 | 3.391.716 | |
| 2026-05-27 |
|
4 | ONC |
BeOne Medicines Ltd.
Ordinary Shares |
S - Sale | -2.743 | 145.326 | -1,85 | 23,85 | -65.424 | 3.466.199 | |
| 2026-05-27 |
|
4 | ONC |
BeOne Medicines Ltd.
Ordinary Shares |
S - Sale | -2.743 | 145.322 | -1,85 | 23,85 | -65.424 | 3.466.104 | |
| 2026-05-11 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15.000 | 28.203.718 | 0,05 | 84,53 | 1.267.950 | 2.384.060.283 | |
| 2026-05-11 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15.000 | 2.833.039 | 0,53 | 84,53 | 1.267.950 | 239.476.787 | |
| 2026-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 421 | 28.188.718 | 0,00 | ||||
| 2026-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 421 | 2.818.039 | 0,01 | ||||
| 2026-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 19.000 | 10.018.674 | 0,19 | ||||
| 2026-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 19.000 | 10.018.674 | 0,19 | ||||
| 2026-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 328 | 28.188.297 | 0,00 | ||||
| 2026-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 328 | 28.188.297 | 0,00 | ||||
| 2025-12-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.391.268 | 18.358.772 | 14,98 | 23,00 | 54.999.164 | 422.251.756 | |
| 2025-12-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 217.428 | 1.560.414 | 16,19 | 23,00 | 5.000.844 | 35.889.522 | |
| 2025-12-11 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 1.838.621 | 7.955.916 | 30,06 | 86,00 | 158.121.406 | 684.208.776 | |
| 2025-12-11 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 167.192 | 701.326 | 31,30 | 86,00 | 14.378.512 | 60.314.036 | |
| 2025-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 388 | 28.187.969 | 0,00 | ||||
| 2025-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 388 | 2.817.290 | 0,01 | ||||
| 2025-09-05 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
A - Award | 46.692 | 135.946 | 52,31 | ||||
| 2025-09-05 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
A - Award | 4.308 | 12.368 | 53,45 | ||||
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10.128 | 1.859.091 | 0,55 | 372,16 | 3.769.209 | 691.874.287 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 933 | 194.625 | 0,48 | 372,16 | 347.223 | 72.431.115 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.494 | 1.848.963 | 0,30 | 371,00 | 2.038.301 | 685.974.518 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 506 | 193.692 | 0,26 | 371,00 | 187.729 | 71.860.700 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.747 | 1.843.469 | 0,15 | 369,34 | 1.014.563 | 680.857.623 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 253 | 193.186 | 0,13 | 369,34 | 93.442 | 71.350.351 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.419 | 1.840.722 | 0,08 | 368,84 | 523.384 | 678.931.902 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 131 | 192.933 | 0,07 | 368,84 | 48.318 | 71.161.408 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.798 | 1.839.303 | 0,26 | 367,77 | 1.764.565 | 676.442.304 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 442 | 192.802 | 0,23 | 367,77 | 162.555 | 70.906.984 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.289 | 1.834.505 | 0,12 | 366,30 | 838.459 | 671.977.714 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 211 | 192.360 | 0,11 | 366,30 | 77.289 | 70.461.314 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.772 | 1.832.216 | 0,15 | 363,75 | 1.008.308 | 666.463.806 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 255 | 192.149 | 0,13 | 363,75 | 92.756 | 69.893.699 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.587 | 1.829.444 | 0,31 | 362,39 | 2.024.662 | 662.968.735 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 515 | 191.894 | 0,27 | 362,39 | 186.630 | 69.540.102 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.443 | 1.823.857 | 0,30 | 361,37 | 1.966.957 | 659.093.770 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 502 | 191.379 | 0,26 | 361,37 | 181.410 | 69.159.318 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8.514 | 1.818.414 | 0,47 | 359,39 | 3.059.873 | 653.525.445 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 784 | 190.877 | 0,41 | 359,39 | 281.764 | 68.599.877 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.472 | 1.809.900 | 0,14 | 358,21 | 885.495 | 648.324.279 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 228 | 190.093 | 0,12 | 358,21 | 81.672 | 68.093.214 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8.328 | 1.807.428 | 0,46 | 357,02 | 2.973.289 | 645.293.728 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 767 | 189.865 | 0,41 | 357,02 | 273.837 | 67.786.210 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 916 | 1.799.100 | 0,05 | 355,00 | 325.180 | 638.680.500 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 84 | 189.098 | 0,04 | 355,00 | 29.820 | 67.129.790 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.923 | 1.798.184 | 0,11 | 353,88 | 680.503 | 636.333.262 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 177 | 189.014 | 0,09 | 353,88 | 62.636 | 66.887.424 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9.362 | 1.947.968 | 0,48 | 392,24 | 3.672.178 | 764.076.617 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 862 | 202.813 | 0,43 | 392,24 | 338.113 | 79.551.959 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.506 | 1.938.606 | 0,13 | 389,89 | 977.059 | 755.838.828 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 231 | 201.951 | 0,11 | 389,89 | 90.064 | 78.738.231 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 366 | 1.936.100 | 0,02 | 389,00 | 142.374 | 753.142.900 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 34 | 201.720 | 0,02 | 389,00 | 13.226 | 78.469.080 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.441 | 1.935.734 | 0,23 | 387,07 | 1.718.969 | 749.260.688 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 409 | 201.686 | 0,20 | 387,07 | 158.311 | 78.066.197 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13.545 | 1.931.293 | 0,71 | 385,06 | 5.215.601 | 743.658.468 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.248 | 201.277 | 0,62 | 385,06 | 480.552 | 77.503.178 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.049 | 1.917.748 | 0,21 | 383,79 | 1.553.954 | 736.007.135 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 373 | 200.029 | 0,19 | 383,79 | 143.153 | 76.768.570 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.838 | 1.913.699 | 0,15 | 382,82 | 1.086.447 | 732.604.739 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 262 | 199.656 | 0,13 | 382,82 | 100.299 | 76.432.569 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.136 | 1.910.861 | 0,06 | 382,29 | 434.280 | 730.501.332 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 105 | 199.394 | 0,05 | 382,29 | 40.140 | 76.226.153 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9.477 | 1.909.725 | 0,50 | 381,12 | 3.611.889 | 727.837.448 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 873 | 199.289 | 0,44 | 381,12 | 332.719 | 75.953.343 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.919 | 1.900.248 | 0,10 | 380,78 | 730.717 | 723.576.433 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 198.416 | 0,09 | 380,78 | 67.017 | 75.552.844 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.209 | 1.898.329 | 0,28 | 380,44 | 1.981.694 | 722.193.641 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 480 | 198.240 | 0,24 | 380,44 | 182.610 | 75.417.732 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7.325 | 1.893.120 | 0,39 | 374,43 | 2.742.728 | 708.848.115 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 675 | 197.760 | 0,34 | 374,43 | 252.743 | 74.048.028 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26.704 | 1.885.795 | 1,44 | 372,87 | 9.957.102 | 703.155.062 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.460 | 197.085 | 1,26 | 372,87 | 917.258 | 73.486.946 | |
| 2025-08-18 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
U - Other | -3.763.362 | 0 | -100,00 | ||||
| 2025-08-18 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
U - Other | -357.048 | 0 | -100,00 | ||||
| 2025-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 492 | 28.187.581 | 0,00 | ||||
| 2025-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 492 | 28.187.581 | 0,00 | ||||
| 2025-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3.763.362 | 0,03 | ||||
| 2025-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3.763.362 | 0,03 | ||||
| 2025-06-30 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 600.309 | 6.117.295 | 10,88 | 44,00 | 26.413.596 | 269.160.980 | |
| 2025-06-30 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 55.191 | 534.134 | 11,52 | 44,00 | 2.428.404 | 23.501.896 | |
| 2025-06-24 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1.430 | 1.796.261 | 0,08 | ||||
| 2025-06-24 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1.430 | 1.796.261 | 0,08 | ||||
| 2025-06-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.518 | 28.187.089 | 0,01 | ||||
| 2025-06-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.518 | 28.187.089 | 0,01 | ||||
| 2025-06-05 | 3 | DNLI |
Denali Therapeutics Inc.
Common Stock |
326.302 | ||||||||
| 2025-06-05 | 3 | DNLI |
Denali Therapeutics Inc.
Common Stock |
3.405.393 | ||||||||
| 2025-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 10.565 | 3.415.958 | 0,31 | ||||
| 2025-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 10.565 | 3.415.958 | 0,31 | ||||
| 2025-06-05 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 8.397 | 2.738.816 | 0,31 | ||||
| 2025-06-05 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 8.397 | 2.738.816 | 0,31 | ||||
| 2025-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 16.214 | 39.365.965 | 0,04 | ||||
| 2025-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 16.214 | 39.365.965 | 0,04 | ||||
| 2025-05-22 |
|
4 | ONC |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 21.970 | 148.069 | 17,42 | ||||
| 2025-05-22 |
|
4 | ONC |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 21.970 | 148.065 | 17,42 | ||||
| 2025-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 487 | 28.184.571 | 0,00 | ||||
| 2025-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 487 | 2.813.892 | 0,02 | ||||
| 2025-04-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3.762.409 | 0,03 | ||||
| 2025-04-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 356.095 | 0,27 | ||||
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 92.349 | 2.144.060 | 4,50 | 29,56 | 2.729.864 | 63.379.057 | |
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 8.589 | 178.596 | 5,05 | 29,56 | 253.893 | 5.279.351 | |
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 646.290 | 2.051.711 | 45,99 | 29,74 | 19.221.699 | 61.021.168 | |
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 60.110 | 170.007 | 54,70 | 29,74 | 1.787.768 | 5.056.280 | |
| 2025-03-07 | 3 | REPL |
Replimune Group, Inc.
Common Stock |
929.241 | ||||||||
| 2025-03-07 | 3 | REPL |
Replimune Group, Inc.
Common Stock |
10.116.095 | ||||||||
| 2025-02-28 |
|
4 | ONC |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -671.976 | 8.068.411 | -7,69 | 260,00 | -174.713.760 | 2.097.786.860 | |
| 2025-02-28 |
|
4 | ONC |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -60.851 | 730.642 | -7,69 | 260,00 | -15.821.260 | 189.966.920 | |
| 2025-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 4.400 | 9.999.674 | 0,04 | ||||
| 2025-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 4.400 | 918.483 | 0,48 | ||||
| 2025-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 446 | 28.184.084 | 0,00 | ||||
| 2025-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 446 | 28.184.084 | 0,00 | ||||
| 2025-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 3.761.456 | 0,05 | ||||
| 2025-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 355.142 | 0,56 | ||||
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 457.631 | 9.995.274 | 4,80 | 15,34 | 7.020.883 | 153.345.495 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 42.369 | 914.083 | 4,86 | 15,34 | 650.017 | 14.023.679 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 566.814 | 9.537.643 | 6,32 | 13,80 | 7.824.300 | 131.657.624 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 52.656 | 871.714 | 6,43 | 13,80 | 726.863 | 12.033.140 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 244.587 | 8.970.829 | 2,80 | 13,72 | 3.356.761 | 123.117.451 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 22.722 | 819.058 | 2,85 | 13,72 | 311.841 | 11.240.916 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 59.995 | 8.726.242 | 0,69 | 13,63 | 817.660 | 118.928.207 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 5.573 | 796.336 | 0,70 | 13,63 | 75.953 | 10.853.104 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 30.241 | 8.666.247 | 0,35 | 13,50 | 408.190 | 116.976.135 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 2.809 | 790.763 | 0,36 | 13,50 | 37.916 | 10.673.640 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -916.964 | 8.740.387 | -9,49 | 186,50 | -171.013.786 | 1.630.082.176 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -83.036 | 791.493 | -9,49 | 186,50 | -15.486.214 | 147.613.444 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -33.943 | 9.657.351 | -0,35 | 208,01 | -7.060.609 | 2.008.861.314 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -3.074 | 874.529 | -0,35 | 208,01 | -639.434 | 181.914.013 | |
| 2024-10-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 4.730 | 2.730.419 | 0,17 | ||||
| 2024-10-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 4.730 | 2.730.419 | 0,17 | ||||
| 2024-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 496 | 28.183.638 | 0,00 | ||||
| 2024-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 496 | 2.812.959 | 0,02 | ||||
| 2024-10-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 3.759.462 | 0,05 | ||||
| 2024-10-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 353.148 | 0,57 | ||||
| 2024-08-22 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 1 | 5.516.986 | 0,00 | 46,41 | 46 | 256.043.320 | |
| 2024-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 537 | 28.183.142 | 0,00 | ||||
| 2024-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 537 | 28.183.142 | 0,00 | ||||
| 2024-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 3.757.468 | 0,05 | ||||
| 2024-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 3.757.468 | 0,05 | ||||
| 2024-06-27 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1.428 | 1.794.831 | 0,08 | ||||
| 2024-06-27 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1.428 | 1.794.831 | 0,08 | ||||
| 2024-06-20 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
C - Conversion | 2.186.686 | 8.636.006 | 33,91 | ||||
| 2024-06-20 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
C - Conversion | 196.098 | 787.954 | 33,13 | ||||
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
D - Sale to Issuer | -5.283.206 | 28.182.605 | -15,79 | 60,00 | -316.992.360 | 1.690.956.300 | |
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
D - Sale to Issuer | -175.977 | 2.811.926 | -5,89 | 60,00 | -10.558.620 | 168.715.560 | |
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.830 | 33.465.811 | 0,01 | ||||
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.830 | 33.465.811 | 0,01 | ||||
| 2024-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 32.682 | 126.099 | 34,99 | ||||
| 2024-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 32.682 | 126.099 | 34,99 | ||||
| 2024-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 6.346 | 2.725.689 | 0,23 | ||||
| 2024-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 6.346 | 2.725.689 | 0,23 | ||||
| 2024-05-31 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18.774 | 39.349.751 | 0,05 | ||||
| 2024-05-31 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18.774 | 39.349.751 | 0,05 | ||||
| 2024-05-29 | 3 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
109.897 | ||||||||
| 2024-05-29 | 3 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
1.405.421 | ||||||||
| 2024-05-09 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15.000 | 33.462.981 | 0,04 | 49,01 | 735.150 | 1.640.020.699 | |
| 2024-05-09 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15.000 | 2.985.073 | 0,51 | 49,01 | 735.150 | 146.298.428 | |
| 2024-04-22 |
|
4 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
A - Award | 12.000 | 6.449.320 | 0,19 | ||||
| 2024-04-22 |
|
4 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
A - Award | 12.000 | 6.449.320 | 0,19 | ||||
| 2024-04-18 | 3 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
579.856 | ||||||||
| 2024-04-18 | 3 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
6.437.320 | ||||||||
| 2024-04-01 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 3.755.474 | 0,05 | ||||
| 2024-04-01 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 3.755.474 | 0,05 | ||||
| 2024-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 543 | 33.447.981 | 0,00 | ||||
| 2024-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 543 | 2.970.073 | 0,02 | ||||
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 89.407 | 3.753.480 | 2,44 | 9,62 | 860.042 | 36.106.226 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 8.066 | 347.166 | 2,38 | 9,62 | 77.590 | 3.339.529 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 8.439 | 3.664.073 | 0,23 | 9,27 | 78.207 | 33.956.064 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 761 | 339.100 | 0,22 | 9,27 | 7.052 | 3.142.541 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 17.101 | 3.655.634 | 0,47 | 9,22 | 157.683 | 33.707.504 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 1.543 | 338.339 | 0,46 | 9,22 | 14.228 | 3.119.722 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 247.656 | 3.638.533 | 7,30 | 8,26 | 2.046.159 | 30.061.923 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 22.344 | 336.796 | 7,11 | 8,26 | 184.608 | 2.782.642 | |
| 2024-03-07 | 3 | VTVT |
vTv Therapeutics Inc.
Common Stock |
12.836 | ||||||||
| 2024-03-07 | 3 | VTVT |
vTv Therapeutics Inc.
Common Stock |
142.135 | ||||||||
| 2024-03-07 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
D - Sale to Issuer | -52.881 | 89.254 | -37,20 | ||||
| 2024-03-07 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
D - Sale to Issuer | -4.776 | 8.060 | -37,21 | ||||
| 2024-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 556 | 33.447.438 | 0,00 | ||||
| 2024-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 556 | 33.447.438 | 0,00 | ||||
| 2024-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 3.390.877 | 0,02 | ||||
| 2024-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 3.390.877 | 0,02 | ||||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -42.977.301 | 0 | -100,00 | 229,00 | -9.841.801.929 | ||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -1.731.202 | 0 | -100,00 | 229,00 | -396.445.258 | ||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -23.277 | 0 | -100,00 | 229,00 | -5.330.433 | ||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -23.280 | 0 | -100,00 | 229,00 | -5.331.120 | ||
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 214.025 | 3.390.323 | 6,74 | 6,60 | 1.412.565 | 22.376.132 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 17.066 | 313.898 | 5,75 | 6,60 | 112.636 | 2.071.727 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 52.528 | 3.176.298 | 1,68 | 6,37 | 334.399 | 20.220.631 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 4.188 | 296.832 | 1,43 | 6,37 | 26.661 | 1.889.662 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 185 | 3.123.770 | 0,01 | 6,36 | 1.176 | 19.851.558 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 15 | 292.644 | 0,01 | 6,36 | 95 | 1.859.753 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 145.749 | 3.123.585 | 4,89 | 6,50 | 947.602 | 20.308.300 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 11.621 | 292.629 | 4,14 | 6,50 | 75.555 | 1.902.557 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 71.219 | 2.977.836 | 2,45 | 5,99 | 426.751 | 17.843.491 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 5.679 | 281.008 | 2,06 | 5,99 | 34.029 | 1.683.828 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 9.649 | 2.906.617 | 0,33 | 5,76 | 55.567 | 16.738.626 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 769 | 275.329 | 0,28 | 5,76 | 4.429 | 1.585.565 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3.857 | 1.699.129 | 0,23 | 221,24 | 853.330 | 375.918.358 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 308 | 178.461 | 0,17 | 221,24 | 68.142 | 39.483.033 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.408 | 1.695.272 | 0,26 | 220,65 | 972.645 | 374.069.565 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 352 | 178.153 | 0,20 | 220,65 | 77.670 | 39.310.279 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15.005 | 1.690.864 | 0,90 | 219,24 | 3.289.711 | 370.706.714 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.195 | 177.801 | 0,68 | 219,24 | 261.993 | 38.981.269 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.873 | 1.675.859 | 0,17 | 217,91 | 626.049 | 365.182.748 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 229 | 176.606 | 0,13 | 217,91 | 49.901 | 38.483.825 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 185 | 1.672.986 | 0,01 | 217,90 | 40.312 | 364.543.649 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15 | 176.377 | 0,01 | 217,90 | 3.268 | 38.432.548 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.769 | 1.672.801 | 0,11 | 216,67 | 383.286 | 362.442.949 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 141 | 176.362 | 0,08 | 216,67 | 30.550 | 38.212.055 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 668 | 1.671.032 | 0,04 | 214,72 | 143.434 | 358.807.834 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 53 | 176.221 | 0,03 | 214,72 | 11.380 | 37.838.578 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 515 | 1.670.364 | 0,03 | 213,80 | 110.107 | 357.122.821 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 41 | 176.168 | 0,02 | 213,80 | 8.766 | 37.664.613 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 185 | 1.669.849 | 0,01 | 213,62 | 39.521 | 356.721.493 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15 | 176.127 | 0,01 | 213,62 | 3.204 | 37.625.130 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 648 | 1.669.664 | 0,04 | 212,04 | 137.403 | 354.037.892 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 52 | 176.112 | 0,03 | 212,04 | 11.026 | 37.343.035 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 1.669.016 | 0,01 | 209,76 | 19.508 | 350.101.141 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7 | 176.060 | 0,00 | 209,76 | 1.468 | 36.931.226 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 370 | 1.668.923 | 0,02 | 208,69 | 77.216 | 348.289.710 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 30 | 176.053 | 0,02 | 208,69 | 6.261 | 36.740.729 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 648 | 1.668.553 | 0,04 | 206,93 | 134.092 | 345.277.176 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 52 | 176.023 | 0,03 | 206,93 | 10.760 | 36.424.809 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 708 | 1.667.905 | 0,04 | 205,60 | 145.565 | 342.921.268 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 56 | 175.971 | 0,03 | 205,60 | 11.514 | 36.179.638 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 1.667.197 | 0,01 | 205,32 | 19.095 | 342.308.888 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7 | 175.915 | 0,00 | 205,32 | 1.437 | 36.118.868 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3.960 | 1.793.403 | 0,22 | 229,86 | 910.264 | 412.240.043 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 316 | 185.979 | 0,17 | 229,86 | 72.637 | 42.750.007 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.204 | 1.789.443 | 0,12 | 228,79 | 504.252 | 409.405.411 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 185.663 | 0,09 | 228,79 | 40.267 | 42.477.708 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 11.602 | 1.787.239 | 0,65 | 227,86 | 2.643.597 | 407.234.917 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 925 | 185.487 | 0,50 | 227,86 | 210.768 | 42.264.511 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.343 | 1.775.637 | 0,08 | 226,97 | 304.822 | 403.018.106 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 107 | 184.562 | 0,06 | 226,97 | 24.286 | 41.890.222 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.594 | 1.774.294 | 0,32 | 224,91 | 1.258.156 | 399.059.480 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 446 | 184.455 | 0,24 | 224,91 | 100.311 | 41.486.088 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 363 | 1.768.700 | 0,02 | 223,94 | 81.289 | 396.078.079 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 29 | 184.009 | 0,02 | 223,94 | 6.494 | 41.206.497 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9.262 | 1.768.337 | 0,53 | 222,68 | 2.062.425 | 393.766.210 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 738 | 183.980 | 0,40 | 222,68 | 164.335 | 40.967.930 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.532 | 1.759.075 | 0,26 | 221,78 | 1.005.101 | 390.125.367 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 361 | 183.242 | 0,20 | 221,78 | 80.062 | 40.639.173 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.518 | 1.754.543 | 0,26 | 219,87 | 993.351 | 385.762.948 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 360 | 182.881 | 0,20 | 219,87 | 79.151 | 40.209.168 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 29.738 | 1.750.025 | 1,73 | 218,46 | 6.496.513 | 382.307.486 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.373 | 182.521 | 1,32 | 218,46 | 518.402 | 39.873.227 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10.894 | 1.720.287 | 0,64 | 217,52 | 2.369.611 | 374.188.571 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 869 | 180.148 | 0,48 | 217,52 | 189.021 | 39.184.928 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10.264 | 1.709.393 | 0,60 | 216,70 | 2.224.203 | 370.424.437 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 818 | 179.279 | 0,46 | 216,70 | 177.260 | 38.849.652 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7.917 | 1.667.104 | 0,48 | 190,14 | 1.505.308 | 316.976.653 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 655 | 175.908 | 0,37 | 190,14 | 124.539 | 33.446.461 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15.620 | 1.659.187 | 0,95 | 188,70 | 2.947.539 | 313.093.399 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.291 | 175.253 | 0,74 | 188,70 | 243.615 | 33.070.749 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13.505 | 1.643.567 | 0,83 | 188,46 | 2.545.218 | 309.754.690 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.117 | 173.962 | 0,65 | 188,46 | 210.515 | 32.785.731 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13.011 | 1.630.062 | 0,80 | 188,32 | 2.450.273 | 306.978.492 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.076 | 172.845 | 0,63 | 188,32 | 202.636 | 32.550.724 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.712 | 1.617.051 | 0,29 | 187,27 | 882.420 | 302.826.273 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 388 | 171.769 | 0,23 | 187,27 | 72.661 | 32.167.301 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.124 | 1.612.339 | 0,13 | 187,24 | 397.706 | 301.900.642 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 171.381 | 0,10 | 187,24 | 32.955 | 32.090.047 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.385 | 1.610.215 | 0,09 | 186,59 | 258.431 | 300.454.847 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 115 | 171.205 | 0,07 | 186,59 | 21.458 | 31.945.655 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 647 | 1.608.830 | 0,04 | 186,32 | 120.547 | 299.752.540 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 53 | 171.090 | 0,03 | 186,32 | 9.875 | 31.876.993 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 369 | 1.608.183 | 0,02 | 183,16 | 67.586 | 294.554.798 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 31 | 171.037 | 0,02 | 183,16 | 5.678 | 31.327.137 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 146 | 1.607.814 | 0,01 | 185,94 | 27.148 | 298.963.688 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12 | 171.006 | 0,01 | 185,94 | 2.231 | 31.797.574 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3.022 | 1.607.668 | 0,19 | 189,70 | 573.267 | 304.971.083 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 250 | 170.994 | 0,15 | 189,70 | 47.424 | 32.437.186 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.147 | 1.604.646 | 0,07 | 188,84 | 216.595 | 303.014.772 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 95 | 170.744 | 0,06 | 188,84 | 17.939 | 32.242.597 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.895 | 1.603.499 | 0,31 | 187,34 | 917.054 | 300.407.520 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 405 | 170.649 | 0,24 | 187,34 | 75.875 | 31.970.237 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.206 | 1.598.604 | 0,08 | 185,86 | 224.153 | 297.124.532 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 100 | 170.244 | 0,06 | 185,86 | 18.586 | 31.642.401 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7.010 | 1.597.398 | 0,44 | 183,40 | 1.285.633 | 292.962.633 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 579 | 170.144 | 0,34 | 183,40 | 106.189 | 31.204.393 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.847 | 1.590.388 | 0,12 | 181,93 | 336.025 | 289.339.289 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 153 | 169.565 | 0,09 | 181,93 | 27.835 | 30.848.960 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10.715 | 1.588.541 | 0,68 | 175,82 | 1.883.889 | 279.293.943 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 903 | 169.412 | 0,54 | 175,82 | 158.764 | 29.785.662 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.923 | 1.577.826 | 0,31 | 175,72 | 865.062 | 277.253.218 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 415 | 168.509 | 0,25 | 175,72 | 72.923 | 29.610.149 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 18.125 | 1.572.903 | 1,17 | 174,87 | 3.169.606 | 275.061.098 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.528 | 168.094 | 0,92 | 174,87 | 267.209 | 29.395.405 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 978 | 1.554.778 | 0,06 | 174,67 | 170.827 | 271.572.762 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 82 | 166.566 | 0,05 | 174,67 | 14.323 | 29.094.050 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.660 | 1.553.800 | 0,11 | 173,75 | 288.422 | 269.969.798 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 140 | 166.484 | 0,08 | 173,75 | 24.325 | 28.926.279 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.151 | 1.552.140 | 0,27 | 173,20 | 718.960 | 268.833.131 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 350 | 166.344 | 0,21 | 173,20 | 60.621 | 28.811.047 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 461 | 1.547.989 | 0,03 | 171,79 | 79.195 | 265.929.030 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 39 | 165.994 | 0,02 | 171,79 | 6.700 | 28.516.109 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.107 | 1.547.528 | 0,07 | 168,78 | 186.842 | 261.195.645 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 165.955 | 0,06 | 168,78 | 15.697 | 28.010.300 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 646 | 1.546.421 | 0,04 | 167,63 | 108.289 | 259.226.552 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 54 | 165.862 | 0,03 | 167,63 | 9.052 | 27.803.447 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13.548 | 1.500.227 | 0,91 | 154,78 | 2.096.961 | 232.205.285 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.142 | 161.969 | 0,71 | 154,78 | 176.759 | 25.069.578 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8.098 | 1.486.679 | 0,55 | 153,97 | 1.246.878 | 228.909.318 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 683 | 160.827 | 0,43 | 153,97 | 105.164 | 24.763.112 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.877 | 1.478.581 | 0,19 | 153,25 | 440.907 | 226.595.939 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 242 | 160.144 | 0,15 | 153,25 | 37.087 | 24.542.436 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 646 | 1.475.704 | 0,04 | 152,21 | 98.330 | 224.621.185 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 54 | 159.902 | 0,03 | 152,21 | 8.219 | 24.339.147 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 6.022 | 1.475.058 | 0,41 | 152,48 | 918.235 | 224.916.844 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 507 | 159.848 | 0,32 | 152,48 | 77.307 | 24.373.623 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3.542 | 1.469.036 | 0,24 | 154,60 | 547.582 | 227.108.412 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 299 | 159.341 | 0,19 | 154,60 | 46.224 | 24.633.625 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26.426 | 1.465.494 | 1,84 | 146,21 | 3.863.756 | 214.270.464 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.228 | 159.042 | 1,42 | 146,21 | 325.757 | 23.253.594 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.994 | 1.439.068 | 0,21 | 145,98 | 437.057 | 210.071.549 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 252 | 156.814 | 0,16 | 145,98 | 36.786 | 22.891.316 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 6.369 | 1.436.074 | 0,45 | 145,46 | 926.430 | 208.890.175 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 537 | 156.562 | 0,34 | 145,46 | 78.112 | 22.773.383 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.291 | 1.429.705 | 0,09 | 142,86 | 184.429 | 204.244.082 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 109 | 156.025 | 0,07 | 142,86 | 15.571 | 22.289.341 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10.790 | 1.428.414 | 0,76 | 141,44 | 1.526.192 | 202.042.018 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 910 | 155.916 | 0,59 | 141,44 | 128.715 | 22.053.539 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.072 | 1.417.624 | 0,36 | 140,90 | 714.657 | 199.746.624 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 427 | 155.006 | 0,28 | 140,90 | 60.165 | 21.840.717 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.631 | 1.412.552 | 0,33 | 137,69 | 637.622 | 194.487.928 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 390 | 154.579 | 0,25 | 137,69 | 53.697 | 21.283.287 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3.693 | 1.407.921 | 0,26 | 136,91 | 505.605 | 192.756.915 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 311 | 154.189 | 0,20 | 136,91 | 42.579 | 21.109.846 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3.144 | 1.404.228 | 0,22 | 136,18 | 428.151 | 191.228.471 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 265 | 153.878 | 0,17 | 136,18 | 36.088 | 20.955.183 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 14.018 | 1.545.775 | 0,92 | 161,97 | 2.270.439 | 250.362.994 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.181 | 165.808 | 0,72 | 161,97 | 191.282 | 26.855.259 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 31.530 | 1.531.757 | 2,10 | 156,42 | 4.932.061 | 239.604.170 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.658 | 164.627 | 1,64 | 156,42 | 415.776 | 25.751.680 | |
| 2023-11-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -1.008.660 | 9.691.294 | -9,43 | 180,50 | -182.063.130 | 1.749.278.567 | |
| 2023-11-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -91.340 | 877.603 | -9,43 | 180,50 | -16.486.870 | 158.407.342 | |
| 2023-10-10 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
X - Other | 535.601 | 1.658.190 | 47,71 | ||||
| 2023-10-10 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
X - Other | 57.049 | 155.874 | 57,73 | ||||
| 2023-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 510 | 33.446.882 | 0,00 | ||||
| 2023-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 510 | 2.968.974 | 0,02 | ||||
| 2023-10-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2.896.968 | 0,02 | ||||
| 2023-10-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 274.560 | 0,20 | ||||
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 61.134 | 5.612.949 | 1,10 | 0,69 | 42.354 | 3.888.651 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 5.041 | 494.133 | 1,03 | 0,69 | 3.492 | 342.335 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 93.091 | 5.551.815 | 1,71 | 0,69 | 64.456 | 3.844.077 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 7.676 | 489.092 | 1,59 | 0,69 | 5.315 | 338.647 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 4.434 | 5.458.724 | 0,08 | 0,68 | 3.028 | 3.727.217 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 366 | 481.416 | 0,08 | 0,68 | 250 | 328.711 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 207.676 | 5.454.290 | 3,96 | 0,68 | 141.324 | 3.711.644 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 17.124 | 481.050 | 3,69 | 0,68 | 11.653 | 327.355 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 4.342 | 5.246.614 | 0,08 | 0,66 | 2.887 | 3.488.998 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 358 | 463.926 | 0,08 | 0,66 | 238 | 308.511 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 1.740.581 | 5.242.272 | 49,71 | 0,63 | 1.097.958 | 3.306.825 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 143.519 | 463.568 | 44,84 | 0,63 | 90.532 | 292.419 | |
| 2023-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 512 | 33.446.372 | 0,00 | ||||
| 2023-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 512 | 33.446.372 | 0,00 | ||||
| 2023-07-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2.896.414 | 0,02 | ||||
| 2023-07-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2.896.414 | 0,02 | ||||
| 2023-06-20 | 3 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
148.821 | ||||||||
| 2023-06-20 | 3 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
1.396.292 | ||||||||
| 2023-06-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4.792 | 1.401.084 | 0,34 | ||||
| 2023-06-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4.792 | 1.401.084 | 0,34 | ||||
| 2023-06-20 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 25.844 | 93.417 | 38,25 | ||||
| 2023-06-20 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 25.844 | 93.417 | 38,25 | ||||
| 2023-06-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.505 | 33.445.860 | 0,01 | ||||
| 2023-06-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.505 | 33.445.860 | 0,01 | ||||
| 2023-06-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 8.746 | 2.719.343 | 0,32 | ||||
| 2023-06-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 8.746 | 2.719.343 | 0,32 | ||||
| 2023-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 13.304 | 39.330.977 | 0,03 | ||||
| 2023-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 13.304 | 39.330.977 | 0,03 | ||||
| 2023-06-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 2.044 | 42.977.301 | 0,00 | ||||
| 2023-06-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 2.044 | 42.977.301 | 0,00 | ||||
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 259.109 | 39.317.673 | 0,66 | 25,65 | 6.646.146 | 1.008.498.312 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24.113 | 3.610.443 | 0,67 | 25,65 | 618.498 | 92.607.863 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28.878 | 39.058.564 | 0,07 | 25,51 | 736.788 | 996.532.390 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2.688 | 3.586.330 | 0,08 | 25,51 | 68.581 | 91.500.906 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 218.171 | 39.029.686 | 0,56 | 25,27 | 5.513.683 | 986.369.933 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 20.304 | 3.583.642 | 0,57 | 25,27 | 513.129 | 90.566.876 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 74.582 | 38.811.515 | 0,19 | 25,54 | 1.904.824 | 991.246.093 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 6.941 | 3.563.338 | 0,20 | 25,54 | 177.273 | 91.007.653 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 116.672 | 38.736.933 | 0,30 | 25,33 | 2.955.325 | 981.214.260 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 10.858 | 3.556.397 | 0,31 | 25,33 | 275.035 | 90.084.247 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12.500 | 38.620.261 | 0,03 | 17,01 | 212.625 | 656.930.640 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12.500 | 38.620.261 | 0,03 | 17,01 | 212.625 | 656.930.640 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 40.632 | 38.607.761 | 0,11 | 24,80 | 1.007.674 | 957.472.473 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.781 | 3.533.039 | 0,11 | 24,80 | 93.769 | 87.619.367 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 82.148 | 38.567.129 | 0,21 | 24,46 | 2.009.373 | 943.367.402 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7.645 | 3.529.258 | 0,22 | 24,46 | 187.000 | 86.327.062 | |
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -209.175 | 23.277 | -89,99 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -209.175 | 23.277 | -89,99 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | 209.175 | 232.452 | 898,63 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | 209.175 | 232.452 | 898,63 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | -2.368.357 | 1.729.158 | -57,80 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 8.750 | 42.975.257 | 0,02 | 36,70 | 321.125 | 1.577.191.932 | |
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 8.750 | 42.975.257 | 0,02 | 36,70 | 321.125 | 1.577.191.932 | |
| 2023-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 429 | 33.443.355 | 0,00 | ||||
| 2023-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 429 | 33.443.355 | 0,00 | ||||
| 2023-04-04 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2.895.860 | 0,02 | ||||
| 2023-04-04 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2.895.860 | 0,02 | ||||
| 2023-03-15 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 33.442.926 | 0,06 | 22,74 | 454.800 | 760.492.137 | |
| 2023-03-15 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 33.442.926 | 0,06 | 22,74 | 454.800 | 760.492.137 | |
| 2023-01-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15.000 | 38.484.981 | 0,04 | 5,22 | 78.300 | 200.891.601 | |
| 2023-01-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15.000 | 38.484.981 | 0,04 | 5,22 | 78.300 | 200.891.601 | |
| 2023-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 397 | 33.422.926 | 0,00 | ||||
| 2023-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 397 | 33.422.926 | 0,00 | ||||
| 2022-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 457 | 33.422.529 | 0,00 | ||||
| 2022-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 457 | 33.422.529 | 0,00 | ||||
| 2022-07-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 433 | 33.422.072 | 0,00 | ||||
| 2022-07-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 433 | 33.422.072 | 0,00 | ||||
| 2022-06-30 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 10.000 | 2.710.597 | 0,37 | ||||
| 2022-06-30 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 10.000 | 2.710.597 | 0,37 | ||||
| 2022-06-24 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 33.384 | 67.573 | 97,65 | ||||
| 2022-06-24 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 33.384 | 67.569 | 97,66 | ||||
| 2022-06-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.144 | 33.421.639 | 0,01 | ||||
| 2022-06-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.144 | 33.421.639 | 0,01 | ||||
| 2022-06-13 |
|
4 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
A - Award | 10.622.568 | 14.575.984 | 268,69 | ||||
| 2022-06-13 |
|
4 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
A - Award | 1.252.432 | 1.585.054 | 376,53 | ||||
| 2022-06-09 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 17.104 | 38.469.981 | 0,04 | ||||
| 2022-06-09 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 17.104 | 38.469.981 | 0,04 | ||||
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 170.549 | 15.967.504 | 1,08 | 7,78 | 1.327.008 | 124.239.955 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 20.108 | 1.342.986 | 1,52 | 7,78 | 156.456 | 10.449.505 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 101.315 | 15.796.955 | 0,65 | 7,75 | 785.070 | 122.407.445 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11.945 | 1.322.878 | 0,91 | 7,75 | 92.559 | 10.250.717 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 78.271 | 15.695.640 | 0,50 | 7,95 | 622.466 | 124.822.716 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9.224 | 1.310.933 | 0,71 | 7,95 | 73.356 | 10.425.457 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13.155 | 15.617.369 | 0,08 | 7,93 | 104.363 | 123.897.273 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.550 | 1.301.709 | 0,12 | 7,93 | 12.297 | 10.326.848 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 138.122 | 15.604.214 | 0,89 | 7,68 | 1.060.680 | 119.829.441 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 16.278 | 1.300.159 | 1,27 | 7,68 | 125.004 | 9.984.311 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.585 | 15.466.092 | 0,07 | 7,51 | 79.540 | 116.218.402 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.247 | 1.283.881 | 0,10 | 7,51 | 9.370 | 9.647.595 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 88.046 | 15.455.507 | 0,57 | 6,92 | 609.278 | 106.952.108 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.386 | 1.282.634 | 0,82 | 6,92 | 71.871 | 8.875.827 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 51.082 | 15.367.461 | 0,33 | 6,78 | 346.367 | 104.200.606 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.026 | 1.272.248 | 0,48 | 6,78 | 40.860 | 8.626.605 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 358 | 15.316.379 | 0,00 | 6,64 | 2.375 | 101.624.175 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42 | 1.266.222 | 0,00 | 6,64 | 279 | 8.401.383 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 984 | 15.316.021 | 0,01 | 6,76 | 6.647 | 103.459.722 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116 | 1.266.180 | 0,01 | 6,76 | 784 | 8.553.046 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 53.401 | 15.315.037 | 0,35 | 6,75 | 360.521 | 103.394.878 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.299 | 1.266.064 | 0,50 | 6,75 | 42.526 | 8.547.451 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29.090 | 15.261.636 | 0,19 | 6,71 | 195.089 | 102.350.636 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.432 | 1.259.765 | 0,27 | 6,71 | 23.016 | 8.448.488 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42.250 | 15.232.546 | 0,28 | 6,60 | 279.002 | 100.589.641 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.984 | 1.256.333 | 0,40 | 6,60 | 32.912 | 8.296.321 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 48.222 | 15.190.296 | 0,32 | 6,53 | 315.058 | 99.245.799 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.688 | 1.251.349 | 0,46 | 6,53 | 37.163 | 8.175.689 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7.489 | 15.142.074 | 0,05 | 5,97 | 44.701 | 90.381.525 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 912 | 1.245.661 | 0,07 | 5,97 | 5.444 | 7.435.226 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 182.827 | 15.134.585 | 1,22 | 5,97 | 1.091.221 | 90.332.284 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22.266 | 1.244.749 | 1,82 | 5,97 | 132.897 | 7.429.409 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9.157 | 14.951.758 | 0,06 | 5,95 | 54.518 | 89.018.282 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.115 | 1.222.483 | 0,09 | 5,95 | 6.638 | 7.278.297 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 90.674 | 14.942.601 | 0,61 | 5,99 | 542.929 | 89.471.812 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11.043 | 1.221.368 | 0,91 | 5,99 | 66.122 | 7.313.185 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8.118 | 14.851.927 | 0,05 | 5,99 | 48.599 | 88.912.546 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 989 | 1.210.325 | 0,08 | 5,99 | 5.921 | 7.245.732 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15.154 | 14.843.809 | 0,10 | 5,75 | 87.098 | 85.314.792 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.846 | 1.209.336 | 0,15 | 5,75 | 10.610 | 6.950.659 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 93.690 | 14.828.655 | 0,64 | 5,71 | 534.979 | 84.673.103 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11.410 | 1.207.490 | 0,95 | 5,71 | 65.152 | 6.894.889 | |
| 2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 3.676 | 3.676 | |||||
| 2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1.503 | 42.966.507 | 0,00 | ||||
| 2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1.503 | 42.966.507 | 0,00 | ||||
| 2022-05-16 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25.000 | 25.000 | |||||
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 22.983 | 2.528.583 | 0,92 | 1,99 | 45.628 | 5.019.996 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 2.882 | 256.209 | 1,14 | 1,99 | 5.722 | 508.652 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 758.094 | 2.505.600 | 43,38 | 1,95 | 1.478.283 | 4.885.920 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 95.060 | 253.327 | 60,06 | 1,95 | 185.367 | 493.988 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 101.831 | 1.747.506 | 6,19 | 1,93 | 196.962 | 3.380.026 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 12.769 | 158.267 | 8,78 | 1,93 | 24.698 | 306.120 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 325.373 | 1.645.675 | 24,64 | 1,70 | 553.134 | 2.797.648 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 40.800 | 145.498 | 38,97 | 1,70 | 69.360 | 247.347 | |
| 2022-04-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
P - Purchase | 2.592.497 | 4.674.392 | 124,53 | 23,00 | 59.627.431 | 107.511.016 | |
| 2022-04-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
P - Purchase | 233.590 | 421.532 | 124,29 | 23,00 | 5.372.570 | 9.695.236 | |
| 2022-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 440 | 33.419.495 | 0,00 | ||||
| 2022-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 440 | 33.419.495 | 0,00 | ||||
| 2022-03-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 29.497 | 29.497 | |||||
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17.500 | 0 | -100,00 | ||||
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17.500 | 0 | -100,00 | ||||
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17.500 | 42.965.004 | 0,04 | 20,06 | 351.050 | 861.877.980 | |
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17.500 | 42.965.004 | 0,04 | 20,06 | 351.050 | 861.877.980 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 175.795 | 33.419.055 | 0,53 | 73,31 | 12.887.303 | 2.449.907.477 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 14.490 | 2.941.147 | 0,50 | 73,31 | 1.062.243 | 215.611.663 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1.017 | 33.243.260 | 0,00 | 71,95 | 73.177 | 2.391.975.557 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 84 | 2.926.657 | 0,00 | 71,95 | 6.044 | 210.583.800 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 25.107 | 33.242.243 | 0,08 | 71,90 | 1.805.126 | 2.390.027.518 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2.070 | 2.926.573 | 0,07 | 71,90 | 148.827 | 210.412.697 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 65.147 | 33.217.136 | 0,20 | 71,72 | 4.672.408 | 2.382.366.211 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5.370 | 2.924.503 | 0,18 | 71,72 | 385.142 | 209.748.280 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 92.385 | 33.151.989 | 0,28 | 70,68 | 6.529.310 | 2.343.016.823 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7.615 | 2.919.133 | 0,26 | 70,68 | 538.190 | 206.309.725 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 33.059.604 | 0,06 | 22,05 | 441.000 | 728.964.268 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 33.059.604 | 0,06 | 22,05 | 441.000 | 728.964.268 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 92.234 | 33.039.604 | 0,28 | 68,07 | 6.278.507 | 2.249.055.404 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7.566 | 2.891.518 | 0,26 | 68,07 | 515.029 | 196.829.968 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 22.178 | 32.947.370 | 0,07 | 68,43 | 1.517.656 | 2.254.611.592 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1.827 | 2.883.952 | 0,06 | 68,43 | 125.023 | 197.350.854 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 100.731 | 32.925.192 | 0,31 | 68,37 | 6.886.696 | 2.251.003.187 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8.296 | 2.882.125 | 0,29 | 68,37 | 567.174 | 197.042.816 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 285.672 | 32.824.461 | 0,88 | 67,74 | 19.352.821 | 2.223.689.828 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7.300 | 32.538.789 | 0,02 | 67,40 | 491.984 | 2.192.951.685 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 271.997 | 14.734.965 | 1,88 | 54,57 | 14.843.883 | 804.141.559 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22.403 | 1.196.080 | 1,91 | 54,57 | 1.222.615 | 65.274.511 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.174 | 14.462.968 | 0,04 | 53,82 | 278.457 | 778.376.690 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 426 | 1.173.677 | 0,04 | 53,82 | 22.927 | 63.165.653 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 64.119 | 14.457.794 | 0,45 | 54,26 | 3.479.200 | 784.503.035 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.281 | 1.173.251 | 0,45 | 54,26 | 286.556 | 63.662.476 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 23.804 | 14.393.675 | 0,17 | 53,73 | 1.279.048 | 773.408.142 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.961 | 1.167.970 | 0,17 | 53,73 | 105.369 | 62.757.948 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.359 | 14.369.871 | 0,04 | 54,16 | 290.217 | 778.200.364 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 441 | 1.166.009 | 0,04 | 54,16 | 23.882 | 63.145.217 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 182.326 | 32.531.489 | 0,56 | 66,04 | 12.040.390 | 2.148.304.711 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 320.526 | 32.349.163 | 1,00 | 66,02 | 21.159.973 | 2.135.575.284 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 10.985 | 32.028.637 | 0,03 | 66,95 | 735.433 | 2.144.278.813 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 265.522 | 32.017.652 | 0,84 | 66,81 | 17.740.295 | 2.139.192.181 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 772.751 | 31.752.130 | 2,49 | 67,54 | 52.192.839 | 2.144.589.664 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6.100 | 30.979.379 | 0,02 | 67,20 | 409.899 | 2.081.705.841 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 40.164 | 30.973.279 | 0,13 | 66,57 | 2.673.577 | 2.061.782.777 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 27.841 | 14.364.512 | 0,19 | 57,22 | 1.593.076 | 821.944.559 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.307 | 1.165.568 | 0,20 | 57,22 | 132.008 | 66.694.384 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11.526 | 14.336.671 | 0,08 | 51,61 | 594.898 | 739.967.202 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 953 | 1.163.261 | 0,08 | 51,61 | 49.188 | 60.040.088 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 17.119 | 14.325.145 | 0,12 | 50,56 | 865.460 | 724.214.868 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.414 | 1.162.308 | 0,12 | 50,56 | 71.485 | 58.761.062 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22.395 | 14.308.026 | 0,16 | 49,70 | 1.113.056 | 711.124.631 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.851 | 1.160.894 | 0,16 | 49,70 | 91.997 | 57.697.709 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 54.024 | 14.285.631 | 0,38 | 51,67 | 2.791.490 | 738.157.125 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.465 | 1.159.043 | 0,39 | 51,67 | 230.712 | 59.889.259 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 117.291 | 14.231.607 | 0,83 | 51,59 | 6.050.820 | 734.181.565 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 86.479 | 14.114.316 | 0,62 | 52,04 | 4.500.497 | 734.530.176 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.500 | 14.027.837 | 0,04 | 58,90 | 323.934 | 826.198.919 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 57.547 | 14.022.337 | 0,41 | 58,87 | 3.387.844 | 825.507.599 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9.350 | 13.964.790 | 0,07 | 58,76 | 549.368 | 820.513.805 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 132.367 | 13.955.440 | 0,96 | 58,13 | 7.693.938 | 811.171.114 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 25.900 | 13.823.073 | 0,19 | 57,59 | 1.491.519 | 796.037.599 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116.083 | 13.797.173 | 0,85 | 56,86 | 6.601.060 | 784.576.243 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.200 | 13.681.090 | 0,01 | 56,60 | 67.914 | 774.281.289 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 19.750 | 13.679.890 | 0,14 | 56,39 | 1.113.649 | 771.372.061 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 31.207 | 13.660.140 | 0,23 | 57,53 | 1.795.292 | 785.847.364 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 102.207 | 13.628.933 | 0,76 | 56,57 | 5.782.279 | 771.045.981 | |
| 2022-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 419 | 30.933.115 | 0,00 | ||||
| 2022-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 419 | 30.933.115 | 0,00 | ||||
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 193.997 | 30.932.696 | 0,63 | 72,91 | 14.144.224 | 2.255.287.399 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 881.875 | 30.738.699 | 2,95 | 72,77 | 64.177.924 | 2.236.990.377 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 29.703 | 29.856.824 | 0,10 | 72,00 | 2.138.616 | 2.149.691.328 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 139.612 | 29.827.121 | 0,47 | 71,96 | 10.045.795 | 2.146.213.474 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 288.368 | 29.687.509 | 0,98 | 71,91 | 20.736.197 | 2.134.793.147 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5.382 | 29.399.141 | 0,02 | 71,03 | 382.302 | 2.088.323.882 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9.893 | 29.393.759 | 0,03 | 70,24 | 694.840 | 2.064.485.360 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 36.476 | 29.383.866 | 0,12 | 69,63 | 2.539.700 | 2.045.898.684 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9.352 | 29.347.390 | 0,03 | 68,52 | 640.841 | 2.011.015.226 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 861 | 29.338.038 | 0,00 | 67,90 | 58.460 | 1.991.999.972 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -51.399 | 42.947.504 | -0,12 | 161,39 | -8.295.146 | 6.931.181.712 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -4.738 | 4.069.762 | -0,12 | 161,39 | -764.653 | 656.807.901 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -8.332 | 42.998.903 | -0,02 | 161,34 | -1.344.327 | 6.937.658.005 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -768 | 4.074.500 | -0,02 | 161,34 | -123.913 | 657.400.202 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -25.833 | 43.007.235 | -0,06 | 160,80 | -4.154.029 | 6.915.701.011 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -2.381 | 4.075.268 | -0,06 | 160,80 | -382.872 | 655.316.135 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1.007 | 43.033.068 | 0,00 | 165,68 | -166.844 | 7.129.895.142 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -93 | 4.077.649 | 0,00 | 165,68 | -15.409 | 675.601.605 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -9.618 | 43.034.075 | -0,02 | 164,82 | -1.585.266 | 7.092.996.737 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -886 | 4.077.742 | -0,02 | 164,82 | -146.033 | 672.104.854 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1.337 | 43.043.693 | 0,00 | 163,39 | -218.449 | 7.032.809.999 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -123 | 4.078.628 | 0,00 | 163,39 | -20.097 | 666.397.648 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -20.154 | 43.045.030 | -0,05 | 160,96 | -3.243.986 | 6.928.523.724 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1.858 | 4.078.751 | -0,05 | 160,96 | -299.063 | 656.515.353 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -29.432 | 43.065.184 | -0,07 | 160,53 | -4.724.631 | 6.913.124.792 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -2.713 | 4.080.609 | -0,07 | 160,53 | -435.510 | 655.047.921 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -5.860 | 43.094.616 | -0,01 | 160,08 | -938.044 | 6.898.400.822 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -540 | 4.083.322 | -0,01 | 160,08 | -86.441 | 653.640.627 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -208.597 | 43.100.476 | -0,48 | 160,00 | -33.375.520 | 6.896.076.160 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -19.226 | 4.083.862 | -0,47 | 160,00 | -3.076.160 | 653.417.920 | |
| 2021-11-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 50.000 | 7.053.176 | 0,71 | 4,36 | 218.250 | 30.787.113 | |
| 2021-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 393 | 29.337.177 | 0,00 | ||||
| 2021-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 393 | 29.337.177 | 0,00 | ||||
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 86.932 | 13.526.726 | 0,65 | 95,83 | 8.330.572 | 1.296.247.215 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
M - Exercise | -138.815 | 0 | -100,00 | ||||
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
M - Exercise | -11.184 | 0 | -100,00 | ||||
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
F - Taxes | -14 | 13.439.794 | 0,00 | 102,00 | -1.428 | 1.370.858.988 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
M - Exercise | 138.815 | 13.439.808 | 1,04 | 0,01 | 1.388 | 134.398 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
F - Taxes | -2 | 1.154.578 | 0,00 | 102,00 | -204 | 117.766.956 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
M - Exercise | 11.184 | 1.154.580 | 0,98 | 0,01 | 112 | 11.546 | |
| 2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.153 | 13.300.993 | 0,01 | 94,59 | 109.064 | 1.258.164.870 | |
| 2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13.299.840 | 0,00 | 94,48 | 37.791 | 1.256.535.634 | |
| 2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 30.285 | 13.299.440 | 0,23 | 94,38 | 2.858.425 | 1.255.257.005 | |
| 2021-09-09 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 52.201 | 13.269.155 | 0,39 | 93,35 | 4.872.948 | 1.238.671.639 | |
| 2021-09-09 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.300 | 13.216.954 | 0,04 | 92,88 | 492.279 | 1.227.629.017 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 73.635 | 13.211.654 | 0,56 | 87,61 | 6.451.464 | 1.157.527.175 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.396 | 13.138.019 | 0,02 | 87,48 | 209.607 | 1.149.341.492 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.649 | 13.135.623 | 0,04 | 87,07 | 404.793 | 1.143.731.830 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.968 | 13.130.974 | 0,02 | 86,94 | 258.033 | 1.141.587.183 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13.128.006 | 0,00 | 89,66 | 35.863 | 1.177.008.444 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.100 | 13.127.606 | 0,01 | 88,16 | 96.982 | 1.157.395.383 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8.186 | 13.126.506 | 0,06 | 87,91 | 719.659 | 1.153.995.773 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 12.898 | 13.118.320 | 0,10 | 87,79 | 1.132.303 | 1.151.644.194 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7.764 | 13.105.422 | 0,06 | 85,95 | 667.333 | 1.126.439.853 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13.097.658 | 0,00 | 84,80 | 33.921 | 1.110.714.143 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13.097.258 | 0,00 | 88,82 | 35.526 | 1.163.232.969 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 16.269 | 13.096.858 | 0,12 | 88,76 | 1.444.017 | 1.162.461.400 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 21.595 | 13.080.589 | 0,17 | 88,59 | 1.913.036 | 1.158.770.138 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.086 | 13.058.994 | 0,05 | 88,01 | 535.634 | 1.149.333.815 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.600 | 13.052.908 | 0,04 | 86,44 | 397.646 | 1.128.354.716 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 300 | 13.048.308 | 0,00 | 85,58 | 25.674 | 1.116.674.199 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.500 | 13.048.008 | 0,03 | 88,00 | 395.990 | 1.148.195.998 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 44.700 | 13.043.508 | 0,34 | 86,07 | 3.847.481 | 1.122.699.081 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 600 | 12.998.808 | 0,00 | 85,72 | 51.434 | 1.114.295.518 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.723 | 12.998.208 | 0,03 | 84,39 | 314.185 | 1.096.922.673 | |
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Non-Voting Common Stock |
C - Conversion | 3.960.811 | 3.960.811 | |||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Series C Convertible Preferred Stock |
C - Conversion | -3.960.811 | 0 | -100,00 | ||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Non-Voting Common Stock |
C - Conversion | 315.777 | 315.777 | |||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Series C Convertible Preferred Stock |
C - Conversion | -315.777 | 0 | -100,00 | ||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 1.320.302 | 1.320.302 | 15,00 | 19.804.530 | 19.804.530 | ||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 104.698 | 104.698 | 15,00 | 1.570.470 | 1.570.470 | ||
| 2021-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 345 | 29.336.784 | 0,00 | ||||
| 2021-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 345 | 29.336.784 | 0,00 | ||||
| 2021-07-01 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 66.474 | 66.474 | |||||
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 7.368 | 7.368 | |||||
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 121.612 | 12.994.485 | 0,94 | 92,75 | 11.279.014 | 1.205.185.206 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7.009 | 12.872.873 | 0,05 | 91,64 | 642.276 | 1.179.617.303 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22.353 | 12.865.864 | 0,17 | 90,20 | 2.016.332 | 1.160.553.683 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.603 | 12.843.511 | 0,04 | 89,74 | 413.070 | 1.152.566.402 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 30.221 | 12.838.908 | 0,24 | 90,70 | 2.741.157 | 1.164.536.460 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.200 | 12.808.687 | 0,01 | 90,40 | 108.474 | 1.157.841.261 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11.731 | 12.807.487 | 0,09 | 90,39 | 1.060.378 | 1.157.682.838 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.847 | 12.795.756 | 0,03 | 89,90 | 345.828 | 1.150.282.163 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7.079 | 12.791.909 | 0,06 | 89,87 | 636.196 | 1.149.620.375 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.459 | 12.784.830 | 0,08 | 91,87 | 960.845 | 1.174.514.205 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22.445 | 12.774.371 | 0,18 | 91,80 | 2.060.393 | 1.172.654.044 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.170 | 12.751.926 | 0,08 | 90,76 | 923.046 | 1.157.386.482 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.200 | 12.741.756 | 0,04 | 90,27 | 469.420 | 1.150.237.814 | |
| 2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Options (right to buy) |
A - Award | 23.274 | 23.274 | |||||
| 2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 12.782 | 38.452.877 | 0,03 | ||||
| 2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 12.782 | 38.452.877 | 0,03 | ||||
| 2021-06-22 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
A - Award | 23.344 | 23.344 | |||||
| 2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 34.996 | 34.996 | |||||
| 2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 15.600 | 34.189 | 83,92 | ||||
| 2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 15.600 | 34.189 | 83,92 | ||||
| 2021-06-10 |
|
4 | AGLE |
Aeglea BioTherapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 40.000 | 40.000 | |||||
| 2021-05-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 8.010 | 8.010 | |||||
| 2021-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1.923 | 29.336.439 | 0,01 | ||||
| 2021-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1.923 | 29.336.439 | 0,01 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 3.462 | 3.462 | |||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17.500 | 0 | -100,00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17.500 | 0 | -100,00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1.402 | 43.309.073 | 0,00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1.402 | 43.309.073 | 0,00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17.500 | 43.307.671 | 0,04 | 19,02 | 332.850 | 823.711.902 | |
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17.500 | 43.307.671 | 0,04 | 19,02 | 332.850 | 823.711.902 | |
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 29.334.516 | 0,07 | 18,97 | 379.400 | 556.475.769 | |
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 2.870.749 | 0,70 | 18,97 | 379.400 | 54.458.109 | |
| 2021-05-13 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25.000 | 25.000 | |||||
| 2021-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29.314.516 | 0,00 | ||||
| 2021-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29.314.516 | 0,00 | ||||
| 2021-02-25 |
|
4 | AGLE |
Aeglea BioTherapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 47.200 | 47.200 | |||||
| 2021-02-25 | 3 | AGLE |
Aeglea BioTherapeutics, Inc.
Common Stock |
315.516 | ||||||||
| 2021-02-25 | 3 | AGLE |
Aeglea BioTherapeutics, Inc.
Common Stock |
3.094.590 | ||||||||
| 2021-02-23 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 6.423 | 6.423 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 6.427.576 | 27.511.741 | 30,49 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 536.438 | 2.345.481 | 29,65 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 7.286.794 | 21.084.165 | 52,81 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 536.414 | 1.809.043 | 42,15 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 1.941 | 5.420 | 55,79 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 6.654.603 | 13.797.371 | 93,17 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 598.860 | 1.272.629 | 88,88 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 7.142.768 | 7.142.768 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 673.769 | 673.769 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 3.479 | 3.479 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
M - Exercise | -9.191.433 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
M - Exercise | -767.106 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-2 Convertible Preferred Stock |
M - Exercise | -10.420.117 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-2 Convertible Preferred Stock |
M - Exercise | -767.072 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-1 Convertible Preferred Stock |
M - Exercise | -2.776 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series D-2 Convertible Preferred Stock |
M - Exercise | -9.516.082 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series D-2 Convertible Preferred Stock |
M - Exercise | -856.370 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -10.214.159 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -963.490 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -4.975 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 5.792.538 | 7.003.176 | 478,47 | 16,00 | 92.680.608 | 112.050.816 | |
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 457.462 | 571.659 | 400,59 | 16,00 | 7.319.392 | 9.146.544 | |
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
A - Award | 9.191.433 | 9.191.433 | 8,55 | 78.586.752 | 78.586.752 | ||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
A - Award | 767.106 | 767.106 | 8,55 | 6.558.756 | 6.558.756 | ||
| 2021-02-16 |
|
5 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -158.456 | 23.277 | -87,19 | ||||
| 2021-02-16 |
|
5 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -158.460 | 23.280 | -87,19 | ||||
| 2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
590 | ||||||||
| 2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
114.197 | ||||||||
| 2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
1.210.638 | ||||||||
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5.188 | 41.500 | -11,11 | ||||
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5.188 | 41.500 | -11,11 | ||||
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 5.188 | 9.252.951 | 0,06 | 12,85 | 66.666 | 118.900.420 | |
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 5.188 | 9.252.951 | 0,06 | 12,85 | 66.666 | 118.900.420 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5.833 | 2.527 | -69,77 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5.833 | 2.527 | -69,77 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5.377 | 6.723 | -44,44 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5.377 | 6.723 | -44,44 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5.833 | 2.895.306 | 0,20 | 40,27 | 234.895 | 116.593.973 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5.833 | 2.895.306 | 0,20 | 40,27 | 234.895 | 116.593.973 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5.377 | 2.889.473 | 0,19 | 16,00 | 86.032 | 46.231.568 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5.377 | 2.889.473 | 0,19 | 16,00 | 86.032 | 46.231.568 | |
| 2021-01-13 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
P - Purchase | 154.222 | 5.212.371 | 3,05 | 60,00 | 9.253.320 | 312.742.260 | |
| 2021-01-13 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
P - Purchase | 12.444 | 509.480 | 2,50 | 60,00 | 746.640 | 30.568.800 | |
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
332.622 | ||||||||
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
3.953.416 | ||||||||
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
American Depositary Shares |
1.200.369 | ||||||||
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
American Depositary Shares |
13.413.895 | ||||||||
| 2021-01-06 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -111.094 | 10.699.954 | -1,03 | 220,50 | -24.496.227 | 2.359.339.857 | |
| 2021-01-06 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -10.060 | 968.943 | -1,03 | 220,50 | -2.218.230 | 213.651.932 | |
| 2021-01-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.884.096 | 0,01 | ||||
| 2021-01-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.884.096 | 0,01 | ||||
| 2021-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 343 | 29.314.152 | 0,00 | ||||
| 2021-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 343 | 29.314.152 | 0,00 | ||||
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-Funded Warrants |
P - Purchase | 518.555 | 10.283.888 | 5,31 | ||||
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-Funded Warrants |
P - Purchase | 38.974 | 1.199.122 | 3,36 | ||||
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 394.360 | 3.501.691 | 12,69 | 15,25 | 6.013.990 | 53.400.788 | |
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 29.640 | 320.049 | 10,21 | 15,25 | 452.010 | 4.880.747 | |
| 2020-12-11 |
|
4 | IGMS |
IGM Biosciences, Inc.
Pre-funded Warrants |
P - Purchase | 616.846 | 616.846 | 89,99 | 55.509.972 | 55.509.972 | ||
| 2020-12-11 |
|
4 | IGMS |
IGM Biosciences, Inc.
Pre-funded Warrants |
P - Purchase | 49.820 | 49.820 | 89,99 | 4.483.302 | 4.483.302 | ||
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -1.386.033 | 10.811.048 | -11,36 | 220,50 | -305.620.276 | 2.383.836.084 | |
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -125.513 | 979.003 | -11,36 | 220,50 | -27.675.616 | 215.870.162 | |
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
G - Gift | -13.516 | 10.418 | -56,47 | ||||
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
G - Gift | -13.516 | 10.418 | -56,47 | ||||
| 2020-11-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.411.619 | 12.736.556 | 12,46 | 108,00 | 152.454.852 | 1.375.548.048 | |
| 2020-11-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116.158 | 1.143.396 | 11,31 | 108,00 | 12.545.064 | 123.486.768 | |
| 2020-10-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.883.873 | 0,01 | ||||
| 2020-10-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.883.873 | 0,01 | ||||
| 2020-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 317 | 29.313.809 | 0,00 | ||||
| 2020-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 317 | 29.313.809 | 0,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 382.884 | 5.058.149 | 8,19 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -382.884 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 30.349 | 497.036 | 6,50 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -30.349 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -574.327 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -45.524 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 2.698.424 | 4.675.265 | 136,50 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -2.698.424 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 247.034 | 466.687 | 112,47 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -247.034 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -4.047.634 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -370.552 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 1.976.841 | 1.976.841 | |||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -1.976.841 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 219.653 | 219.653 | |||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -219.653 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -2.965.263 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -329.478 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
P - Purchase | 1.474.319 | 9.247.763 | 18,97 | 19,00 | 28.012.061 | 175.707.497 | |
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
P - Purchase | 104.628 | 870.873 | 13,65 | 19,00 | 1.987.932 | 16.546.587 | |
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 574.327 | 7.773.444 | 7,98 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 45.524 | 766.245 | 6,32 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 4.047.634 | 7.199.117 | 128,44 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 370.552 | 720.721 | 105,82 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 2.965.263 | 3.151.483 | 1.592,34 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 329.478 | 350.169 | 1.592,37 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Option (right to buy) |
A - Award | 46.688 | 46.688 | |||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Preferred Stock |
P - Purchase | 957.211 | 957.211 | 14,52 | 13.898.321 | 13.898.321 | ||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Preferred Stock |
P - Purchase | 75.873 | 75.873 | 14,52 | 1.101.646 | 1.101.646 | ||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Preferred Stock |
P - Purchase | 3.373.029 | 3.373.029 | 3,93 | 13.264.099 | 13.264.099 | ||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Preferred Stock |
P - Purchase | 308.793 | 308.793 | 3,93 | 1.214.298 | 1.214.298 | ||
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7.843 | 11.324.937 | 0,07 | 58,09 | 455.565 | 657.814.628 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 557 | 1.027.238 | 0,05 | 58,09 | 32.354 | 59.667.633 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 19.235 | 11.317.094 | 0,17 | 56,92 | 1.094.854 | 644.167.859 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.365 | 1.026.681 | 0,13 | 56,92 | 77.696 | 58.438.580 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.705 | 11.297.859 | 0,04 | 56,76 | 267.055 | 641.265.347 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 334 | 1.025.316 | 0,03 | 56,76 | 18.958 | 58.196.834 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13.153 | 11.293.154 | 0,12 | 55,35 | 728.057 | 625.108.824 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 933 | 1.024.982 | 0,09 | 55,35 | 51.644 | 56.735.726 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29.327 | 11.280.001 | 0,26 | 52,11 | 1.528.374 | 587.856.124 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.081 | 1.024.049 | 0,20 | 52,11 | 108.451 | 53.368.211 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.306 | 11.250.674 | 0,04 | 51,41 | 221.368 | 578.388.150 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 306 | 1.021.968 | 0,03 | 51,41 | 15.731 | 52.538.557 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 74.381 | 11.246.368 | 0,67 | 52,44 | 3.900.235 | 589.713.428 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.278 | 1.021.662 | 0,52 | 52,44 | 276.757 | 53.571.766 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.467 | 11.171.987 | 0,09 | 52,40 | 548.468 | 585.408.767 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 743 | 1.016.384 | 0,07 | 52,40 | 38.933 | 53.258.217 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.120 | 11.161.520 | 0,01 | 51,97 | 58.206 | 580.064.194 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 80 | 1.015.641 | 0,01 | 51,97 | 4.158 | 52.782.863 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22.361 | 11.160.400 | 0,20 | 51,98 | 1.162.235 | 580.072.950 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.587 | 1.015.561 | 0,16 | 51,98 | 82.486 | 52.784.799 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 36.647 | 11.138.039 | 0,33 | 50,15 | 1.837.909 | 558.591.591 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.601 | 1.013.974 | 0,26 | 50,15 | 130.445 | 50.852.520 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.983 | 11.101.392 | 0,10 | 49,72 | 546.102 | 551.988.964 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 779 | 1.011.373 | 0,08 | 49,72 | 38.734 | 50.287.994 | |
| 2020-09-24 | 3 | PRLD |
Prelude Therapeutics Inc
Common Stock |
20.691 | ||||||||
| 2020-09-24 | 3 | PRLD |
Prelude Therapeutics Inc
Common Stock |
186.220 | ||||||||
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15.172 | 11.090.409 | 0,14 | 47,47 | 720.200 | 526.450.625 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.220 | 1.010.594 | 0,12 | 47,47 | 57.912 | 47.971.887 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 76.473 | 11.075.237 | 0,70 | 47,39 | 3.623.857 | 524.826.686 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.151 | 1.009.374 | 0,61 | 47,39 | 291.480 | 47.831.609 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15.807 | 10.998.764 | 0,14 | 47,04 | 743.482 | 517.326.865 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.272 | 1.003.223 | 0,13 | 47,04 | 59.829 | 47.186.594 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 185 | 10.982.957 | 0,00 | 45,88 | 8.487 | 503.843.152 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15 | 1.001.951 | 0,00 | 45,88 | 688 | 45.964.502 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9.101 | 10.982.772 | 0,08 | 47,50 | 432.281 | 521.661.901 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 712 | 1.001.936 | 0,07 | 47,50 | 33.819 | 47.590.157 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 26.238 | 10.973.671 | 0,24 | 47,26 | 1.239.984 | 518.605.815 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.054 | 1.001.224 | 0,21 | 47,26 | 97.070 | 47.316.945 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29.319 | 10.947.433 | 0,27 | 46,62 | 1.366.767 | 510.337.579 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.295 | 999.170 | 0,23 | 46,62 | 106.986 | 46.578.408 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 12.132 | 10.918.114 | 0,11 | 45,30 | 549.535 | 494.550.167 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 950 | 996.875 | 0,10 | 45,30 | 43.031 | 45.154.749 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 32.088 | 10.905.982 | 0,30 | 49,00 | 1.572.312 | 534.393.118 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.512 | 995.925 | 0,25 | 49,00 | 123.088 | 48.800.325 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 77.456 | 10.873.894 | 0,72 | 47,60 | 3.686.658 | 517.562.558 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.062 | 993.413 | 0,61 | 47,60 | 288.532 | 47.283.280 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.987 | 10.796.438 | 0,03 | 47,45 | 141.725 | 512.260.753 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 234 | 987.351 | 0,02 | 47,45 | 11.103 | 46.847.040 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.359 | 10.793.451 | 0,02 | 46,97 | 110.798 | 506.947.886 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 185 | 987.117 | 0,02 | 46,97 | 8.689 | 46.363.010 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 83.832 | 10.791.092 | 0,78 | 49,08 | 4.114.734 | 529.660.248 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.645 | 986.932 | 0,68 | 49,08 | 326.157 | 48.441.682 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.286 | 10.707.260 | 0,02 | 48,74 | 111.430 | 521.922.177 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 181 | 980.287 | 0,02 | 48,74 | 8.823 | 47.783.796 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42.714 | 10.704.974 | 0,40 | 47,74 | 2.039.256 | 511.077.939 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.386 | 980.106 | 0,35 | 47,74 | 161.655 | 46.792.319 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 754 | 10.662.260 | 0,01 | 47,82 | 36.058 | 509.896.995 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 60 | 976.720 | 0,01 | 47,82 | 2.869 | 46.709.290 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 41.155 | 10.661.506 | 0,39 | 47,72 | 1.963.970 | 508.780.926 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.262 | 976.660 | 0,34 | 47,72 | 155.667 | 46.607.485 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.640 | 10.620.351 | 0,10 | 46,50 | 494.716 | 493.802.778 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 843 | 973.398 | 0,09 | 46,50 | 39.196 | 45.259.016 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.576 | 10.609.711 | 0,03 | 46,30 | 165.575 | 491.248.717 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 283 | 972.555 | 0,03 | 46,30 | 13.103 | 45.031.047 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.585 | 10.606.135 | 0,03 | 46,99 | 168.447 | 498.345.162 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 284 | 972.272 | 0,03 | 46,99 | 13.344 | 45.683.658 | |
| 2020-07-28 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1.335.362 | 11.638.314 | 12,96 | 21,00 | 28.042.602 | 244.404.594 | |
| 2020-07-28 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 93.210 | 1.143.650 | 8,87 | 21,00 | 1.957.410 | 24.016.650 | |
| 2020-07-17 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 13.589.904 | 18.840.379 | 258,83 | 14,23 | 193.395.206 | 268.113.665 | |
| 2020-07-17 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 994.276 | 1.021.851 | 3.605,72 | 14,23 | 14.149.343 | 14.541.757 | |
| 2020-07-06 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.883.650 | 0,01 | ||||
| 2020-07-06 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.883.650 | 0,01 | ||||
| 2020-07-02 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 7.106 | 7.106 | |||||
| 2020-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 294 | 29.313.492 | 0,00 | ||||
| 2020-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 294 | 29.313.492 | 0,00 | ||||
| 2020-07-02 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37.520 | 37.520 | |||||
| 2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Options (right to buy) |
A - Award | 11.158 | 11.158 | |||||
| 2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 6.118 | 38.440.095 | 0,02 | ||||
| 2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 6.118 | 38.440.095 | 0,02 | ||||
| 2020-06-19 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 90.766 | 90.766 | |||||
| 2020-06-10 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 4.135 | 4.135 | |||||
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1 | 29.313.198 | 0,00 | 102,55 | 103 | 3.006.068.455 | |
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1 | 29.313.198 | 0,00 | 102,55 | 103 | 3.006.068.455 | |
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 10.514 | 10.514 | |||||
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1.282 | 29.313.197 | 0,00 | ||||
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1.282 | 29.313.197 | 0,00 | ||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 3.171 | 3.171 | |||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 1.335 | 43.290.171 | 0,00 | ||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 1.335 | 43.290.171 | 0,00 | ||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -1.602.312 | 43.288.836 | -3,57 | 160,00 | -256.369.920 | 6.926.213.760 | |
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -147.688 | 4.082.851 | -3,49 | 160,00 | -23.630.080 | 653.256.160 | |
| 2020-05-18 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1.465.603 | 10.302.952 | 16,58 | 18,25 | 26.747.255 | 188.028.874 | |
| 2020-05-18 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 134.397 | 1.050.440 | 14,67 | 18,25 | 2.452.745 | 19.170.530 | |
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1.189 | 7.846.213 | 0,02 | ||||
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1.189 | 7.846.213 | 0,02 | ||||
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.468 | 7.845.024 | 0,04 | ||||
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.468 | 7.845.024 | 0,04 | ||||
| 2020-05-12 |
|
4 | ZYME |
Zymeworks Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 9.000 | 9.000 | |||||
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -457.803 | 44.891.148 | -1,01 | 158,50 | -72.561.776 | 7.115.246.958 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -42.197 | 4.230.539 | -0,99 | 158,50 | -6.688.224 | 670.540.432 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4.343 | 45.348.951 | -0,01 | 166,15 | -721.610 | 7.534.941.349 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -400 | 4.272.736 | -0,01 | 166,15 | -66.462 | 709.935.168 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -48.880 | 45.353.294 | -0,11 | 164,96 | -8.063.118 | 7.481.361.460 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4.505 | 4.273.136 | -0,11 | 164,96 | -743.133 | 704.885.404 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -84.663 | 45.402.174 | -0,19 | 164,19 | -13.901.157 | 7.454.764.558 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -7.805 | 4.277.641 | -0,18 | 164,19 | -1.281.534 | 702.362.986 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -16.159 | 45.486.837 | -0,04 | 163,41 | -2.640.610 | 7.433.195.079 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -1.489 | 4.285.446 | -0,03 | 163,41 | -243.324 | 700.302.730 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -41.072 | 45.502.996 | -0,09 | 166,62 | -6.843.564 | 7.581.873.004 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -3.786 | 4.286.935 | -0,09 | 166,62 | -630.837 | 714.304.543 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -91.613 | 45.544.068 | -0,20 | 165,70 | -15.180.641 | 7.546.834.244 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -8.444 | 4.290.721 | -0,20 | 165,70 | -1.399.205 | 710.989.633 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -178.862 | 45.635.681 | -0,39 | 164,60 | -29.440.041 | 7.511.468.804 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -16.485 | 4.299.165 | -0,38 | 164,60 | -2.713.372 | 707.627.082 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -45.606 | 45.814.543 | -0,10 | 164,06 | -7.482.107 | 7.516.320.180 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4.204 | 4.315.650 | -0,10 | 164,06 | -689.707 | 708.024.244 | |
| 2020-05-07 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25.000 | 25.000 | |||||
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 29.311.915 | 0,07 | 13,34 | 266.800 | 391.020.946 | |
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 29.311.915 | 0,07 | 13,34 | 266.800 | 391.020.946 | |
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -17.500 | 0 | -100,00 | ||||
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -17.500 | 0 | -100,00 | ||||
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 17.500 | 45.860.149 | 0,04 | 12,76 | 223.300 | 585.175.501 | |
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 17.500 | 45.860.149 | 0,04 | 12,76 | 223.300 | 585.175.501 | |
| 2020-04-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.883.427 | 0,01 | ||||
| 2020-04-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.883.427 | 0,01 | ||||
| 2020-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 392 | 29.291.915 | 0,00 | 73,23 | 28.706 | 2.145.046.935 | |
| 2020-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 392 | 29.291.915 | 0,00 | 73,23 | 28.706 | 2.145.046.935 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 42.473 | 38.433.977 | 0,11 | 34,47 | 1.463.896 | 1.324.684.668 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.837 | 3.470.609 | 0,11 | 34,47 | 132.248 | 119.619.745 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 33.464 | 38.391.504 | 0,09 | 33,63 | 1.125.465 | 1.291.186.902 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.023 | 3.466.772 | 0,09 | 33,63 | 101.670 | 116.594.823 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2.201 | 38.358.040 | 0,01 | 32,85 | 72.302 | 1.260.053.942 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 199 | 3.463.749 | 0,01 | 32,85 | 6.537 | 113.783.462 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 46.225 | 38.355.839 | 0,12 | 32,61 | 1.507.268 | 1.250.676.513 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4.175 | 3.463.550 | 0,12 | 32,61 | 136.135 | 112.936.668 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 275 | 38.309.614 | 0,00 | 31,94 | 8.782 | 1.223.417.523 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25 | 3.459.375 | 0,00 | 31,94 | 798 | 110.475.141 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 93.006 | 38.309.339 | 0,24 | 33,86 | 3.149.406 | 1.297.246.161 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 8.402 | 3.459.350 | 0,24 | 33,86 | 284.512 | 117.141.893 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24.223 | 38.216.333 | 0,06 | 32,32 | 782.873 | 1.235.128.953 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2.188 | 3.450.948 | 0,06 | 32,32 | 70.715 | 111.532.569 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 29.624 | 38.192.110 | 0,08 | 32,19 | 953.620 | 1.229.434.575 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2.676 | 3.448.760 | 0,08 | 32,19 | 86.143 | 111.018.343 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7.612 | 38.162.486 | 0,02 | 31,83 | 242.290 | 1.214.711.929 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 688 | 3.446.084 | 0,02 | 31,83 | 21.899 | 109.688.854 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 43.212 | 38.154.874 | 0,11 | 31,74 | 1.371.359 | 1.210.867.819 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.903 | 3.445.396 | 0,11 | 31,74 | 123.864 | 109.341.709 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.913 | 38.111.662 | 0,01 | 31,00 | 121.285 | 1.181.290.020 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 353 | 3.441.493 | 0,01 | 31,00 | 10.941 | 106.670.796 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 631.281 | 38.107.749 | 1,68 | 31,51 | 19.893.937 | 1.200.912.359 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 57.022 | 3.441.140 | 1,68 | 31,51 | 1.796.968 | 108.442.710 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5.503 | 37.476.468 | 0,01 | 31,19 | 171.613 | 1.168.714.898 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 497 | 3.384.118 | 0,01 | 31,19 | 15.499 | 105.534.735 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9.172 | 10.602.550 | 0,09 | 38,38 | 352.019 | 406.922.688 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 828 | 971.988 | 0,09 | 38,38 | 31.778 | 37.304.608 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.237 | 10.593.378 | 0,06 | 37,75 | 235.433 | 399.876.714 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 563 | 971.160 | 0,06 | 37,75 | 21.252 | 36.659.153 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 17.058 | 10.587.141 | 0,16 | 36,69 | 625.914 | 388.477.141 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.542 | 970.597 | 0,16 | 36,69 | 56.581 | 35.614.407 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9.172 | 10.570.083 | 0,09 | 38,98 | 357.570 | 412.074.686 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 828 | 969.055 | 0,09 | 38,98 | 32.280 | 37.778.609 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 95.934 | 10.560.911 | 0,92 | 39,97 | 3.834.588 | 422.131.230 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8.666 | 968.227 | 0,90 | 39,97 | 346.390 | 38.701.098 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 14.731 | 7.841.556 | 0,19 | 83,14 | 1.224.797 | 651.979.900 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.331 | 994.296 | 0,13 | 83,14 | 110.665 | 82.669.945 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.321 | 7.826.825 | 0,02 | 82,92 | 109.537 | 648.995.633 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 119 | 992.965 | 0,01 | 82,92 | 9.867 | 82.336.062 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15.928 | 7.825.504 | 0,20 | 82,13 | 1.308.149 | 642.700.035 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.439 | 992.846 | 0,15 | 82,13 | 118.183 | 81.541.350 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 25.640 | 7.809.576 | 0,33 | 81,79 | 2.097.003 | 638.717.107 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.314 | 991.407 | 0,23 | 81,79 | 189.254 | 81.083.609 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.203 | 7.783.936 | 0,05 | 81,47 | 342.438 | 634.193.850 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 380 | 989.093 | 0,04 | 81,47 | 30.960 | 80.586.055 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12.815 | 7.779.733 | 0,16 | 81,09 | 1.039.177 | 630.863.995 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.158 | 988.713 | 0,12 | 81,09 | 93.903 | 80.175.429 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3.298 | 7.766.918 | 0,04 | 80,91 | 266.845 | 628.431.432 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 298 | 987.555 | 0,03 | 80,91 | 24.112 | 79.904.359 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10.285 | 7.763.620 | 0,13 | 79,87 | 821.429 | 620.054.709 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 929 | 987.257 | 0,09 | 79,87 | 74.196 | 78.848.959 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26.022 | 7.753.335 | 0,34 | 79,72 | 2.074.362 | 618.062.527 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.351 | 986.328 | 0,24 | 79,72 | 187.412 | 78.625.827 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.888 | 7.727.313 | 0,04 | 79,29 | 228.980 | 612.673.148 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 261 | 983.977 | 0,03 | 79,29 | 20.694 | 78.016.289 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.191 | 7.724.425 | 0,05 | 79,16 | 331.760 | 611.467.028 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 379 | 983.716 | 0,04 | 79,16 | 30.002 | 77.871.155 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 565 | 7.720.234 | 0,01 | 78,66 | 44.443 | 607.273.606 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 51 | 983.337 | 0,01 | 78,66 | 4.012 | 77.349.288 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 65.505 | 7.719.669 | 0,86 | 76,67 | 5.022.445 | 591.887.865 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.917 | 983.286 | 0,61 | 76,67 | 453.672 | 75.391.192 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 27.866 | 7.654.164 | 0,37 | 76,10 | 2.120.480 | 582.448.202 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.517 | 977.369 | 0,26 | 76,10 | 191.533 | 74.373.480 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 62.129 | 7.626.298 | 0,82 | 79,76 | 4.955.720 | 608.311.660 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.612 | 974.852 | 0,58 | 79,76 | 447.641 | 77.759.070 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 133.042 | 7.564.169 | 1,79 | 79,14 | 10.529.170 | 598.641.194 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12.017 | 969.240 | 1,26 | 79,14 | 951.046 | 76.707.301 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7.612 | 7.431.127 | 0,10 | 77,94 | 593.260 | 579.163.461 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 688 | 957.223 | 0,07 | 77,94 | 53.621 | 74.603.568 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8.309 | 7.423.515 | 0,11 | 77,89 | 647.203 | 578.230.946 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 750 | 956.535 | 0,08 | 77,89 | 58.419 | 74.506.233 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 32.228 | 7.415.206 | 0,44 | 75,66 | 2.438.422 | 561.046.350 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.911 | 955.785 | 0,31 | 75,66 | 220.251 | 72.316.222 | |
| 2020-03-16 |
|
4 | ZYME |
Zymeworks Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 18.000 | 18.000 | |||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 82.740 | 10.464.977 | 0,80 | 57,82 | 4.783.944 | 605.074.505 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7.460 | 959.561 | 0,78 | 57,82 | 431.330 | 55.480.857 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8.989 | 10.382.237 | 0,09 | 59,61 | 535.824 | 618.873.727 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 811 | 952.101 | 0,09 | 59,61 | 48.343 | 56.753.693 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14.631 | 10.373.248 | 0,14 | 59,99 | 877.642 | 622.240.319 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.319 | 951.290 | 0,14 | 59,99 | 79.120 | 57.063.226 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 145.994 | 10.358.617 | 1,43 | 57,68 | 8.421.518 | 597.526.463 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13.164 | 949.971 | 1,41 | 57,68 | 759.352 | 54.798.127 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14.051 | 10.212.623 | 0,14 | 57,22 | 803.980 | 584.353.012 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.267 | 936.807 | 0,14 | 57,22 | 72.496 | 53.602.879 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14.402 | 10.198.572 | 0,14 | 58,80 | 846.819 | 599.662.775 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.298 | 935.540 | 0,14 | 58,80 | 76.321 | 55.008.536 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8.623 | 10.184.170 | 0,08 | 60,77 | 524.043 | 618.919.508 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 777 | 934.242 | 0,08 | 60,77 | 47.220 | 56.776.409 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.788 | 10.175.547 | 0,07 | 58,54 | 397.393 | 595.711.118 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 612 | 933.465 | 0,07 | 58,54 | 35.829 | 54.648.215 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7.122 | 10.168.759 | 0,07 | 58,39 | 415.826 | 593.714.180 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 642 | 932.853 | 0,07 | 58,39 | 37.484 | 54.465.649 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.577 | 10.161.637 | 0,04 | 57,62 | 206.108 | 585.517.589 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 323 | 932.211 | 0,03 | 57,62 | 18.611 | 53.714.371 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 21.301 | 10.158.060 | 0,21 | 56,69 | 1.207.513 | 575.841.121 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.921 | 931.888 | 0,21 | 56,69 | 108.898 | 52.826.960 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.804 | 10.136.759 | 0,06 | 56,62 | 328.631 | 573.958.500 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 523 | 929.967 | 0,06 | 56,62 | 29.613 | 52.656.126 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.121 | 10.130.955 | 0,10 | 56,25 | 569.277 | 569.836.839 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 912 | 929.444 | 0,10 | 56,25 | 51.297 | 52.278.530 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 92 | 10.120.834 | 0,00 | 55,45 | 5.102 | 561.225.547 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8 | 928.532 | 0,00 | 55,45 | 444 | 51.489.421 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.813 | 10.120.742 | 0,02 | 55,77 | 101.117 | 564.468.192 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 164 | 928.524 | 0,02 | 55,77 | 9.147 | 51.786.940 | |
| 2020-02-07 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 10.000 | 10.000 | |||||
| 2020-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 316 | 29.291.523 | 0,00 | 87,32 | 27.593 | 2.557.735.788 | |
| 2020-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 316 | 29.291.523 | 0,00 | 87,32 | 27.593 | 2.557.735.788 | |
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-funded Warrants |
A - Award | 9.765.333 | 9.765.333 | |||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-funded Warrants |
A - Award | 1.160.148 | 1.161.048 | 128.905,33 | ||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | -9.765.333 | 3.107.331 | -75,86 | ||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | -1.160.148 | 290.409 | -79,98 | ||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 2.767.505 | 12.872.664 | 27,39 | 8,40 | 23.247.042 | 108.130.378 | |
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 250.037 | 1.450.557 | 20,83 | 8,40 | 2.100.311 | 12.184.679 | |
| 2019-12-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.743.993 | 10.118.929 | 20,82 | 46,00 | 80.223.678 | 465.470.734 | |
| 2019-12-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 158.180 | 928.360 | 20,54 | 46,00 | 7.276.280 | 42.704.560 | |
| 2019-10-15 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 22.000 | 22.000 | |||||
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 7.642.042 | 0,00 | 67,28 | 24.894 | 514.156.586 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 7.642.042 | 0,00 | 67,28 | 24.894 | 514.156.586 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 1.217.279 | 0,03 | 67,28 | 24.894 | 81.898.531 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 244.595 | 0,15 | 67,28 | 24.894 | 16.456.352 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 160.223 | 0,23 | 67,28 | 24.894 | 10.779.803 | |
| 2019-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29.291.207 | 0,00 | 74,23 | 27.020 | 2.174.286.296 | |
| 2019-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29.291.207 | 0,00 | 74,23 | 27.020 | 2.174.286.296 | |
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
C - Conversion | 2.081.895 | 2.081.895 | |||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Series C Convertible Preferred |
C - Conversion | -2.081.895 | 0 | -100,00 | ||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
C - Conversion | 187.942 | 187.942 | |||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Series C Convertible Preferred |
C - Conversion | -187.942 | 0 | -100,00 | ||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 2.883.204 | 2.883.204 | 16,00 | 46.131.264 | 46.131.264 | ||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 260.796 | 260.796 | 16,00 | 4.172.736 | 4.172.736 | ||
| 2019-09-20 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.494.025 | 37.470.965 | 4,15 | 40,00 | 59.761.000 | 1.498.838.600 | |
| 2019-09-20 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 68.475 | 3.383.621 | 2,07 | 40,00 | 2.739.000 | 135.344.840 | |
| 2019-09-20 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
X - Other | -1 | 138.815 | 0,00 | ||||
| 2019-09-20 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
X - Other | 1 | 8.374.936 | 0,00 | 0,01 | 0 | 83.749 | |
| 2019-09-19 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 12.100 | 12.100 | |||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | -95.289 | 0 | -100,00 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | -95.289 | 0 | -100,00 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | 8.341 | 95.289 | 9,59 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | 8.340 | 95.289 | 9,59 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | -8.866 | 43.361 | -16,98 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | -7.815 | 165.610 | -4,51 | ||||
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 50.436 | 10.105.159 | 0,50 | 3,15 | 159.020 | 31.860.556 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4.564 | 1.200.520 | 0,38 | 3,15 | 14.390 | 3.785.120 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 209.382 | 10.054.723 | 2,13 | 3,02 | 633.255 | 30.409.504 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 18.943 | 1.195.956 | 1,61 | 3,02 | 57.291 | 3.617.049 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5.869 | 9.845.341 | 0,06 | 2,96 | 17.358 | 29.118.581 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 531 | 1.177.013 | 0,05 | 2,96 | 1.570 | 3.481.134 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 65.568 | 9.839.472 | 0,67 | 2,85 | 186.666 | 28.011.993 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5.932 | 1.176.482 | 0,51 | 2,85 | 16.888 | 3.349.327 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9.445 | 9.773.904 | 0,10 | 2,83 | 26.756 | 27.687.515 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 855 | 1.170.550 | 0,07 | 2,83 | 2.422 | 3.315.934 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 7.641.672 | 0,01 | 58,86 | 24.957 | 449.788.814 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 7.641.672 | 0,01 | 58,86 | 24.957 | 449.788.814 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 1.390.806 | 0,03 | 58,86 | 24.957 | 81.862.841 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 418.122 | 0,10 | 58,86 | 24.957 | 24.610.661 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 333.750 | 0,13 | 58,86 | 24.957 | 19.644.525 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 226.124 | 0,19 | 58,86 | 24.957 | 13.309.659 | |
| 2019-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 310 | 29.290.843 | 0,00 | 84,96 | 26.338 | 2.488.550.021 | |
| 2019-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 310 | 29.290.843 | 0,00 | 84,96 | 26.338 | 2.488.550.021 | |
| 2019-06-28 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30.000 | 30.000 | |||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 13.166 | 13.166 | |||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1.910 | 7.641.248 | 0,03 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1.910 | 7.641.248 | 0,03 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1.910 | 1.390.382 | 0,14 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1.910 | 417.698 | 0,46 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1.910 | 333.326 | 0,58 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1.910 | 225.700 | 0,85 | ||||
| 2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 74.229 | 181.733 | 69,05 | ||||
| 2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 74.229 | 181.733 | 69,05 | ||||
| 2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -1.002.483 | 4.302.354 | -18,90 | ||||
| 2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | 14.840 | 14.840 | |||||
| 2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | 14.840 | 14.840 | |||||
| 2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | -200.423 | 98.980 | -66,94 | ||||
| 2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 31.229 | 102.876 | 43,59 | ||||
| 2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 31.229 | 102.876 | 43,59 | ||||
| 2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | -421.756 | 3.315.146 | -11,29 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | 43.109 | 43.109 | |||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | 43.109 | 43.109 | |||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | -582.200 | 18.591 | -96,91 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 13.516 | 20.618 | 190,31 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 13.516 | 20.618 | 190,31 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | -182.539 | 1.028.034 | -15,08 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Shares Option (Right to Buy) |
A - Award | 129.220 | 129.220 | |||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | 220.141 | 281.190 | 360,60 | ||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | 220.141 | 281.190 | 360,60 | ||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | -692.706 | 0 | -100,00 | ||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | -1.603.238 | 2.826.766 | -36,19 | ||||
| 2019-06-05 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 24.747 | 24.747 | |||||
| 2019-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37.520 | 37.520 | |||||
| 2019-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37.520 | 37.520 | |||||
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -22.720 | 7.382.978 | -0,31 | 120,77 | -2.743.928 | 891.653.328 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2.729 | 952.874 | -0,29 | 120,77 | -329.585 | 115.080.022 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -13.213 | 7.405.698 | -0,18 | 122,31 | -1.616.054 | 905.775.370 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1.587 | 955.603 | -0,17 | 122,31 | -194.103 | 116.877.796 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -15.355 | 7.418.911 | -0,21 | 120,12 | -1.844.459 | 891.167.750 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1.845 | 957.190 | -0,19 | 120,12 | -221.623 | 114.978.716 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -35.796 | 7.434.266 | -0,48 | 122,37 | -4.380.432 | 909.746.742 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -4.300 | 959.035 | -0,45 | 122,37 | -526.200 | 117.359.127 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -30.766 | 7.470.062 | -0,41 | 123,06 | -3.786.036 | 919.259.107 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -3.696 | 963.335 | -0,38 | 123,06 | -454.826 | 118.547.138 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -39.732 | 7.500.828 | -0,53 | 121,37 | -4.822.189 | 910.359.743 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -4.772 | 967.031 | -0,49 | 121,37 | -579.168 | 117.366.522 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -71.819 | 7.540.560 | -0,94 | 127,06 | -9.125.258 | 958.096.767 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -8.627 | 971.803 | -0,88 | 127,06 | -1.096.139 | 123.476.415 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -22.886 | 7.612.379 | -0,30 | 125,05 | -2.861.901 | 951.930.278 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2.749 | 980.430 | -0,28 | 125,05 | -343.763 | 122.603.066 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -15.541 | 7.635.265 | -0,20 | 126,25 | -1.962.085 | 963.969.004 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1.867 | 983.179 | -0,19 | 126,25 | -235.713 | 124.128.512 | |
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 7.038 | 7.038 | |||||
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 7.038 | 7.038 | |||||
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 2.963 | 45.842.649 | 0,01 | ||||
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 2.963 | 45.842.649 | 0,01 | ||||
| 2019-05-17 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2.726 | 7.650.806 | 0,04 | ||||
| 2019-05-17 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2.726 | 7.650.806 | 0,04 | ||||
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 45.839.686 | 0,02 | 8,38 | 83.800 | 384.136.569 | |
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 45.839.686 | 0,02 | 8,38 | 83.800 | 384.136.569 | |
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12.472 | 12.472 | |||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12.472 | 12.472 | |||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12.472 | 12.472 | |||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1.520 | 812.602 | 0,19 | ||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1.520 | 812.602 | 0,19 | ||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1.520 | 812.602 | 0,19 | ||||
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9.232 | 7.639.338 | -0,12 | 65,32 | -603.070 | 499.031.352 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.417 | 1.214.575 | -0,12 | 65,32 | -92.564 | 79.340.776 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -244 | 241.891 | -0,10 | 65,32 | -15.939 | 15.801.263 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -142 | 157.519 | -0,09 | 65,32 | -9.276 | 10.289.755 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 49.893 | -0,02 | 65,32 | -719 | 3.259.205 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -158 | 171.091 | -0,09 | 65,32 | -10.321 | 11.176.331 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63.775 | 7.648.570 | -0,83 | 67,13 | -4.281.177 | 513.443.915 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9.791 | 1.215.992 | -0,80 | 67,13 | -657.264 | 81.628.813 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.688 | 242.135 | -0,69 | 67,13 | -113.314 | 16.254.377 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -979 | 157.661 | -0,62 | 67,13 | -65.720 | 10.583.688 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 49.904 | -0,15 | 67,13 | -4.968 | 3.350.026 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.093 | 171.249 | -0,63 | 67,13 | -73.372 | 11.495.843 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -173.085 | 7.712.345 | -2,19 | 64,62 | -11.184.701 | 498.369.420 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -26.575 | 1.225.783 | -2,12 | 64,62 | -1.717.269 | 79.209.730 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.581 | 243.823 | -1,84 | 64,62 | -296.023 | 15.755.769 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.656 | 158.640 | -1,65 | 64,62 | -171.630 | 10.251.269 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -202 | 49.978 | -0,40 | 64,62 | -13.053 | 3.229.563 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.966 | 172.342 | -1,69 | 64,62 | -191.662 | 11.136.688 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -106.054 | 7.885.430 | -1,33 | 66,61 | -7.063.981 | 525.227.990 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16.282 | 1.252.358 | -1,28 | 66,61 | -1.084.502 | 83.416.310 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.807 | 248.404 | -1,12 | 66,61 | -186.967 | 16.545.545 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.628 | 161.296 | -1,00 | 66,61 | -108.437 | 10.743.507 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -124 | 50.180 | -0,25 | 66,61 | -8.259 | 3.342.359 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.817 | 175.308 | -1,03 | 66,61 | -121.026 | 11.676.810 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -60.618 | 7.991.484 | -0,75 | 67,42 | -4.086.914 | 538.792.244 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9.307 | 1.268.640 | -0,73 | 67,42 | -627.485 | 85.532.724 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.604 | 251.211 | -0,63 | 67,42 | -108.143 | 16.936.847 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -930 | 162.924 | -0,57 | 67,42 | -62.701 | 10.984.466 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 50.304 | -0,14 | 67,42 | -4.787 | 3.391.536 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.039 | 177.125 | -0,58 | 67,42 | -70.050 | 11.941.909 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10.832 | 8.052.102 | -0,13 | 69,12 | -748.735 | 556.581.420 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.663 | 1.277.947 | -0,13 | 69,12 | -114.951 | 88.334.892 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -287 | 252.815 | -0,11 | 69,12 | -19.838 | 17.475.205 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -166 | 163.854 | -0,10 | 69,12 | -11.474 | 11.325.998 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 50.375 | -0,03 | 69,12 | -899 | 3.482.046 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -185 | 178.164 | -0,10 | 69,12 | -12.788 | 12.315.141 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -102.618 | 8.062.934 | -1,26 | 68,70 | -7.049.918 | 553.928.404 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15.755 | 1.279.610 | -1,22 | 68,70 | -1.082.378 | 87.909.975 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.716 | 253.102 | -1,06 | 68,70 | -186.591 | 17.388.259 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.575 | 164.020 | -0,95 | 68,70 | -108.203 | 11.268.272 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -120 | 50.388 | -0,24 | 68,70 | -8.244 | 3.461.686 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.758 | 178.349 | -0,98 | 68,70 | -120.776 | 12.252.683 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15.543 | 8.165.552 | -0,19 | 67,68 | -1.051.888 | 552.611.897 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.386 | 1.295.365 | -0,18 | 67,68 | -161.475 | 87.665.122 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -411 | 255.818 | -0,16 | 67,68 | -27.815 | 17.312.739 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -239 | 165.595 | -0,14 | 67,68 | -16.175 | 11.206.807 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 50.508 | -0,04 | 67,68 | -1.218 | 3.418.179 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -266 | 180.107 | -0,15 | 67,68 | -18.002 | 12.188.921 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.813 | 8.181.095 | -0,02 | 67,87 | -123.047 | 555.244.373 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -278 | 1.297.751 | -0,02 | 67,87 | -18.868 | 88.077.322 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 256.229 | -0,02 | 67,87 | -3.258 | 17.390.057 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 165.834 | -0,02 | 67,87 | -1.900 | 11.255.021 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 50.526 | 0,00 | 67,87 | -136 | 3.429.159 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -31 | 180.373 | -0,02 | 67,87 | -2.104 | 12.241.771 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18.661 | 8.182.908 | -0,23 | 67,90 | -1.267.017 | 555.590.813 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.865 | 1.298.029 | -0,22 | 67,90 | -194.523 | 88.131.626 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -494 | 256.277 | -0,19 | 67,90 | -33.541 | 17.400.311 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -286 | 165.862 | -0,17 | 67,90 | -19.418 | 11.261.449 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22 | 50.528 | -0,04 | 67,90 | -1.494 | 3.430.674 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -320 | 180.404 | -0,18 | 67,90 | -21.727 | 12.248.800 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42.863 | 8.201.569 | -0,52 | 68,72 | -2.945.370 | 563.578.195 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.581 | 1.300.894 | -0,50 | 68,72 | -452.219 | 89.392.102 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.134 | 256.771 | -0,44 | 68,72 | -77.924 | 17.644.250 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -658 | 166.148 | -0,39 | 68,72 | -45.215 | 11.417.009 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -50 | 50.550 | -0,10 | 68,72 | -3.436 | 3.473.589 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -734 | 180.724 | -0,40 | 68,72 | -50.437 | 12.418.612 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21.116 | 8.244.432 | -0,26 | 68,63 | -1.449.147 | 565.798.055 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.242 | 1.307.475 | -0,25 | 68,63 | -222.492 | 89.729.264 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -559 | 257.905 | -0,22 | 68,63 | -38.363 | 17.699.479 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -324 | 166.806 | -0,19 | 68,63 | -22.235 | 11.447.545 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 50.600 | -0,05 | 68,63 | -1.716 | 3.472.572 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -362 | 181.458 | -0,20 | 68,63 | -24.843 | 12.453.081 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66.784 | 8.265.548 | -0,80 | 66,64 | -4.450.459 | 550.812.813 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10.253 | 1.310.717 | -0,78 | 66,64 | -683.256 | 87.345.657 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.768 | 258.464 | -0,68 | 66,64 | -117.819 | 17.223.938 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.025 | 167.130 | -0,61 | 66,64 | -68.306 | 11.137.476 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -78 | 50.625 | -0,15 | 66,64 | -5.198 | 3.373.630 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.145 | 181.820 | -0,63 | 66,64 | -76.302 | 12.116.412 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -80.146 | 8.332.332 | -0,95 | 68,90 | -5.521.963 | 574.087.676 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12.305 | 1.320.970 | -0,92 | 68,90 | -847.800 | 91.013.248 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.121 | 260.232 | -0,81 | 68,90 | -146.134 | 17.929.673 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.230 | 168.155 | -0,73 | 68,90 | -84.746 | 11.585.678 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -93 | 50.703 | -0,18 | 68,90 | -6.408 | 3.493.376 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.374 | 182.965 | -0,75 | 68,90 | -94.667 | 12.606.069 | |
| 2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4.161 | 89.233 | 4,89 | 2,59 | 10.777 | 231.113 | |
| 2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4.161 | 89.233 | 4,89 | 2,59 | 10.777 | 231.113 | |
| 2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4.161 | 4.288.031 | 0,10 | 2,59 | 10.777 | 11.106.000 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 8.412.478 | 0,00 | 66,84 | 19.918 | 562.290.030 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 8.412.478 | 0,00 | 66,84 | 19.918 | 562.290.030 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 1.507.172 | 0,02 | 66,84 | 19.918 | 100.739.376 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 436.250 | 0,07 | 66,84 | 19.918 | 29.158.950 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 343.282 | 0,09 | 66,84 | 19.918 | 22.944.969 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 224.693 | 0,13 | 66,84 | 19.918 | 15.018.480 | |
| 2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811.082 | 0,03 | 86,01 | 18.922 | 69.761.163 | |
| 2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811.082 | 0,03 | 86,01 | 18.922 | 69.761.163 | |
| 2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811.082 | 0,03 | 86,01 | 18.922 | 69.761.163 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46.678 | 8.412.180 | -0,55 | 74,71 | -3.487.122 | 628.439.478 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7.167 | 1.332.977 | -0,53 | 74,71 | -535.417 | 99.581.246 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.235 | 262.055 | -0,47 | 74,71 | -92.262 | 19.577.055 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -716 | 169.087 | -0,42 | 74,71 | -53.489 | 12.631.797 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -55 | 50.498 | -0,11 | 74,71 | -4.109 | 3.772.499 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -800 | 184.041 | -0,43 | 74,71 | -59.765 | 13.748.949 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41.281 | 8.458.858 | -0,49 | 74,34 | -3.068.962 | 628.858.572 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.338 | 1.340.144 | -0,47 | 74,34 | -471.187 | 99.630.593 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.092 | 263.290 | -0,41 | 74,34 | -81.183 | 19.573.821 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -634 | 169.803 | -0,37 | 74,34 | -47.134 | 12.623.698 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 50.553 | -0,09 | 74,34 | -3.568 | 3.758.272 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -707 | 184.841 | -0,38 | 74,34 | -52.561 | 13.741.671 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -86.620 | 8.500.139 | -1,01 | 74,63 | -6.464.529 | 634.373.024 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13.298 | 1.346.482 | -0,98 | 74,63 | -992.442 | 100.489.163 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.293 | 264.382 | -0,86 | 74,63 | -171.129 | 19.731.067 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.329 | 170.437 | -0,77 | 74,63 | -99.184 | 12.719.867 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -101 | 50.601 | -0,20 | 74,63 | -7.538 | 3.776.398 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.485 | 185.548 | -0,79 | 74,63 | -110.827 | 13.847.614 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -90.251 | 8.586.759 | -1,04 | 74,19 | -6.695.487 | 637.029.325 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13.856 | 1.359.780 | -1,01 | 74,19 | -1.027.941 | 100.878.543 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.388 | 266.675 | -0,89 | 74,19 | -177.160 | 19.783.925 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.385 | 171.766 | -0,80 | 74,19 | -102.750 | 12.742.873 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -106 | 50.702 | -0,21 | 74,19 | -7.864 | 3.761.450 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.547 | 187.033 | -0,82 | 74,19 | -114.768 | 13.875.492 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -413 | 8.677.010 | 0,00 | 74,56 | -30.795 | 647.001.251 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 1.373.636 | 0,00 | 74,56 | -4.698 | 102.425.168 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 269.063 | 0,00 | 74,56 | -820 | 20.062.683 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 173.151 | 0,00 | 74,56 | -447 | 12.911.004 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7 | 188.580 | 0,00 | 74,56 | -522 | 14.061.468 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42.124 | 8.677.423 | -0,48 | 74,50 | -3.138.238 | 646.468.014 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.467 | 1.373.699 | -0,47 | 74,50 | -481.792 | 102.340.576 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.115 | 269.074 | -0,41 | 74,50 | -83.068 | 20.046.013 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -647 | 173.157 | -0,37 | 74,50 | -48.202 | 12.900.196 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -49 | 50.808 | -0,10 | 74,50 | -3.650 | 3.785.196 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -722 | 188.587 | -0,38 | 74,50 | -53.789 | 14.049.732 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.068 | 8.719.547 | -0,04 | 76,57 | -234.915 | 667.649.610 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -471 | 1.380.166 | -0,03 | 76,57 | -36.064 | 105.678.345 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -81 | 270.189 | -0,03 | 76,57 | -6.202 | 20.688.183 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -47 | 173.804 | -0,03 | 76,57 | -3.599 | 13.308.051 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 50.857 | -0,01 | 76,57 | -306 | 3.894.085 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -52 | 189.309 | -0,03 | 76,57 | -3.982 | 14.495.258 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41.281 | 8.458.858 | -0,49 | 74,34 | -3.068.962 | 628.858.572 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.338 | 1.340.144 | -0,47 | 74,34 | -471.187 | 99.630.593 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.092 | 263.290 | -0,41 | 74,34 | -81.183 | 19.573.821 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -634 | 169.803 | -0,37 | 74,34 | -47.134 | 12.623.698 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 50.553 | -0,09 | 74,34 | -3.568 | 3.758.272 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -707 | 184.841 | -0,38 | 74,34 | -52.561 | 13.741.671 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.648 | 8.722.615 | -0,02 | 76,03 | -125.301 | 663.197.864 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1.380.637 | -0,02 | 76,03 | -19.236 | 104.972.592 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 270.270 | -0,02 | 76,03 | -3.345 | 20.549.169 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 173.851 | -0,01 | 76,03 | -1.901 | 13.218.239 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 50.861 | 0,00 | 76,03 | -152 | 3.867.064 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 189.361 | -0,01 | 76,03 | -2.129 | 14.397.496 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51.987 | 8.724.263 | -0,59 | 76,50 | -3.977.031 | 667.410.482 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7.982 | 1.380.890 | -0,57 | 76,50 | -610.627 | 105.638.775 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.375 | 270.314 | -0,51 | 76,50 | -105.188 | 20.679.156 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -798 | 173.876 | -0,46 | 76,50 | -61.047 | 13.301.601 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -61 | 50.863 | -0,12 | 76,50 | -4.667 | 3.891.045 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -891 | 189.389 | -0,47 | 76,50 | -68.162 | 14.488.353 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -247 | 8.776.250 | 0,00 | 75,40 | -18.624 | 661.729.250 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39 | 1.388.872 | 0,00 | 75,40 | -2.941 | 104.720.949 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7 | 271.689 | 0,00 | 75,40 | -528 | 20.485.351 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 174.674 | 0,00 | 75,40 | -302 | 13.170.420 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 174.674 | 0,00 | 75,40 | -302 | 13.170.420 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 50.924 | 0,00 | 75,40 | -75 | 3.839.670 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63.047 | 8.776.497 | -0,71 | 75,92 | -4.786.390 | 666.292.344 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9.679 | 1.388.911 | -0,69 | 75,92 | -734.808 | 105.443.068 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.668 | 271.696 | -0,61 | 75,92 | -126.631 | 20.626.563 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -967 | 174.678 | -0,55 | 75,92 | -73.413 | 13.261.169 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -73 | 50.925 | -0,14 | 75,92 | -5.542 | 3.866.114 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.080 | 190.284 | -0,56 | 75,92 | -81.991 | 14.445.943 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.832 | 8.839.544 | -0,03 | 76,05 | -215.369 | 672.232.294 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -435 | 1.398.590 | -0,03 | 76,05 | -33.081 | 106.360.392 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -75 | 273.364 | -0,03 | 76,05 | -5.704 | 20.788.867 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 175.645 | -0,02 | 76,05 | -3.270 | 13.357.504 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 | 50.998 | -0,01 | 76,05 | -228 | 3.878.311 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -49 | 191.364 | -0,03 | 76,05 | -3.726 | 14.552.907 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -61.122 | 8.842.376 | -0,69 | 75,63 | -4.622.669 | 668.750.665 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9.384 | 1.399.025 | -0,67 | 75,63 | -709.714 | 105.808.541 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.618 | 273.439 | -0,59 | 75,63 | -122.370 | 20.680.246 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -938 | 175.688 | -0,53 | 75,63 | -70.941 | 13.287.319 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 51.001 | -0,14 | 75,63 | -5.370 | 3.857.216 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.047 | 191.413 | -0,54 | 75,63 | -79.185 | 14.476.603 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.296 | 8.903.498 | -0,04 | 74,03 | -244.007 | 659.137.531 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -506 | 1.408.409 | -0,04 | 74,03 | -37.460 | 104.266.349 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -87 | 275.057 | -0,03 | 74,03 | -6.441 | 20.362.827 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51 | 176.626 | -0,03 | 74,03 | -3.776 | 13.075.852 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 51.072 | -0,01 | 74,03 | -296 | 3.780.927 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 192.460 | -0,03 | 74,03 | -4.146 | 14.248.064 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37.107 | 8.906.794 | -0,41 | 75,08 | -2.786.101 | 668.747.923 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5.697 | 1.408.915 | -0,40 | 75,08 | -427.747 | 105.785.424 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -982 | 275.144 | -0,36 | 75,08 | -73.731 | 20.658.609 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -569 | 176.677 | -0,32 | 75,08 | -42.722 | 13.265.422 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 51.076 | -0,08 | 75,08 | -3.229 | 3.834.934 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -637 | 192.516 | -0,33 | 75,08 | -47.828 | 14.454.660 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18.703 | 8.943.901 | -0,21 | 73,55 | -1.375.551 | 657.797.981 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.872 | 1.414.612 | -0,20 | 73,55 | -211.227 | 104.040.610 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -495 | 276.126 | -0,18 | 73,55 | -36.406 | 20.308.267 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -287 | 177.246 | -0,16 | 73,55 | -21.108 | 13.035.929 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22 | 51.119 | -0,04 | 73,55 | -1.618 | 3.759.654 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -321 | 193.153 | -0,17 | 73,55 | -23.609 | 14.205.843 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.647 | 8.962.604 | -0,02 | 73,72 | -121.421 | 660.745.573 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1.417.484 | -0,02 | 73,72 | -18.652 | 104.500.464 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 276.621 | -0,02 | 73,72 | -3.244 | 20.393.192 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 177.533 | -0,01 | 73,72 | -1.843 | 13.088.177 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 51.141 | 0,00 | 73,72 | -147 | 3.770.242 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29 | 193.474 | -0,01 | 73,72 | -2.138 | 14.263.387 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.486 | 8.964.251 | -0,09 | 77,04 | -653.755 | 690.598.726 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.303 | 1.417.737 | -0,09 | 77,04 | -100.382 | 109.221.324 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -225 | 276.665 | -0,08 | 77,04 | -17.334 | 21.314.050 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -130 | 177.558 | -0,07 | 77,04 | -10.015 | 13.678.926 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 51.143 | -0,02 | 77,04 | -770 | 3.940.016 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -146 | 193.503 | -0,08 | 77,04 | -11.248 | 14.907.316 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22.914 | 8.972.737 | -0,25 | 76,49 | -1.752.680 | 686.320.167 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.518 | 1.419.040 | -0,25 | 76,49 | -269.090 | 108.541.660 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -607 | 276.890 | -0,22 | 76,49 | -46.429 | 21.179.178 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -352 | 177.688 | -0,20 | 76,49 | -26.924 | 13.591.266 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 51.153 | -0,05 | 76,49 | -2.065 | 3.912.667 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -393 | 193.649 | -0,20 | 76,49 | -30.060 | 14.812.115 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -58.412 | 8.995.651 | -0,65 | 77,15 | -4.506.626 | 694.036.064 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.968 | 1.422.558 | -0,63 | 77,15 | -691.903 | 109.753.764 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.546 | 277.497 | -0,55 | 77,15 | -119.278 | 21.409.560 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -896 | 178.040 | -0,50 | 77,15 | -69.129 | 13.736.213 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -68 | 51.180 | -0,13 | 77,15 | -5.246 | 3.948.660 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.001 | 194.042 | -0,51 | 77,15 | -77.230 | 14.970.806 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.909 | 9.054.063 | -0,08 | 77,64 | -536.386 | 702.919.424 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.060 | 1.431.526 | -0,07 | 77,64 | -82.294 | 111.137.666 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -183 | 279.043 | -0,07 | 77,64 | -14.207 | 21.663.727 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -107 | 178.936 | -0,06 | 77,64 | -8.307 | 13.891.840 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 51.248 | -0,02 | 77,64 | -621 | 3.978.679 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -118 | 195.043 | -0,06 | 77,64 | -9.161 | 15.142.319 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -493 | 9.060.972 | -0,01 | 76,20 | -37.565 | 690.423.414 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 1.432.586 | -0,01 | 76,20 | -5.791 | 109.159.472 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 279.226 | 0,00 | 76,20 | -991 | 21.276.323 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 179.043 | 0,00 | 76,20 | -610 | 13.642.629 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51.256 | 0,00 | 76,20 | -76 | 3.905.579 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 195.161 | 0,00 | 76,20 | -686 | 14.870.780 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -742 | 9.061.465 | -0,01 | 76,20 | -56.540 | 690.483.633 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -114 | 1.432.662 | -0,01 | 76,20 | -8.687 | 109.168.844 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -20 | 279.239 | -0,01 | 76,20 | -1.524 | 21.278.012 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 179.051 | -0,01 | 76,20 | -838 | 13.643.686 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51.257 | 0,00 | 76,20 | -76 | 3.905.783 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 195.170 | -0,01 | 76,20 | -991 | 14.871.954 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -31.482 | 9.062.207 | -0,35 | 76,66 | -2.413.501 | 694.735.069 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.833 | 1.432.776 | -0,34 | 76,66 | -370.512 | 109.840.763 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -833 | 279.259 | -0,30 | 76,66 | -63.860 | 21.408.805 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -484 | 179.062 | -0,27 | 76,66 | -37.105 | 13.727.412 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37 | 51.258 | -0,07 | 76,66 | -2.837 | 3.929.587 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -539 | 195.183 | -0,28 | 76,66 | -41.321 | 14.963.295 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -620 | 9.093.689 | -0,01 | 77,81 | -48.239 | 707.539.019 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -95 | 1.437.609 | -0,01 | 77,81 | -7.392 | 111.853.887 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 280.092 | -0,01 | 77,81 | -1.245 | 21.792.698 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 179.546 | -0,01 | 77,81 | -778 | 13.969.666 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51.295 | 0,00 | 77,81 | -78 | 3.991.033 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 195.722 | -0,01 | 77,81 | -856 | 15.228.248 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.506 | 9.094.309 | -0,07 | 78,13 | -508.342 | 710.577.468 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -999 | 1.437.704 | -0,07 | 78,13 | -78.056 | 112.333.996 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -172 | 280.108 | -0,06 | 78,13 | -13.439 | 21.886.043 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -100 | 179.556 | -0,06 | 78,13 | -7.813 | 14.029.482 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 51.296 | -0,02 | 78,13 | -625 | 4.007.977 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -112 | 195.733 | -0,06 | 78,13 | -8.751 | 15.293.461 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 9.100.815 | 0,09 | 17,59 | 145.118 | 160.083.336 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 9.100.815 | 0,09 | 17,59 | 145.118 | 160.083.336 | |
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 29.288.793 | 0,07 | 2,80 | 56.000 | 82.008.620 | |
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 29.288.793 | 0,07 | 2,80 | 56.000 | 82.008.620 | |
| 2019-02-06 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1.818.475 | 8.837.349 | 25,91 | ||||
| 2019-02-06 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 181.525 | 916.043 | 24,71 | ||||
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13.634 | 9.092.565 | -0,15 | 70,55 | -961.887 | 641.485.916 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.093 | 1.430.453 | -0,15 | 70,55 | -147.662 | 100.919.317 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -361 | 280.280 | -0,13 | 70,55 | -25.469 | 19.773.922 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -210 | 179.656 | -0,12 | 70,55 | -14.816 | 12.674.839 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 51.304 | -0,03 | 70,55 | -1.129 | 3.619.528 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -234 | 195.845 | -0,12 | 70,55 | -16.509 | 13.816.982 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24.660 | 9.106.199 | -0,27 | 71,35 | -1.759.553 | 649.750.064 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.786 | 1.432.546 | -0,26 | 71,35 | -270.141 | 102.215.738 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -653 | 280.641 | -0,23 | 71,35 | -46.593 | 20.024.437 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -378 | 179.866 | -0,21 | 71,35 | -26.971 | 12.833.889 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29 | 51.320 | -0,06 | 71,35 | -2.069 | 3.661.810 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -423 | 196.079 | -0,22 | 71,35 | -30.182 | 13.990.727 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -75.736 | 9.130.859 | -0,82 | 72,20 | -5.468.397 | 659.279.065 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11.627 | 1.436.332 | -0,80 | 72,20 | -839.509 | 103.708.054 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.004 | 281.294 | -0,71 | 72,20 | -144.696 | 20.310.383 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.162 | 180.244 | -0,64 | 72,20 | -83.900 | 13.014.230 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89 | 51.349 | -0,17 | 72,20 | -6.426 | 3.707.572 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.298 | 196.502 | -0,66 | 72,20 | -93.720 | 14.188.113 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -65.426 | 9.206.595 | -0,71 | 72,02 | -4.711.967 | 663.057.131 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10.044 | 1.447.959 | -0,69 | 72,02 | -723.367 | 104.281.718 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.732 | 283.298 | -0,61 | 72,02 | -124.738 | 20.403.065 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.004 | 181.406 | -0,55 | 72,02 | -72.308 | 13.064.824 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 51.438 | -0,15 | 72,02 | -5.474 | 3.704.554 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.121 | 197.800 | -0,56 | 72,02 | -80.734 | 14.245.516 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.648 | 9.272.021 | -0,02 | 73,46 | -121.054 | 681.076.303 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1.458.003 | -0,02 | 73,46 | -18.584 | 107.097.610 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 285.030 | -0,02 | 73,46 | -3.232 | 20.936.879 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 182.410 | -0,01 | 73,46 | -1.836 | 13.398.927 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 51.514 | 0,00 | 73,46 | -147 | 3.783.961 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 198.921 | -0,01 | 73,46 | -2.057 | 14.611.742 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29.260 | 9.273.669 | -0,31 | 70,52 | -2.063.313 | 653.946.680 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.492 | 1.458.256 | -0,31 | 70,52 | -316.760 | 102.831.109 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -774 | 285.074 | -0,27 | 70,52 | -54.580 | 20.102.421 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -450 | 182.435 | -0,25 | 70,52 | -31.732 | 12.864.678 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -34 | 51.516 | -0,07 | 70,52 | -2.398 | 3.632.728 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -502 | 198.949 | -0,25 | 70,52 | -35.399 | 14.029.187 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42.521 | 9.302.929 | -0,45 | 71,00 | -3.018.995 | 660.508.889 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.529 | 1.462.748 | -0,44 | 71,00 | -463.560 | 103.855.254 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.125 | 285.848 | -0,39 | 71,00 | -79.875 | 20.295.237 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -652 | 182.885 | -0,36 | 71,00 | -46.292 | 12.984.853 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -50 | 51.550 | -0,10 | 71,00 | -3.550 | 3.660.055 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -729 | 199.451 | -0,36 | 71,00 | -51.759 | 14.161.041 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10.547 | 9.345.450 | -0,11 | 71,61 | -755.298 | 669.251.973 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.619 | 1.469.277 | -0,11 | 71,61 | -115.941 | 105.218.746 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -279 | 286.973 | -0,10 | 71,61 | -19.980 | 20.550.883 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -162 | 183.537 | -0,09 | 71,61 | -11.601 | 13.143.562 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12 | 51.600 | -0,02 | 71,61 | -859 | 3.695.210 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -181 | 200.180 | -0,09 | 71,61 | -12.962 | 14.335.410 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13.595 | 9.355.997 | -0,15 | 72,23 | -981.964 | 675.781.792 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.087 | 1.470.896 | -0,14 | 72,23 | -150.744 | 106.242.524 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 287.252 | -0,13 | 72,23 | -26.003 | 20.748.155 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -209 | 183.699 | -0,11 | 72,23 | -15.096 | 13.268.542 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 51.612 | -0,03 | 72,23 | -1.156 | 3.727.924 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -233 | 200.361 | -0,12 | 72,23 | -16.830 | 14.472.035 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -132.363 | 9.369.592 | -1,39 | 72,79 | -9.634.226 | 681.978.871 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -20.322 | 1.472.983 | -1,36 | 72,79 | -1.479.165 | 107.213.130 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.503 | 287.612 | -1,20 | 72,79 | -254.971 | 20.934.242 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.031 | 183.908 | -1,09 | 72,79 | -147.829 | 13.386.001 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -155 | 51.628 | -0,30 | 72,79 | -11.282 | 3.757.816 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.268 | 200.594 | -1,12 | 72,79 | -165.080 | 14.600.515 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -149.754 | 9.501.955 | -1,55 | 70,79 | -10.601.295 | 672.656.697 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22.991 | 1.493.305 | -1,52 | 70,79 | -1.627.565 | 105.713.152 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.963 | 291.115 | -1,34 | 70,79 | -280.546 | 20.608.438 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.298 | 185.939 | -1,22 | 70,79 | -162.679 | 13.162.882 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -175 | 51.783 | -0,34 | 70,79 | -12.388 | 3.665.791 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.566 | 202.862 | -1,25 | 70,79 | -181.651 | 14.360.885 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -493 | 9.651.709 | -0,01 | 70,07 | -34.545 | 676.311.658 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 1.516.296 | -0,01 | 70,07 | -5.325 | 106.249.438 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 295.078 | 0,00 | 70,07 | -911 | 20.676.617 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 188.237 | 0,00 | 70,07 | -561 | 13.190.087 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51.958 | 0,00 | 70,07 | -70 | 3.640.785 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 205.428 | 0,00 | 70,07 | -631 | 14.394.689 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -23.462 | 9.652.202 | -0,24 | 70,22 | -1.647.574 | 677.807.546 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.602 | 1.516.372 | -0,24 | 70,22 | -252.944 | 106.484.343 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -621 | 295.091 | -0,21 | 70,22 | -43.609 | 20.722.205 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 188.245 | -0,19 | 70,22 | -25.280 | 13.219.147 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 51.959 | -0,05 | 70,22 | -1.896 | 3.648.722 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -402 | 205.437 | -0,20 | 70,22 | -28.230 | 14.426.423 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.392 | 9.675.664 | -0,09 | 70,28 | -589.772 | 679.985.347 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.288 | 1.519.974 | -0,08 | 70,28 | -90.518 | 106.820.581 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -222 | 295.712 | -0,08 | 70,28 | -15.602 | 20.782.018 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 188.605 | -0,07 | 70,28 | -9.066 | 13.254.763 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 51.986 | -0,02 | 70,28 | -703 | 3.653.467 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -144 | 205.839 | -0,07 | 70,28 | -10.120 | 14.465.933 | |
| 2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.658 | 85.072 | 4,49 | 3,52 | 12.876 | 299.453 | |
| 2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.658 | 85.072 | 4,49 | 3,52 | 12.876 | 299.453 | |
| 2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.658 | 85.072 | 4,49 | 3,52 | 12.876 | 299.453 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295.934 | 0,10 | 64,41 | 19.967 | 19.061.109 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295.934 | 0,10 | 64,41 | 19.967 | 19.061.109 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295.934 | 0,10 | 64,41 | 19.967 | 19.061.109 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 1.695.159 | 0,02 | 64,41 | 19.967 | 109.185.191 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 225.893 | 0,14 | 64,41 | 19.967 | 14.549.768 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 362.631 | 0,09 | 64,41 | 19.967 | 23.357.063 | |
| 2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 810.862 | 0,04 | 63,59 | 18.950 | 51.562.715 | |
| 2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 810.862 | 0,04 | 63,59 | 18.950 | 51.562.715 | |
| 2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 29.421.884 | 0,00 | 63,59 | 18.950 | 1.870.937.604 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15.243 | 9.683.746 | -0,16 | 73,09 | -1.114.047 | 707.744.323 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.340 | 1.520.952 | -0,15 | 73,09 | -171.021 | 111.159.994 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -403 | 295.624 | -0,14 | 73,09 | -29.454 | 21.605.917 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -234 | 188.424 | -0,12 | 73,09 | -17.102 | 13.771.119 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 51.686 | -0,03 | 73,09 | -1.316 | 3.777.513 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -262 | 205.673 | -0,13 | 73,09 | -19.148 | 15.031.776 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12.627 | 9.698.989 | -0,13 | 71,81 | -906.797 | 696.524.166 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.939 | 1.523.292 | -0,13 | 71,81 | -139.248 | 109.393.844 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -334 | 296.027 | -0,11 | 71,81 | -23.986 | 21.258.913 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -194 | 188.658 | -0,10 | 71,81 | -13.932 | 13.548.304 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15 | 51.704 | -0,03 | 71,81 | -1.077 | 3.713.076 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -216 | 205.935 | -0,10 | 71,81 | -15.512 | 14.789.037 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -34.794 | 9.711.616 | -0,36 | 74,88 | -2.605.510 | 727.243.681 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5.342 | 1.525.231 | -0,35 | 74,88 | -400.030 | 114.215.246 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -921 | 296.361 | -0,31 | 74,88 | -68.968 | 22.192.667 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -534 | 188.852 | -0,28 | 74,88 | -39.988 | 14.141.974 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41 | 51.719 | -0,08 | 74,88 | -3.070 | 3.872.920 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -597 | 206.151 | -0,29 | 74,88 | -44.706 | 15.437.391 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7.718 | 9.746.410 | -0,08 | 73,83 | -569.813 | 719.568.679 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.185 | 1.530.573 | -0,08 | 73,83 | -87.487 | 113.000.827 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -204 | 297.282 | -0,07 | 73,83 | -15.061 | 21.948.063 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -118 | 189.386 | -0,06 | 73,83 | -8.712 | 13.982.198 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 51.760 | -0,02 | 73,83 | -664 | 3.821.394 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -132 | 206.748 | -0,06 | 73,83 | -9.745 | 15.264.019 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -84.418 | 9.754.128 | -0,86 | 76,15 | -6.428.768 | 742.815.864 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12.961 | 1.531.758 | -0,84 | 76,15 | -987.032 | 116.649.499 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.234 | 297.486 | -0,75 | 76,15 | -170.128 | 22.654.749 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.296 | 189.504 | -0,68 | 76,15 | -98.696 | 14.431.488 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -99 | 51.769 | -0,19 | 76,15 | -7.539 | 3.942.416 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.447 | 206.880 | -0,69 | 76,15 | -110.195 | 15.754.740 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76.364 | 9.838.546 | -0,77 | 75,46 | -5.762.481 | 742.423.568 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11.724 | 1.544.719 | -0,75 | 75,46 | -884.701 | 116.565.577 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.021 | 299.720 | -0,67 | 75,46 | -152.506 | 22.617.081 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.172 | 190.800 | -0,61 | 75,46 | -88.440 | 14.397.902 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89 | 51.868 | -0,17 | 75,46 | -6.716 | 3.913.996 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.309 | 208.327 | -0,62 | 75,46 | -98.778 | 15.720.501 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.538 | 9.914.910 | -0,03 | 77,75 | -197.318 | 770.839.635 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -390 | 1.556.443 | -0,03 | 77,75 | -30.321 | 121.006.439 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -67 | 301.741 | -0,02 | 77,75 | -5.209 | 23.459.005 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39 | 191.972 | -0,02 | 77,75 | -3.032 | 14.924.959 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 | 51.957 | -0,01 | 77,75 | -233 | 4.039.423 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 209.636 | -0,02 | 77,75 | -3.343 | 16.298.256 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5.493 | 9.917.448 | -0,06 | 73,81 | -405.449 | 732.025.680 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -843 | 1.556.833 | -0,05 | 73,81 | -62.223 | 114.912.802 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -146 | 301.808 | -0,05 | 73,81 | -10.777 | 22.277.022 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -84 | 192.011 | -0,04 | 73,81 | -6.200 | 14.172.697 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 51.960 | -0,01 | 73,81 | -443 | 3.835.266 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -95 | 209.679 | -0,05 | 73,81 | -7.012 | 15.476.805 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18.604 | 9.922.941 | -0,19 | 75,83 | -1.410.758 | 752.465.547 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.856 | 1.557.676 | -0,18 | 75,83 | -216.573 | 118.119.973 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -492 | 301.954 | -0,16 | 75,83 | -37.309 | 22.897.444 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -286 | 192.095 | -0,15 | 75,83 | -21.688 | 14.566.737 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21 | 51.966 | -0,04 | 75,83 | -1.592 | 3.940.629 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -319 | 209.774 | -0,15 | 75,83 | -24.190 | 15.907.351 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -371 | 9.941.545 | 0,00 | 77,11 | -28.608 | 766.592.535 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -57 | 1.560.532 | 0,00 | 77,11 | -4.395 | 120.332.623 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 302.446 | 0,00 | 77,11 | -771 | 23.321.611 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 192.381 | 0,00 | 77,11 | -463 | 14.834.499 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 192.381 | 0,00 | 77,11 | -463 | 14.834.499 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51.987 | 0,00 | 77,11 | -77 | 4.008.718 | |
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | 1.569 | 1.569 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | 1.569 | 1.569 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | -10.731 | 0 | -100,00 | ||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 71.647 | 71.647 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 71.647 | 71.647 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | -489.977 | 0 | -100,00 | ||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11.178.823 | 35.976.940 | 45,08 | 17,00 | 190.039.991 | 611.607.980 | |
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 585.882 | 3.736.902 | 18,59 | 17,00 | 9.959.994 | 63.527.334 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -247 | 9.941.916 | 0,00 | 76,62 | -18.925 | 761.724.749 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38 | 1.560.589 | 0,00 | 76,62 | -2.911 | 119.568.428 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 302.456 | 0,00 | 76,62 | -460 | 23.173.423 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 192.387 | 0,00 | 76,62 | -306 | 14.740.211 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 192.387 | 0,00 | 76,62 | -306 | 14.740.211 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51.988 | 0,00 | 76,62 | -77 | 3.983.191 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -32.598 | 9.942.163 | -0,33 | 77,52 | -2.527.147 | 770.762.210 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5.005 | 1.560.627 | -0,32 | 77,52 | -388.011 | 120.986.984 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -863 | 302.462 | -0,28 | 77,52 | -66.904 | 23.448.246 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -500 | 192.391 | -0,26 | 77,52 | -38.762 | 14.915.035 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38 | 51.989 | -0,07 | 77,52 | -2.946 | 4.030.426 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -559 | 210.103 | -0,27 | 77,52 | -43.336 | 16.288.151 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89.047 | 9.974.761 | -0,88 | 78,05 | -6.950.074 | 778.525.109 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13.671 | 1.565.632 | -0,87 | 78,05 | -1.067.015 | 122.196.795 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.357 | 303.325 | -0,77 | 78,05 | -183.963 | 23.674.365 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.367 | 192.891 | -0,70 | 78,05 | -106.694 | 15.055.046 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -104 | 52.027 | -0,20 | 78,05 | -8.117 | 4.060.681 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.526 | 210.662 | -0,72 | 78,05 | -119.104 | 16.442.064 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44.659 | 10.063.808 | -0,44 | 80,09 | -3.576.721 | 806.006.357 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.856 | 1.579.303 | -0,43 | 80,09 | -549.094 | 126.485.746 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.182 | 305.682 | -0,39 | 80,09 | -94.666 | 24.481.949 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -685 | 194.258 | -0,35 | 80,09 | -54.861 | 15.558.046 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -52 | 52.131 | -0,10 | 80,09 | -4.165 | 4.175.151 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -765 | 212.188 | -0,36 | 80,09 | -61.269 | 16.994.052 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129.121 | 10.108.467 | -1,26 | 79,07 | -10.209.675 | 799.282.551 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19.824 | 1.586.159 | -1,23 | 79,07 | -1.567.496 | 125.418.544 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.417 | 306.864 | -1,10 | 79,07 | -270.184 | 24.263.921 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.981 | 194.943 | -1,01 | 79,07 | -156.639 | 15.414.260 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -151 | 52.183 | -0,29 | 79,07 | -11.940 | 4.126.141 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.214 | 212.953 | -1,03 | 79,07 | -175.062 | 16.838.321 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39.591 | 10.237.588 | -0,39 | 79,63 | -3.152.536 | 815.194.562 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.078 | 1.605.983 | -0,38 | 79,63 | -483.977 | 127.880.572 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.048 | 310.281 | -0,34 | 79,63 | -83.450 | 24.706.931 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -608 | 196.924 | -0,31 | 79,63 | -48.414 | 15.680.586 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46 | 52.334 | -0,09 | 79,63 | -3.663 | 4.167.231 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -678 | 215.167 | -0,31 | 79,63 | -53.988 | 17.133.232 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -30.257 | 10.277.179 | -0,29 | 77,61 | -2.348.376 | 797.656.054 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.646 | 1.612.061 | -0,29 | 77,61 | -360.596 | 125.118.986 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -801 | 311.329 | -0,26 | 77,61 | -62.169 | 24.163.582 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -465 | 197.532 | -0,23 | 77,61 | -36.091 | 15.331.308 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -35 | 52.380 | -0,07 | 77,61 | -2.717 | 4.065.437 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -518 | 215.845 | -0,24 | 77,61 | -40.204 | 16.752.659 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11.994 | 10.307.436 | -0,12 | 78,80 | -945.149 | 812.244.510 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.841 | 1.616.707 | -0,11 | 78,80 | -145.074 | 127.399.422 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -317 | 312.130 | -0,10 | 78,80 | -24.980 | 24.596.406 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -184 | 197.997 | -0,09 | 78,80 | -14.500 | 15.602.520 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -14 | 52.415 | -0,03 | 78,80 | -1.103 | 4.130.396 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -206 | 216.363 | -0,10 | 78,80 | -16.233 | 17.049.794 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -77.976 | 10.319.430 | -0,75 | 76,81 | -5.989.017 | 792.593.109 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11.972 | 1.618.548 | -0,73 | 76,81 | -919.520 | 124.314.036 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.064 | 312.447 | -0,66 | 76,81 | -158.527 | 23.997.773 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.197 | 198.181 | -0,60 | 76,81 | -91.937 | 15.221.470 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -91 | 52.429 | -0,17 | 76,81 | -6.989 | 4.026.857 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.335 | 216.569 | -0,61 | 76,81 | -102.536 | 16.633.777 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13.595 | 10.397.406 | -0,13 | 74,01 | -1.006.150 | 769.499.541 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.087 | 1.630.520 | -0,13 | 74,01 | -154.456 | 120.672.829 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 314.511 | -0,11 | 74,01 | -26.643 | 23.276.582 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -209 | 199.378 | -0,10 | 74,01 | -15.468 | 14.755.727 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 52.520 | -0,03 | 74,01 | -1.184 | 3.886.942 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -233 | 217.904 | -0,11 | 74,01 | -17.244 | 16.126.814 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -57.979 | 10.411.001 | -0,55 | 74,71 | -4.331.524 | 777.790.268 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.901 | 1.632.607 | -0,54 | 74,71 | -664.980 | 121.969.620 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.534 | 314.871 | -0,48 | 74,71 | -114.603 | 23.523.540 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -890 | 199.587 | -0,44 | 74,71 | -66.491 | 14.910.845 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -68 | 52.536 | -0,13 | 74,71 | -5.080 | 3.924.886 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -994 | 218.137 | -0,45 | 74,71 | -74.260 | 16.296.688 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56.764 | 10.468.980 | -0,54 | 75,27 | -4.272.831 | 788.037.813 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.715 | 1.641.508 | -0,53 | 75,27 | -656.009 | 123.562.217 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.502 | 316.405 | -0,47 | 75,27 | -113.061 | 23.816.943 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -871 | 200.477 | -0,43 | 75,27 | -65.563 | 15.090.626 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66 | 52.604 | -0,13 | 75,27 | -4.968 | 3.959.692 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -973 | 219.131 | -0,44 | 75,27 | -73.241 | 16.494.779 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -36.652 | 10.525.744 | -0,35 | 73,76 | -2.703.294 | 776.333.617 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5.627 | 1.650.223 | -0,34 | 73,76 | -415.023 | 121.713.353 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -970 | 317.907 | -0,30 | 73,76 | -71.543 | 23.447.453 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -563 | 201.348 | -0,28 | 73,76 | -41.524 | 14.850.563 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 52.670 | -0,08 | 73,76 | -3.171 | 3.884.713 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -628 | 220.104 | -0,28 | 73,76 | -46.319 | 16.233.925 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -77.558 | 10.562.396 | -0,73 | 74,24 | -5.758.092 | 784.177.629 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11.907 | 1.655.850 | -0,71 | 74,24 | -884.004 | 122.934.278 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.052 | 318.877 | -0,64 | 74,24 | -152.345 | 23.674.194 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.190 | 201.911 | -0,59 | 74,24 | -88.348 | 14.990.357 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -91 | 52.713 | -0,17 | 74,24 | -6.756 | 3.913.540 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.329 | 220.732 | -0,60 | 74,24 | -98.668 | 16.387.673 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.204 | 10.639.954 | -0,08 | 74,05 | -607.484 | 787.859.866 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.260 | 1.667.757 | -0,08 | 74,05 | -93.300 | 123.492.903 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -217 | 320.929 | -0,07 | 74,05 | -16.068 | 23.763.926 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -126 | 203.101 | -0,06 | 74,05 | -9.330 | 15.039.081 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 52.804 | -0,02 | 74,05 | -740 | 3.909.994 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -141 | 222.061 | -0,06 | 74,05 | -10.441 | 16.443.017 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24.487 | 10.648.158 | -0,23 | 74,36 | -1.820.848 | 791.794.899 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.759 | 1.669.017 | -0,22 | 74,36 | -279.518 | 124.107.770 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -648 | 321.146 | -0,20 | 74,36 | -48.185 | 23.880.352 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -376 | 203.227 | -0,18 | 74,36 | -27.959 | 15.111.919 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 52.814 | -0,05 | 74,36 | -2.082 | 3.927.238 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -419 | 222.202 | -0,19 | 74,36 | -31.157 | 16.522.896 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -55.365 | 10.672.645 | -0,52 | 76,35 | -4.227.024 | 814.838.302 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.499 | 1.672.776 | -0,51 | 76,35 | -648.884 | 127.713.604 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.466 | 321.794 | -0,45 | 76,35 | -111.927 | 24.568.425 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -850 | 203.603 | -0,42 | 76,35 | -64.896 | 15.544.743 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -65 | 52.842 | -0,12 | 76,35 | -4.963 | 4.034.397 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -949 | 222.621 | -0,42 | 76,35 | -72.455 | 16.996.735 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16.646 | 10.728.010 | -0,15 | 77,66 | -1.292.763 | 833.159.785 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.556 | 1.681.275 | -0,15 | 77,66 | -198.504 | 130.571.347 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -440 | 323.260 | -0,14 | 77,66 | -34.171 | 25.105.050 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -255 | 204.453 | -0,12 | 77,66 | -19.804 | 15.878.249 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19 | 52.907 | -0,04 | 77,66 | -1.476 | 4.108.869 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -285 | 223.570 | -0,13 | 77,66 | -22.134 | 17.362.916 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38.330 | 10.744.656 | -0,36 | 79,13 | -3.033.110 | 850.240.746 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5.885 | 1.683.831 | -0,35 | 79,13 | -465.689 | 133.244.073 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.014 | 323.700 | -0,31 | 79,13 | -80.239 | 25.614.867 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -588 | 204.708 | -0,29 | 79,13 | -46.529 | 16.198.851 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -45 | 52.926 | -0,08 | 79,13 | -3.561 | 4.188.114 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -657 | 223.855 | -0,29 | 79,13 | -51.989 | 17.713.982 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.296 | 10.782.986 | -0,03 | 80,09 | -263.978 | 863.613.662 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -506 | 1.689.716 | -0,03 | 80,09 | -40.526 | 135.330.030 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -87 | 324.714 | -0,03 | 80,09 | -6.968 | 26.006.474 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51 | 205.296 | -0,02 | 80,09 | -4.085 | 16.442.239 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 52.971 | -0,01 | 80,09 | -320 | 4.242.469 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 224.512 | -0,02 | 80,09 | -4.485 | 17.981.256 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -53.013 | 10.786.282 | -0,49 | 80,07 | -4.244.714 | 863.650.049 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.139 | 1.690.222 | -0,48 | 80,07 | -651.684 | 135.334.892 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.403 | 324.801 | -0,43 | 80,07 | -112.337 | 26.006.589 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -814 | 205.347 | -0,39 | 80,07 | -65.176 | 16.441.991 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -62 | 52.975 | -0,12 | 80,07 | -4.964 | 4.241.671 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -908 | 224.568 | -0,40 | 80,07 | -72.703 | 17.981.003 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -99.280 | 10.839.295 | -0,91 | 78,09 | -7.752.428 | 846.402.609 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15.242 | 1.698.361 | -0,89 | 78,09 | -1.190.194 | 132.619.066 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.628 | 326.204 | -0,80 | 78,09 | -205.211 | 25.472.129 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.524 | 206.161 | -0,73 | 78,09 | -119.004 | 16.098.391 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -115 | 53.037 | -0,22 | 78,09 | -8.980 | 4.141.474 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.702 | 225.476 | -0,75 | 78,09 | -132.903 | 17.606.632 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15.014 | 10.938.575 | -0,14 | 81,26 | -1.220.038 | 888.868.604 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.305 | 1.713.603 | -0,13 | 81,26 | -187.304 | 139.247.380 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -397 | 328.832 | -0,12 | 81,26 | -32.260 | 26.720.888 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -230 | 207.685 | -0,11 | 81,26 | -18.690 | 16.876.483 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 53.152 | -0,03 | 81,26 | -1.463 | 4.319.132 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -257 | 227.178 | -0,11 | 81,26 | -20.884 | 18.460.484 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46.511 | 10.953.589 | -0,42 | 81,16 | -3.774.912 | 889.011.904 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7.140 | 1.715.908 | -0,41 | 81,16 | -579.495 | 139.266.010 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.231 | 329.229 | -0,37 | 81,16 | -99.910 | 26.720.785 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -714 | 207.915 | -0,34 | 81,16 | -57.949 | 16.874.735 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -54 | 53.170 | -0,10 | 81,16 | -4.383 | 4.315.368 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -796 | 227.435 | -0,35 | 81,16 | -64.605 | 18.459.011 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7.533 | 11.000.100 | -0,07 | 80,51 | -606.473 | 885.604.851 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.156 | 1.723.048 | -0,07 | 80,51 | -93.068 | 138.720.527 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -199 | 330.460 | -0,06 | 80,51 | -16.021 | 26.604.938 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -116 | 208.629 | -0,06 | 80,51 | -9.339 | 16.796.470 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 53.224 | -0,02 | 80,51 | -725 | 4.285.000 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 228.231 | -0,06 | 80,51 | -10.386 | 18.374.604 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11.877 | 11.007.633 | -0,11 | 80,38 | -954.711 | 884.828.765 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.824 | 1.724.204 | -0,11 | 80,38 | -146.619 | 138.597.035 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -314 | 330.659 | -0,09 | 80,38 | -25.240 | 26.579.429 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -182 | 208.745 | -0,09 | 80,38 | -14.630 | 16.779.591 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -14 | 53.233 | -0,03 | 80,38 | -1.125 | 4.279.039 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -204 | 228.360 | -0,09 | 80,38 | -16.398 | 18.356.308 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19.367 | 11.019.510 | -0,18 | 85,11 | -1.648.296 | 937.853.967 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.973 | 1.726.028 | -0,17 | 85,11 | -253.028 | 146.899.654 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -513 | 330.973 | -0,15 | 85,11 | -43.661 | 28.168.616 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -297 | 208.927 | -0,14 | 85,11 | -25.277 | 17.781.464 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -23 | 53.247 | -0,04 | 85,11 | -1.957 | 4.531.772 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -332 | 228.564 | -0,15 | 85,11 | -28.256 | 19.452.739 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -112.010 | 11.038.877 | -1,00 | 82,06 | -9.191.025 | 905.799.468 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -17.198 | 1.729.001 | -0,98 | 82,06 | -1.411.189 | 141.873.869 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.964 | 331.486 | -0,89 | 82,06 | -243.212 | 27.200.216 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.720 | 209.224 | -0,82 | 82,06 | -141.135 | 17.167.959 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 53.270 | -0,24 | 82,06 | -10.585 | 4.371.091 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.919 | 228.896 | -0,83 | 82,06 | -157.464 | 18.782.153 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.157 | 11.150.887 | -0,07 | 82,55 | -673.321 | 920.452.198 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.252 | 1.746.199 | -0,07 | 82,55 | -103.347 | 144.140.346 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -216 | 334.450 | -0,06 | 82,55 | -17.830 | 27.607.242 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -125 | 210.944 | -0,06 | 82,55 | -10.318 | 17.412.415 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 53.399 | -0,02 | 82,55 | -743 | 4.407.831 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -140 | 230.815 | -0,06 | 82,55 | -11.556 | 19.052.670 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.120 | 11.159.044 | -0,04 | 83,90 | -345.678 | 936.271.689 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -633 | 1.747.451 | -0,04 | 83,90 | -53.110 | 146.615.508 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -109 | 334.666 | -0,03 | 83,90 | -9.145 | 28.079.314 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 211.069 | -0,03 | 83,90 | -5.286 | 17.709.217 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53.408 | -0,01 | 83,90 | -420 | 4.481.065 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 230.955 | -0,03 | 83,90 | -5.957 | 19.377.702 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -62.929 | 11.163.164 | -0,56 | 83,20 | -5.235.598 | 928.758.500 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9.661 | 1.748.084 | -0,55 | 83,20 | -803.781 | 145.437.967 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.665 | 334.775 | -0,49 | 83,20 | -138.526 | 27.852.778 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -966 | 211.132 | -0,46 | 83,20 | -80.370 | 17.565.866 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 53.413 | -0,14 | 83,20 | -6.157 | 4.443.881 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.078 | 231.026 | -0,46 | 83,20 | -89.688 | 19.221.017 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -17.602 | 11.226.093 | -0,16 | 85,87 | -1.511.565 | 964.036.246 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.702 | 1.757.745 | -0,15 | 85,87 | -232.033 | 150.945.649 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -466 | 336.440 | -0,14 | 85,87 | -40.018 | 28.891.650 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -270 | 212.098 | -0,13 | 85,87 | -23.186 | 18.213.831 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21 | 53.487 | -0,04 | 85,87 | -1.803 | 4.593.175 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -302 | 232.104 | -0,13 | 85,87 | -25.934 | 19.931.838 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.120 | 11.243.695 | -0,04 | 82,00 | -337.840 | 921.982.990 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -633 | 1.760.447 | -0,04 | 82,00 | -51.906 | 144.356.654 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -109 | 336.906 | -0,03 | 82,00 | -8.938 | 27.626.292 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 212.368 | -0,03 | 82,00 | -5.166 | 17.414.176 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53.508 | -0,01 | 82,00 | -410 | 4.387.656 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 232.406 | -0,03 | 82,00 | -5.822 | 19.057.292 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.565 | 11.247.815 | -0,01 | 83,85 | -131.227 | 943.138.286 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -240 | 1.761.080 | -0,01 | 83,85 | -20.124 | 147.667.967 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42 | 337.015 | -0,01 | 83,85 | -3.522 | 28.258.977 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24 | 212.431 | -0,01 | 83,85 | -2.012 | 17.812.509 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 53.513 | 0,00 | 83,85 | -168 | 4.487.108 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 232.477 | -0,01 | 83,85 | -2.264 | 19.493.382 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9.301 | 11.249.380 | -0,08 | 84,84 | -789.121 | 954.426.648 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.428 | 1.761.320 | -0,08 | 84,84 | -121.155 | 149.434.968 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -246 | 337.057 | -0,07 | 84,84 | -20.871 | 28.596.792 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -143 | 212.455 | -0,07 | 84,84 | -12.132 | 18.025.235 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 53.515 | -0,02 | 84,84 | -933 | 4.540.352 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -159 | 232.504 | -0,07 | 84,84 | -13.490 | 19.726.244 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21.423 | 11.258.681 | -0,19 | 89,34 | -1.913.901 | 1.005.834.798 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.289 | 1.762.748 | -0,19 | 89,34 | -293.835 | 157.481.438 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -567 | 337.303 | -0,17 | 89,34 | -50.655 | 30.134.178 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -329 | 212.598 | -0,15 | 89,34 | -29.392 | 18.993.208 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 53.526 | -0,05 | 89,34 | -2.233 | 4.781.938 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -367 | 232.663 | -0,16 | 89,34 | -32.787 | 20.785.787 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -30.555 | 11.280.104 | -0,27 | 85,15 | -2.601.670 | 960.468.143 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.692 | 1.766.037 | -0,26 | 85,15 | -399.510 | 150.372.929 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -809 | 337.870 | -0,24 | 85,15 | -68.884 | 28.768.651 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -470 | 212.927 | -0,22 | 85,15 | -40.019 | 18.130.117 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37 | 53.551 | -0,07 | 85,15 | -3.150 | 4.559.712 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -522 | 233.030 | -0,22 | 85,15 | -44.447 | 19.841.829 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -36.174 | 11.310.659 | -0,32 | 85,78 | -3.102.970 | 970.217.018 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5.554 | 1.770.729 | -0,31 | 85,78 | -476.417 | 151.891.363 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -957 | 338.679 | -0,28 | 85,78 | -82.091 | 29.051.546 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -555 | 213.397 | -0,26 | 85,78 | -47.607 | 18.304.981 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42 | 53.588 | -0,08 | 85,78 | -3.603 | 4.596.725 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -620 | 233.552 | -0,26 | 85,78 | -53.183 | 20.033.857 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.663 | 11.346.833 | -0,03 | 87,30 | -319.780 | 990.579.656 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -562 | 1.776.283 | -0,03 | 87,30 | -49.063 | 155.069.684 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -97 | 339.636 | -0,03 | 87,30 | -8.468 | 29.650.257 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 213.952 | -0,03 | 87,30 | -4.889 | 18.678.031 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 53.630 | -0,01 | 87,30 | -349 | 4.681.904 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 234.172 | -0,03 | 87,30 | -5.500 | 20.443.239 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.306 | 11.350.496 | -0,04 | 88,38 | -380.544 | 1.003.104.624 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -661 | 1.776.845 | -0,04 | 88,38 | -58.416 | 157.029.388 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -114 | 339.733 | -0,03 | 88,38 | -10.075 | 30.024.040 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66 | 214.008 | -0,03 | 88,38 | -5.833 | 18.913.043 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53.634 | -0,01 | 88,38 | -442 | 4.739.926 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 234.235 | -0,03 | 88,38 | -6.540 | 20.700.612 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15.798 | 11.354.802 | -0,14 | 83,94 | -1.326.160 | 953.176.583 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.425 | 1.777.506 | -0,14 | 83,94 | -203.566 | 149.212.386 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -418 | 339.847 | -0,12 | 83,94 | -35.089 | 28.528.388 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -242 | 214.074 | -0,11 | 83,94 | -20.315 | 17.970.399 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 53.639 | -0,03 | 83,94 | -1.511 | 4.502.715 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -271 | 234.309 | -0,12 | 83,94 | -22.749 | 19.669.022 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Secured Bridge Notes 30% 12/1/2020 |
C - Conversion | -3.660.993 | 0 | -100,00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Secured Bridge Notes 30% 12/1/2020 |
C - Conversion | -294.948 | 0 | -100,00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Series B Redeemable Convertible Preferred Shares |
C - Conversion | -4.627.208 | 0 | -100,00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Series B Redeemable Convertible Preferred Shares |
C - Conversion | -372.792 | 0 | -100,00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.248.102 | 8.374.935 | 36,69 | 10,00 | 22.481.020 | 83.749.350 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 251.898 | 770.180 | 48,60 | 10,00 | 2.518.980 | 7.701.800 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
J - Other | 767.427 | 6.126.833 | 14,32 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
J - Other | 86.501 | 518.282 | 20,03 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 732.198 | 5.359.406 | 15,82 | 5,00 | 3.660.990 | 26.797.030 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 58.989 | 431.781 | 15,82 | 5,00 | 294.945 | 2.158.905 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 4.627.208 | 4.627.208 | |||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 372.792 | 372.792 | |||||
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 340.265 | 0,08 | 70,18 | 19.931 | 23.879.798 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 340.265 | 0,08 | 70,18 | 19.931 | 23.879.798 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 11.544.497 | 0,00 | 70,18 | 19.931 | 810.192.799 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 1.953.828 | 0,01 | 70,18 | 19.931 | 137.119.649 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 227.554 | 0,12 | 70,18 | 19.931 | 15.969.740 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 388.213 | 0,07 | 70,18 | 19.931 | 27.244.788 | |
| 2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2.340 | 81.414 | 2,96 | 8,71 | 20.381 | 709.116 | |
| 2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2.340 | 81.414 | 2,96 | 8,71 | 20.381 | 709.116 | |
| 2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2.340 | 4.280.212 | 0,05 | 8,71 | 20.381 | 37.280.647 | |
| 2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 810.564 | 0,03 | 69,08 | 18.997 | 55.993.761 | |
| 2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 810.564 | 0,03 | 69,08 | 18.997 | 55.993.761 | |
| 2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 1.269.837 | 0,02 | 69,08 | 18.997 | 87.720.340 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 131.007 | 24.798.117 | 0,53 | 19,09 | 2.501.238 | 473.455.569 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 14.555 | 3.151.020 | 0,46 | 19,09 | 277.890 | 60.160.534 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 38.207 | 24.667.110 | 0,16 | 19,01 | 726.353 | 468.946.428 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4.245 | 3.136.465 | 0,14 | 19,01 | 80.702 | 59.627.336 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 920.495 | 24.628.903 | 3,88 | 18,64 | 17.154.897 | 458.999.014 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 102.267 | 3.132.220 | 3,38 | 18,64 | 1.905.909 | 58.373.931 | |
| 2018-08-06 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
P - Purchase | 5.231.900 | 5.250.491 | 28.142,11 | 108,00 | 565.045.200 | 567.053.028 | |
| 2018-08-06 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
P - Purchase | 582.200 | 600.791 | 3.131,62 | 108,00 | 62.877.600 | 64.885.428 | |
| 2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16.383 | 632.599 | 2,66 | 1,32 | 21.626 | 835.031 | |
| 2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16.383 | 632.599 | 2,66 | 1,32 | 21.626 | 835.031 | |
| 2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16.383 | 34.222.983 | 0,05 | 1,32 | 21.626 | 45.174.338 | |
| 2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810.289 | 0,03 | 67,00 | 18.961 | 54.289.363 | |
| 2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810.289 | 0,03 | 67,00 | 18.961 | 54.289.363 | |
| 2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810.289 | 0,03 | 67,00 | 18.961 | 54.289.363 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339.981 | 0,12 | 50,40 | 19.958 | 17.135.042 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339.981 | 0,12 | 50,40 | 19.958 | 17.135.042 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339.981 | 0,12 | 50,40 | 19.958 | 17.135.042 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 1.953.544 | 0,02 | 50,40 | 19.958 | 98.458.618 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 227.270 | 0,17 | 50,40 | 19.958 | 11.454.408 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 387.929 | 0,10 | 50,40 | 19.958 | 19.551.622 | |
| 2018-06-21 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100.000 | 100.000 | |||||
| 2018-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20.000 | 20.000 | |||||
| 2018-06-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30.000 | 30.000 | |||||
| 2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 34.884 | 34.884 | |||||
| 2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
A - Award | 18.580 | 73.180.602 | 0,03 | ||||
| 2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
A - Award | 18.580 | 73.180.602 | 0,03 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class B1 Common Shares |
C - Conversion | 14.658.102 | 14.658.102 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series A Preferred |
C - Conversion | -14.658.102 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class B1 Common Shares |
C - Conversion | 1.399.516 | 1.399.516 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series A Preferred |
C - Conversion | -1.399.516 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 3.284.771 | 7.018.874 | 87,97 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series B Preferred |
C - Conversion | -3.284.771 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 313.621 | 734.518 | 74,51 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series B Preferred |
C - Conversion | -313.621 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 3.734.103 | 3.734.103 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
C - Conversion | -3.734.103 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 420.897 | 420.897 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
C - Conversion | -420.897 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
P - Purchase | 2.700.597 | 2.700.597 | 18,00 | 48.610.746 | 48.610.746 | ||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
P - Purchase | 299.403 | 299.403 | 18,00 | 5.389.254 | 5.389.254 | ||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
P - Purchase | 3.734.103 | 3.734.103 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
P - Purchase | 420.897 | 420.897 | |||||
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 45.829.686 | 0,01 | 56,77 | 210.049 | 2.601.751.274 | |
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 45.829.686 | 0,01 | 56,77 | 210.049 | 2.601.751.274 | |
| 2018-05-11 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2.174 | 7.648.080 | 0,03 | ||||
| 2018-05-11 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2.174 | 7.648.080 | 0,03 | ||||
| 2018-05-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30.000 | 30.000 | |||||
| 2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 126.399 | 45.825.986 | 0,28 | 54,02 | 6.828.339 | 2.475.615.998 | |
| 2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 129.715 | 45.699.587 | 0,28 | 53,70 | 6.966.305 | 2.454.282.610 | |
| 2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 204.537 | 45.569.872 | 0,45 | 52,68 | 10.775.582 | 2.400.748.453 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 810.006 | 2,53 | 9,92 | 198.400 | 8.035.260 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 810.006 | 2,53 | 9,92 | 198.400 | 8.035.260 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 810.006 | 2,53 | 9,92 | 198.400 | 8.035.260 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.105 | 45.365.335 | 0,02 | 54,42 | 495.488 | 2.468.749.775 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21.442 | 45.356.230 | 0,05 | 52,26 | 1.120.576 | 2.370.352.865 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37.400 | 45.334.788 | 0,08 | 52,33 | 1.957.022 | 2.372.224.385 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.000 | 45.297.388 | 0,00 | 51,88 | 103.750 | 2.349.802.002 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.951 | 45.295.388 | 0,01 | 52,33 | 311.418 | 2.370.321.243 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37.963 | 45.289.437 | 0,08 | 52,06 | 1.976.213 | 2.357.600.519 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57.270 | 45.251.474 | 0,13 | 51,37 | 2.941.708 | 2.324.369.113 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.500 | 45.194.204 | 0,02 | 51,36 | 539.280 | 2.321.174.317 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22.700 | 45.183.704 | 0,05 | 51,30 | 1.164.424 | 2.317.752.317 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72.533 | 45.161.004 | 0,16 | 51,26 | 3.717.693 | 2.314.736.292 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100.000 | 45.088.471 | 0,22 | 51,14 | 5.114.000 | 2.305.824.407 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 44.988.471 | 0,02 | 10,08 | 100.800 | 453.483.788 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 44.988.471 | 0,02 | 10,08 | 100.800 | 453.483.788 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 168.097 | 44.978.471 | 0,38 | 51,25 | 8.614.786 | 2.305.097.162 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 52.700 | 44.810.374 | 0,12 | 51,07 | 2.691.173 | 2.288.282.078 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 248.121 | 44.757.674 | 0,56 | 51,03 | 12.661.069 | 2.283.885.637 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 154.218 | 44.509.553 | 0,35 | 50,90 | 7.849.897 | 2.265.594.110 | |
| 2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13.349 | 616.216 | 2,21 | 1,62 | 21.625 | 998.270 | |
| 2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13.349 | 616.216 | 2,21 | 1,62 | 21.625 | 998.270 | |
| 2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13.349 | 616.216 | 2,21 | 1,62 | 21.625 | 998.270 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 339.585 | 0,19 | 31,29 | 19.963 | 10.625.615 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1.382.967 | 0,05 | 31,29 | 19.963 | 43.273.037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1.382.967 | 0,05 | 31,29 | 19.963 | 43.273.037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1.382.967 | 0,05 | 31,29 | 19.963 | 43.273.037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1.382.967 | 0,05 | 31,29 | 19.963 | 43.273.037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 339.585 | 0,19 | 31,29 | 19.963 | 10.625.615 | |
| 2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 790.006 | 0,03 | 83,33 | 18.999 | 65.831.200 | |
| 2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 1.249.279 | 0,02 | 83,33 | 18.999 | 104.102.419 | |
| 2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 790.006 | 0,03 | 83,33 | 18.999 | 65.831.200 | |
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -439.036 | 0 | -100,00 | ||||
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -17.626.445 | 0 | -100,00 | ||||
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -2.250.846 | 0 | -100,00 | ||||
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 439.036 | 602.867 | 267,98 | 0,47 | 206.347 | 283.347 | |
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 17.626.445 | 34.193.251 | 106,40 | 0,47 | 8.284.429 | 16.070.828 | |
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 2.250.846 | 4.102.796 | 121,54 | 0,47 | 1.057.898 | 1.928.314 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 338.947 | 2,49 | 18,50 | 152.625 | 6.270.520 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 338.947 | 2,49 | 18,50 | 152.625 | 6.270.520 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 1.382.329 | 0,60 | 18,50 | 152.625 | 25.573.086 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 1.382.329 | 0,60 | 18,50 | 152.625 | 25.573.086 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 1.382.329 | 0,60 | 18,50 | 152.625 | 25.573.086 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 338.947 | 2,49 | 18,50 | 152.625 | 6.270.520 | |
| 2018-02-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.456.543 | 44.355.335 | 8,45 | 52,00 | 179.740.236 | 2.306.477.420 | |
| 2018-02-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 389.610 | 5.278.174 | 7,97 | 52,00 | 20.259.720 | 274.465.048 | |
| 2018-01-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1.645.148 | 5.121.404 | 47,33 | 101,00 | 166.159.948 | 517.261.804 | |
| 2018-01-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 335.050 | 708.025 | 89,83 | 101,00 | 33.840.050 | 71.510.525 | |
| 2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9.333 | 163.831 | 6,04 | 2,21 | 20.626 | 362.067 | |
| 2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9.333 | 163.831 | 6,04 | 2,21 | 20.626 | 362.067 | |
| 2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9.333 | 163.831 | 6,04 | 2,21 | 20.626 | 362.067 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330.697 | 0,18 | 34,20 | 19.973 | 11.309.837 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330.697 | 0,18 | 34,20 | 19.973 | 11.309.837 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1.374.079 | 0,04 | 34,20 | 19.973 | 46.993.502 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1.374.079 | 0,04 | 34,20 | 19.973 | 46.993.502 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1.374.079 | 0,04 | 34,20 | 19.973 | 46.993.502 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330.697 | 0,18 | 34,20 | 19.973 | 11.309.837 | |
| 2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789.778 | 0,03 | 94,71 | 18.942 | 74.799.874 | |
| 2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789.778 | 0,03 | 94,71 | 18.942 | 74.799.874 | |
| 2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789.778 | 0,03 | 94,71 | 18.942 | 74.799.874 | |
| 2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
M - Exercise | -39.378 | 0 | -100,00 | ||||
| 2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
F - Taxes | -1.941 | 489.977 | -0,39 | 28,00 | -54.348 | 13.719.356 | |
| 2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 39.378 | 491.918 | 8,70 | 1,38 | 54.342 | 678.847 | |
| 2017-10-30 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7.204.652 | 16.557.473 | 77,03 | 1,50 | 10.806.978 | 24.836.210 | |
| 2017-10-30 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 795.348 | 1.842.617 | 75,94 | 1,50 | 1.193.022 | 2.763.926 | |
| 2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
M - Exercise | -1.426.590 | 0 | -100,00 | ||||
| 2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
F - Taxes | -55.457 | 23.708.408 | -0,23 | 35,40 | -1.963.178 | 839.277.643 | |
| 2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1.426.590 | 23.763.865 | 6,39 | 1,38 | 1.968.694 | 32.794.134 | |
| 2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 7.102 | 7.102 | |||||
| 2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 7.102 | 7.102 | |||||
| 2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | -49.200 | 0 | -100,00 | ||||
| 2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9.045 | 154.498 | 6,22 | 2,28 | 20.623 | 352.255 | |
| 2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9.045 | 154.498 | 6,22 | 2,28 | 20.623 | 352.255 | |
| 2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9.045 | 154.498 | 6,22 | 2,28 | 20.623 | 352.255 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330.113 | 0,19 | 32,09 | 19.960 | 10.593.326 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330.113 | 0,19 | 32,09 | 19.960 | 10.593.326 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1.373.495 | 0,05 | 32,09 | 19.960 | 44.075.455 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1.373.495 | 0,05 | 32,09 | 19.960 | 44.075.455 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1.373.495 | 0,05 | 32,09 | 19.960 | 44.075.455 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330.113 | 0,19 | 32,09 | 19.960 | 10.593.326 | |
| 2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789.578 | 0,02 | 116,74 | 18.912 | 92.175.336 | |
| 2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789.578 | 0,02 | 116,74 | 18.912 | 92.175.336 | |
| 2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789.578 | 0,02 | 116,74 | 18.912 | 92.175.336 | |
| 2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2.029 | 789.416 | 0,26 | 132,00 | 267.828 | 104.202.912 | |
| 2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 85.402 | 29.247.347 | 0,29 | 132,00 | 11.273.064 | 3.860.649.804 | |
| 2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12.569 | 4.386.818 | 0,29 | 132,00 | 1.659.108 | 579.059.976 | |
| 2017-08-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 158.279 | 3.476.256 | 4,77 | 71,00 | 11.237.809 | 246.814.176 | |
| 2017-08-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 17.777 | 372.975 | 5,00 | 71,00 | 1.262.167 | 26.481.225 | |
| 2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11.787 | 145.453 | 8,82 | 1,75 | 20.627 | 254.543 | |
| 2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11.787 | 145.453 | 8,82 | 1,75 | 20.627 | 254.543 | |
| 2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11.787 | 145.453 | 8,82 | 1,75 | 20.627 | 254.543 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1.372.873 | 0,04 | 32,55 | 19.986 | 44.687.016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1.372.873 | 0,04 | 32,55 | 19.986 | 44.687.016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1.372.873 | 0,04 | 32,55 | 19.986 | 44.687.016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1.372.873 | 0,04 | 32,55 | 19.986 | 44.687.016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1.372.873 | 0,04 | 32,55 | 19.986 | 44.687.016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 329.491 | 0,19 | 32,55 | 19.986 | 10.724.932 | |
| 2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 1.246.660 | 0,01 | 125,91 | 18.886 | 156.966.961 | |
| 2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 1.246.660 | 0,01 | 125,91 | 18.886 | 156.966.961 | |
| 2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 787.387 | 0,02 | 125,91 | 18.886 | 99.139.897 | |
| 2017-06-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20.000 | 20.000 | |||||
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 22.560 | 7.317.906 | 0,31 | 117,95 | 2.660.914 | 863.134.572 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2.564 | 647.367 | 0,40 | 117,95 | 302.419 | 76.355.837 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 197.126 | 7.295.346 | 2,78 | 117,51 | 23.163.488 | 857.246.927 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 22.399 | 644.803 | 3,60 | 117,51 | 2.632.017 | 75.768.221 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 32.172 | 7.098.220 | 0,46 | 117,22 | 3.771.228 | 832.059.027 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.656 | 622.404 | 0,59 | 117,22 | 428.559 | 72.958.695 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 65.264 | 7.066.048 | 0,93 | 117,01 | 7.636.802 | 826.826.541 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7.416 | 618.748 | 1,21 | 117,01 | 867.776 | 72.402.178 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 898 | 7.000.784 | 0,01 | 116,96 | 105.030 | 818.811.697 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 102 | 611.332 | 0,02 | 116,96 | 11.930 | 71.501.391 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 31.974 | 6.999.886 | 0,46 | 116,71 | 3.731.542 | 816.925.196 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.634 | 611.230 | 0,60 | 116,71 | 424.108 | 71.333.903 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 12.726 | 6.967.912 | 0,18 | 116,37 | 1.480.897 | 810.840.590 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.446 | 607.596 | 0,24 | 116,37 | 168.268 | 70.704.610 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 385.774 | 6.955.186 | 5,87 | 116,37 | 44.891.517 | 809.356.911 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 43.835 | 606.150 | 7,80 | 116,37 | 5.100.965 | 70.536.100 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.976 | 6.569.412 | 0,03 | 116,18 | 229.562 | 763.202.753 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 224 | 562.315 | 0,04 | 116,18 | 26.023 | 65.327.058 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 169.897 | 6.567.436 | 2,66 | 115,77 | 19.668.568 | 760.296.304 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 19.305 | 562.091 | 3,56 | 115,77 | 2.234.894 | 65.071.926 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 207.814 | 6.397.539 | 3,36 | 115,71 | 24.046.636 | 740.273.952 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 23.614 | 542.786 | 4,55 | 115,71 | 2.732.430 | 62.807.016 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 18.678 | 6.189.725 | 0,30 | 115,06 | 2.149.048 | 712.175.522 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2.122 | 519.172 | 0,41 | 115,06 | 244.152 | 59.734.736 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 64.455 | 6.171.047 | 1,06 | 114,33 | 7.369.301 | 705.551.231 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7.324 | 517.050 | 1,44 | 114,33 | 837.371 | 59.115.619 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 160.000 | 980.146 | 19,51 | 117,71 | 18.832.960 | 115.369.065 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 103.200 | 820.146 | 14,39 | 117,63 | 12.139.416 | 96.473.774 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 32.008 | 716.946 | 4,67 | 117,60 | 3.764.067 | 84.311.201 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 300 | 684.938 | 0,04 | 116,75 | 35.025 | 79.966.512 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.747 | 7.645.906 | 0,05 | 116,75 | 437.462 | 892.659.526 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 426 | 684.638 | 0,06 | 116,75 | 49.736 | 79.931.486 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 44.898 | 7.642.159 | 0,59 | 117,50 | 5.275.484 | 897.948.333 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5.102 | 684.212 | 0,75 | 117,50 | 599.481 | 80.394.431 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5.373 | 7.597.261 | 0,07 | 117,21 | 629.790 | 890.504.591 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 611 | 679.110 | 0,09 | 117,21 | 71.618 | 79.601.132 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 217.305 | 7.591.888 | 2,95 | 117,05 | 25.434.638 | 888.598.604 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24.692 | 678.499 | 3,78 | 117,05 | 2.890.095 | 79.415.458 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 8.950 | 7.374.583 | 0,12 | 116,95 | 1.046.720 | 862.471.494 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.017 | 653.807 | 0,16 | 116,95 | 118.940 | 76.463.971 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 39.473 | 7.365.633 | 0,54 | 116,65 | 4.604.506 | 859.197.407 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4.485 | 652.790 | 0,69 | 116,65 | 523.173 | 76.147.627 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4.310 | 7.326.160 | 0,06 | 116,54 | 502.277 | 853.773.836 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 490 | 648.305 | 0,08 | 116,54 | 57.103 | 75.551.974 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.944 | 7.321.850 | 0,05 | 118,00 | 465.392 | 863.978.300 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 448 | 647.815 | 0,07 | 118,00 | 52.864 | 76.442.170 | |
| 2017-06-14 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30.000 | 30.000 | |||||
| 2017-06-09 |
|
4/A | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100.000 | 100.000 | |||||
| 2017-06-08 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100.000 | 100.000 | |||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 328.877 | 2,57 | 18,13 | 149.572 | 5.962.540 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 1.372.259 | 0,60 | 18,13 | 149.572 | 24.879.056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 1.372.259 | 0,60 | 18,13 | 149.572 | 24.879.056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 1.372.259 | 0,60 | 18,13 | 149.572 | 24.879.056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 1.372.259 | 0,60 | 18,13 | 149.572 | 24.879.056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 328.877 | 2,57 | 18,13 | 149.572 | 5.962.540 | |
| 2017-05-31 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 40.898.792 | 0,01 | 66,60 | 246.420 | 2.723.859.547 | |
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 40.898.792 | 0,01 | 66,60 | 246.420 | 2.723.859.547 | |
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 40.895.092 | 0,02 | 10,20 | 102.000 | 417.129.938 | |
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 40.895.092 | 0,02 | 10,20 | 102.000 | 417.129.938 | |
| 2017-05-12 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2.030 | 6.559.338 | 0,03 | ||||
| 2017-05-12 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2.030 | 6.106.592 | 0,03 | ||||
| 2017-05-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Non-Qualified Stock Option (right to buy) |
A - Award | 36.000 | 36.000 | |||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 787.237 | 2,61 | 7,26 | 145.200 | 5.715.341 | |
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 787.237 | 2,61 | 7,26 | 145.200 | 5.715.341 | |
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 787.237 | 2,61 | 7,26 | 145.200 | 5.715.341 | |
| 2017-04-21 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (right to buy) |
A - Award | 399.984 | 399.984 | |||||
| 2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.487 | 133.666 | 6,78 | 2,43 | 20.623 | 324.808 | |
| 2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.487 | 133.666 | 6,78 | 2,43 | 20.623 | 324.808 | |
| 2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.487 | 133.666 | 6,78 | 2,43 | 20.623 | 324.808 | |
| 2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 767.237 | 0,02 | 133,67 | 18.981 | 102.556.570 | |
| 2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 1.226.510 | 0,01 | 133,67 | 18.981 | 163.947.592 | |
| 2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 767.237 | 0,02 | 133,67 | 18.981 | 102.556.570 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 320.627 | 0,20 | 31,49 | 19.965 | 10.096.544 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1.364.009 | 0,05 | 31,49 | 19.965 | 42.952.643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1.364.009 | 0,05 | 31,49 | 19.965 | 42.952.643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1.364.009 | 0,05 | 31,49 | 19.965 | 42.952.643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1.364.009 | 0,05 | 31,49 | 19.965 | 42.952.643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 320.627 | 0,20 | 31,49 | 19.965 | 10.096.544 | |
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -6.050.000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -5.674.000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -243.450.000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -228.326.000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -25.000.000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -25.000.000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 121.672 | 767.095 | 18,85 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 111.514 | 645.423 | 20,89 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 4.896.067 | 29.141.653 | 20,19 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 4.487.412 | 24.245.586 | 22,71 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 502.779 | 4.353.957 | 13,06 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 491.338 | 3.851.178 | 14,62 | ||||
| 2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14.169 | 125.179 | 12,76 | 1,50 | 21.254 | 187.768 | |
| 2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14.169 | 125.179 | 12,76 | 1,50 | 21.254 | 187.768 | |
| 2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14.169 | 125.179 | 12,76 | 1,50 | 21.254 | 187.768 | |
| 2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 993.182 | 0,02 | 100,27 | 18.951 | 99.586.359 | |
| 2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 993.182 | 0,02 | 100,27 | 18.951 | 99.586.359 | |
| 2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 533.909 | 0,04 | 100,27 | 18.951 | 53.535.055 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14.045.614 | 0,00 | 29,39 | 19.985 | 412.800.595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14.045.614 | 0,00 | 29,39 | 19.985 | 412.800.595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14.045.614 | 0,00 | 29,39 | 19.985 | 412.800.595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14.045.614 | 0,00 | 29,39 | 19.985 | 412.800.595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 1.363.375 | 0,05 | 29,39 | 19.985 | 40.069.591 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 319.993 | 0,21 | 29,39 | 19.985 | 9.404.594 | |
| 2016-11-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1.594.671 | 3.317.977 | 92,54 | 32,00 | 51.029.472 | 106.175.264 | |
| 2016-11-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 165.824 | 355.198 | 87,56 | 32,00 | 5.306.368 | 11.366.336 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 294.178 | 40.885.092 | 0,72 | 59,46 | 17.493.177 | 2.431.215.642 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32.122 | 4.874.864 | 0,66 | 59,46 | 1.910.122 | 289.881.838 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50.667 | 40.590.914 | 0,12 | 58,74 | 2.976.321 | 2.384.423.943 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.533 | 4.842.742 | 0,11 | 58,74 | 325.024 | 284.476.225 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18.616 | 40.540.247 | 0,05 | 55,99 | 1.042.351 | 2.269.937.618 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.039 | 4.837.209 | 0,04 | 55,99 | 114.168 | 270.845.974 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16.854 | 40.521.631 | 0,04 | 56,42 | 950.861 | 2.286.129.117 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.846 | 4.835.170 | 0,04 | 56,42 | 104.147 | 272.788.203 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 143.016 | 40.504.777 | 0,35 | 56,48 | 8.078.001 | 2.287.839.420 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15.662 | 4.833.324 | 0,33 | 56,48 | 884.640 | 273.001.606 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 361 | 40.361.761 | 0,00 | 56,49 | 20.393 | 2.280.035.879 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39 | 4.817.662 | 0,00 | 56,49 | 2.203 | 272.149.726 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 456 | 40.361.400 | 0,00 | 56,55 | 25.788 | 2.282.558.254 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50 | 4.817.623 | 0,00 | 56,55 | 2.828 | 272.451.034 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 341.438 | 40.360.944 | 0,85 | 56,91 | 19.430.383 | 2.296.840.421 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37.392 | 4.817.573 | 0,78 | 56,91 | 2.127.885 | 274.156.035 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 95.280 | 40.019.506 | 0,24 | 55,84 | 5.320.673 | 2.234.789.264 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.434 | 4.780.181 | 0,22 | 55,84 | 582.661 | 266.937.257 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.335 | 39.924.226 | 0,01 | 55,87 | 186.336 | 2.230.686.279 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 365 | 4.769.747 | 0,01 | 55,87 | 20.394 | 266.500.074 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6.289 | 39.920.891 | 0,02 | 56,12 | 352.915 | 2.240.208.704 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 689 | 4.769.382 | 0,01 | 56,12 | 38.664 | 267.639.594 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 26.381 | 39.914.602 | 0,07 | 56,13 | 1.480.758 | 2.240.394.636 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.889 | 4.768.693 | 0,06 | 56,13 | 162.159 | 267.665.307 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 289.278 | 39.888.221 | 0,73 | 56,26 | 16.274.202 | 2.244.031.537 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31.679 | 4.765.804 | 0,67 | 56,26 | 1.782.197 | 268.114.601 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.884 | 39.598.943 | 0,01 | 51,83 | 149.479 | 2.052.425.095 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 316 | 4.734.125 | 0,01 | 51,83 | 16.378 | 245.371.119 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.434 | 39.596.059 | 0,01 | 53,33 | 129.815 | 2.111.812.251 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 266 | 4.733.809 | 0,01 | 53,33 | 14.187 | 252.472.496 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32.717 | 39.593.625 | 0,08 | 53,66 | 1.755.578 | 2.124.574.121 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.583 | 4.733.543 | 0,08 | 53,66 | 192.262 | 253.999.551 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40.332 | 39.560.908 | 0,10 | 54,37 | 2.192.976 | 2.151.049.207 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.417 | 4.729.960 | 0,09 | 54,37 | 240.166 | 257.182.588 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 924 | 39.520.576 | 0,00 | 54,51 | 50.365 | 2.154.183.605 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4.725.543 | 0,00 | 54,51 | 5.505 | 257.579.425 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.803 | 39.519.652 | 0,00 | 54,61 | 98.455 | 2.158.021.973 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 197 | 4.725.442 | 0,00 | 54,61 | 10.757 | 258.038.903 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 85.353 | 39.517.849 | 0,22 | 54,93 | 4.688.039 | 2.170.529.712 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.347 | 4.725.245 | 0,20 | 54,93 | 513.387 | 259.535.499 | |
| 2016-10-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.928.596 | 9.309.333 | 45,90 | 2,00 | 5.857.192 | 18.618.666 | |
| 2016-10-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 321.404 | 1.003.781 | 47,10 | 2,00 | 642.808 | 2.007.562 | |
| 2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.299 | 111.010 | 8,08 | 2,56 | 21.245 | 284.186 | |
| 2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.299 | 111.010 | 8,08 | 2,56 | 21.245 | 284.186 | |
| 2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.299 | 111.010 | 8,08 | 2,56 | 21.245 | 284.186 | |
| 2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 992.993 | 0,02 | 94,29 | 18.952 | 93.629.310 | |
| 2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 992.993 | 0,02 | 94,29 | 18.952 | 93.629.310 | |
| 2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 533.720 | 0,04 | 94,29 | 18.952 | 50.324.459 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1.362.695 | 0,05 | 28,92 | 19.955 | 39.409.139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1.362.695 | 0,05 | 28,92 | 19.955 | 39.409.139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1.362.695 | 0,05 | 28,92 | 19.955 | 39.409.139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1.362.695 | 0,05 | 28,92 | 19.955 | 39.409.139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1.362.695 | 0,05 | 28,92 | 19.955 | 39.409.139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 319.313 | 0,22 | 28,92 | 19.955 | 9.234.532 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24.339 | 39.432.496 | 0,06 | 51,55 | 1.254.571 | 2.032.575.609 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.730 | 4.715.898 | 0,06 | 51,55 | 140.720 | 243.084.264 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 58.541 | 39.408.157 | 0,15 | 51,41 | 3.009.341 | 2.025.803.896 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6.565 | 4.713.168 | 0,14 | 51,41 | 337.478 | 242.283.700 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 899 | 39.349.616 | 0,00 | 50,64 | 45.523 | 1.992.546.505 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4.706.603 | 0,00 | 50,64 | 5.114 | 238.328.256 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21.804 | 39.348.717 | 0,06 | 50,42 | 1.099.388 | 1.984.017.399 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.445 | 4.706.502 | 0,05 | 50,42 | 123.280 | 237.308.420 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21.290 | 39.326.913 | 0,05 | 50,41 | 1.073.191 | 1.982.398.896 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.388 | 4.704.057 | 0,05 | 50,41 | 120.375 | 237.123.046 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90 | 39.305.623 | 0,00 | 50,00 | 4.500 | 1.965.281.150 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10 | 4.701.669 | 0,00 | 50,00 | 500 | 235.083.450 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 899 | 39.305.533 | 0,00 | 49,84 | 44.802 | 1.958.791.237 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4.701.659 | 0,00 | 49,84 | 5.033 | 234.307.176 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8.380 | 39.304.634 | 0,02 | 50,99 | 427.266 | 2.004.001.791 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 940 | 4.701.558 | 0,02 | 50,99 | 47.927 | 239.715.517 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.338 | 39.296.254 | 0,01 | 50,48 | 118.029 | 1.983.788.861 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 262 | 4.700.618 | 0,01 | 50,48 | 13.227 | 237.300.828 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33.241 | 39.293.916 | 0,08 | 51,25 | 1.703.751 | 2.013.990.018 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.728 | 4.700.356 | 0,08 | 51,25 | 191.077 | 240.914.397 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23.440 | 39.260.675 | 0,06 | 50,33 | 1.179.656 | 1.975.856.286 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.637 | 4.696.628 | 0,06 | 50,33 | 132.711 | 236.365.319 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 170.652 | 39.237.235 | 0,44 | 50,38 | 8.597.226 | 1.976.720.891 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19.201 | 4.693.991 | 0,41 | 50,38 | 967.321 | 236.477.164 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7.944 | 39.066.583 | 0,02 | 51,05 | 405.541 | 1.994.349.062 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 894 | 4.674.790 | 0,02 | 51,05 | 45.639 | 238.648.030 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 28.271 | 39.058.639 | 0,07 | 50,55 | 1.428.963 | 1.974.226.720 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.181 | 4.673.896 | 0,07 | 50,55 | 160.784 | 236.243.008 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33.893 | 39.030.368 | 0,09 | 50,48 | 1.710.844 | 1.970.167.110 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.813 | 4.670.715 | 0,08 | 50,48 | 192.472 | 235.767.418 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 48.036 | 38.996.475 | 0,12 | 50,10 | 2.406.829 | 1.953.906.681 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.405 | 4.666.902 | 0,12 | 50,10 | 270.816 | 233.833.725 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101.290 | 38.948.439 | 0,26 | 50,05 | 5.069.433 | 1.949.318.739 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11.397 | 4.661.497 | 0,25 | 50,05 | 570.405 | 233.301.865 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.581 | 38.847.149 | 0,01 | 49,46 | 276.030 | 1.921.337.258 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 628 | 4.650.100 | 0,01 | 49,46 | 31.060 | 229.988.831 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 944 | 38.841.568 | 0,00 | 49,18 | 46.427 | 1.910.267.156 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 106 | 4.649.472 | 0,00 | 49,18 | 5.213 | 228.665.682 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13.825 | 38.840.624 | 0,04 | 48,61 | 672.033 | 1.888.042.733 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.556 | 4.649.366 | 0,03 | 48,61 | 75.637 | 226.005.681 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 12.955 | 38.826.799 | 0,03 | 48,95 | 634.191 | 1.900.703.822 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.457 | 4.647.810 | 0,03 | 48,95 | 71.325 | 227.526.102 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 548 | 38.813.844 | 0,00 | 47,27 | 25.904 | 1.834.718.762 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 62 | 4.646.353 | 0,00 | 47,27 | 2.931 | 219.631.712 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11.681 | 38.813.296 | 0,03 | 48,16 | 562.550 | 1.869.225.047 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.314 | 4.646.291 | 0,03 | 48,16 | 63.281 | 223.762.587 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8.598 | 38.801.615 | 0,02 | 48,44 | 416.460 | 1.879.426.065 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 967 | 4.644.977 | 0,02 | 48,44 | 46.838 | 224.987.822 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.930 | 38.793.017 | 0,02 | 48,29 | 286.332 | 1.873.132.464 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 667 | 4.644.010 | 0,01 | 48,29 | 32.206 | 224.237.416 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 84.331 | 4.643.343 | 1,85 | 46,17 | 3.893.638 | 214.387.325 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.600 | 4.559.012 | 0,08 | 45,10 | 162.369 | 205.623.295 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 35.263 | 4.555.412 | 0,78 | 45,39 | 1.600.457 | 206.753.296 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8.360 | 4.520.149 | 0,19 | 46,10 | 385.414 | 208.388.813 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.735 | 4.511.789 | 0,06 | 44,98 | 123.025 | 202.948.842 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.074 | 4.509.054 | 0,20 | 45,80 | 415.623 | 206.531.357 | |
| 2016-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 89.896 | 11.348.958 | 0,80 | 27,02 | 2.428.621 | 306.602.314 | |
| 2016-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10.104 | 1.758.289 | 0,58 | 27,02 | 272.969 | 47.501.760 | |
| 2016-08-12 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.169.877 | 22.337.275 | 5,53 | 33,00 | 38.605.941 | 737.130.075 | |
| 2016-08-12 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 133.153 | 3.029.953 | 4,60 | 33,00 | 4.394.049 | 99.988.449 | |
| 2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13.038 | 102.711 | 14,54 | 1,63 | 21.252 | 167.419 | |
| 2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13.038 | 102.711 | 14,54 | 1,63 | 21.252 | 167.419 | |
| 2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13.038 | 102.711 | 14,54 | 1,63 | 21.252 | 167.419 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 13.937.394 | 0,01 | 26,74 | 19.948 | 372.685.916 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 13.937.394 | 0,01 | 26,74 | 19.948 | 372.685.916 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 1.362.005 | 0,05 | 26,74 | 19.948 | 36.420.014 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 1.362.005 | 0,05 | 26,74 | 19.948 | 36.420.014 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 318.623 | 0,23 | 26,74 | 19.948 | 8.519.979 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 318.623 | 0,23 | 26,74 | 19.948 | 8.519.979 | |
| 2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 23.803.844 | 0,00 | 79,98 | 18.955 | 1.903.831.443 | |
| 2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 533.519 | 0,04 | 79,98 | 18.955 | 42.670.850 | |
| 2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 533.519 | 0,04 | 79,98 | 18.955 | 42.670.850 | |
| 2016-06-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70.000 | 70.000 | |||||
| 2016-06-13 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 26.500 | 26.500 | |||||
| 2016-06-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20.000 | 20.000 | |||||
| 2016-05-31 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 38.787.087 | 0,01 | 38,82 | 143.634 | 1.505.714.717 | |
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 38.787.087 | 0,01 | 38,82 | 143.634 | 1.505.714.717 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 13.932.918 | 0,06 | 10,73 | 88.522 | 149.500.210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 13.932.918 | 0,06 | 10,73 | 88.522 | 149.500.210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 13.932.918 | 0,06 | 10,73 | 88.522 | 149.500.210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 13.932.918 | 0,06 | 10,73 | 88.522 | 149.500.210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 13.932.918 | 0,06 | 10,73 | 88.522 | 149.500.210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 317.877 | 2,66 | 10,73 | 88.522 | 3.410.820 | |
| 2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 2.294 | 2.294 | |||||
| 2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 835 | 6.104.562 | 0,01 | ||||
| 2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 835 | 6.104.562 | 0,01 | ||||
| 2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10.788 | 7.110.113 | 0,15 | 1,97 | 21.252 | 14.006.923 | |
| 2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10.788 | 89.673 | 13,68 | 1,97 | 21.252 | 176.656 | |
| 2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10.788 | 89.673 | 13,68 | 1,97 | 21.252 | 176.656 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13.883.418 | 0,01 | 25,48 | 19.976 | 353.749.491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13.883.418 | 0,01 | 25,48 | 19.976 | 353.749.491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13.883.418 | 0,01 | 25,48 | 19.976 | 353.749.491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13.883.418 | 0,01 | 25,48 | 19.976 | 353.749.491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 309.627 | 0,25 | 25,48 | 19.976 | 7.889.296 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 309.627 | 0,25 | 25,48 | 19.976 | 7.889.296 | |
| 2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533.282 | 0,05 | 72,47 | 18.987 | 38.646.947 | |
| 2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533.282 | 0,05 | 72,47 | 18.987 | 38.646.947 | |
| 2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533.282 | 0,05 | 72,47 | 18.987 | 38.646.947 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 262.253 | 21.167.398 | 1,25 | 28,55 | 7.486.904 | 604.295.345 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28.647 | 2.896.800 | 1,00 | 28,55 | 817.826 | 82.699.005 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 10.818 | 20.905.145 | 0,05 | 27,82 | 300.959 | 581.585.315 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.182 | 2.868.153 | 0,04 | 27,82 | 32.883 | 79.792.590 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 318.969 | 20.894.327 | 1,55 | 27,72 | 8.840.959 | 579.134.330 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 34.844 | 2.866.971 | 1,23 | 27,72 | 965.782 | 79.464.695 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 60.587 | 20.575.358 | 0,30 | 27,56 | 1.669.705 | 567.032.176 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 6.618 | 2.832.127 | 0,23 | 27,56 | 182.384 | 78.050.022 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28.433 | 20.514.771 | 0,14 | 26,55 | 755.024 | 544.759.487 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.106 | 2.825.509 | 0,11 | 26,55 | 82.478 | 75.029.979 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 180.122 | 20.486.338 | 0,89 | 26,49 | 4.772.224 | 542.773.234 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 19.676 | 2.822.403 | 0,70 | 26,49 | 521.304 | 74.777.874 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 13.433 | 20.306.216 | 0,07 | 26,28 | 353.086 | 533.748.888 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.467 | 2.802.727 | 0,05 | 26,28 | 38.560 | 73.669.679 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 14.775 | 20.292.783 | 0,07 | 25,61 | 378.343 | 519.637.294 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.614 | 2.801.260 | 0,06 | 25,61 | 41.330 | 71.731.865 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 16.057 | 2.799.646 | 0,58 | 26,35 | 423.057 | 73.762.833 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 37.882 | 2.783.589 | 1,38 | 25,98 | 983.985 | 72.303.724 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 408.607 | 2.745.707 | 17,48 | 25,92 | 10.593.014 | 71.181.630 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 92.140 | 38.783.387 | 0,24 | 31,73 | 2.923.547 | 1.230.573.599 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.034 | 4.496.280 | 0,22 | 31,73 | 318.373 | 142.664.267 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19.741 | 38.691.247 | 0,05 | 32,41 | 639.713 | 1.253.801.466 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.150 | 4.486.246 | 0,05 | 32,41 | 69.671 | 145.378.148 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 206.421.153 | 0,01 | 3,86 | 77.200 | 796.785.651 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 90.179 | 19.757.285 | 0,46 | 62,59 | 5.644.024 | 1.236.547.221 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9.821 | 3.358.951 | 0,29 | 62,59 | 614.666 | 210.226.330 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 127.964 | 19.667.106 | 0,65 | 61,38 | 7.854.149 | 1.207.123.699 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 13.936 | 3.349.130 | 0,42 | 61,38 | 855.361 | 205.562.231 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 24.431 | 19.539.142 | 0,13 | 61,03 | 1.490.975 | 1.192.434.758 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2.660 | 3.335.194 | 0,08 | 61,03 | 162.334 | 203.540.219 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 20.659 | 19.514.711 | 0,11 | 60,95 | 1.259.178 | 1.189.433.344 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2.250 | 3.332.534 | 0,07 | 60,95 | 137.139 | 203.119.947 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 97.484 | 19.494.052 | 0,50 | 60,85 | 5.931.960 | 1.186.224.761 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 10.616 | 3.330.284 | 0,32 | 60,85 | 645.990 | 202.649.780 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 533.020 | 3,90 | 3,86 | 77.200 | 2.057.457 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 533.020 | 3,90 | 3,86 | 77.200 | 2.057.457 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1.182 | 19.376.568 | 0,01 | 65,29 | 77.176 | 1.265.142.628 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 129 | 3.299.668 | 0,00 | 65,29 | 8.423 | 215.443.243 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 179.176 | 19.375.386 | 0,93 | 65,80 | 11.789.387 | 1.274.857.773 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19.513 | 3.299.539 | 0,59 | 65,80 | 1.283.912 | 217.102.407 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 180.358 | 19.196.210 | 0,95 | 67,15 | 12.110.607 | 1.288.979.431 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19.642 | 3.280.026 | 0,60 | 67,15 | 1.318.913 | 220.245.874 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 198.484 | 38.671.506 | 0,52 | 31,60 | 6.272.531 | 1.222.104.667 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21.616 | 4.484.096 | 0,48 | 31,60 | 683.113 | 141.707.299 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32.810 | 38.473.022 | 0,09 | 31,86 | 1.045.205 | 1.225.608.131 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.573 | 4.462.480 | 0,08 | 31,86 | 113.823 | 142.158.102 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8.627 | 38.440.212 | 0,02 | 31,50 | 271.712 | 1.210.693.697 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 940 | 4.458.907 | 0,02 | 31,50 | 29.606 | 140.435.505 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 273.381 | 38.431.585 | 0,72 | 31,89 | 8.719.077 | 1.225.717.756 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29.772 | 4.457.967 | 0,67 | 31,89 | 949.533 | 142.180.171 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 145.272 | 38.158.204 | 0,38 | 31,74 | 4.611.296 | 1.211.236.790 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15.821 | 4.428.195 | 0,36 | 31,74 | 502.198 | 140.561.980 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 63.560 | 38.012.932 | 0,17 | 31,50 | 2.002.401 | 1.197.563.211 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6.922 | 4.412.374 | 0,16 | 31,50 | 218.071 | 139.007.872 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 387.336 | 37.949.372 | 1,03 | 32,31 | 12.514.051 | 1.226.068.311 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42.182 | 4.405.452 | 0,97 | 32,31 | 1.362.816 | 142.331.343 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 107.260 | 37.562.036 | 0,29 | 33,77 | 3.622.063 | 1.268.432.394 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11.681 | 4.363.270 | 0,27 | 33,77 | 394.456 | 147.343.265 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.874 | 37.454.776 | 0,01 | 32,34 | 157.646 | 1.211.448.511 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 547 | 4.351.589 | 0,01 | 32,34 | 17.692 | 140.749.100 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 147.831 | 37.449.902 | 0,40 | 33,15 | 4.900.997 | 1.241.565.366 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16.608 | 4.351.042 | 0,38 | 33,15 | 550.600 | 144.248.790 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23.289 | 37.302.071 | 0,06 | 32,96 | 767.582 | 1.229.438.958 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.616 | 4.334.434 | 0,06 | 32,96 | 86.221 | 142.858.610 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 95.682 | 37.278.782 | 0,26 | 32,41 | 3.100.652 | 1.208.048.754 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.749 | 4.331.818 | 0,25 | 32,41 | 348.330 | 140.376.028 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 165.237 | 37.183.100 | 0,45 | 32,30 | 5.337.915 | 1.201.185.172 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18.563 | 4.321.069 | 0,43 | 32,30 | 599.670 | 139.590.406 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 36.589 | 37.017.863 | 0,10 | 31,15 | 1.139.842 | 1.153.202.679 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.111 | 4.302.506 | 0,10 | 31,15 | 128.068 | 134.034.248 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 97.272 | 36.981.274 | 0,26 | 32,12 | 3.124.484 | 1.187.879.200 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.927 | 4.298.395 | 0,25 | 32,12 | 350.987 | 138.069.176 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 53.734 | 36.884.002 | 0,15 | 32,47 | 1.744.598 | 1.197.523.958 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6.037 | 4.287.468 | 0,14 | 32,47 | 196.005 | 139.202.510 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 286.671.473 | 0,00 | 4,18 | 41.800 | 1.198.286.757 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 88.732 | 36.830.268 | 0,24 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.968 | 4.281.431 | 0,23 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 48.996 | 36.741.536 | 0,13 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.504 | 4.271.463 | 0,13 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 36.692.540 | 0,03 | 4,18 | 41.800 | 153.374.817 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14.157 | 36.682.540 | 0,04 | 33,72 | 477.445 | 1.237.118.662 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.590 | 4.255.959 | 0,04 | 33,72 | 53.623 | 143.532.217 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40.921 | 36.668.383 | 0,11 | 33,68 | 1.378.043 | 1.234.833.465 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.597 | 4.254.369 | 0,11 | 33,68 | 154.807 | 143.268.854 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 218.550 | 36.627.462 | 0,60 | 32,49 | 7.101.280 | 1.190.125.135 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23.908 | 4.249.772 | 0,57 | 32,49 | 776.835 | 138.086.567 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 41.104 | 36.408.912 | 0,11 | 31,68 | 1.302.257 | 1.153.507.150 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.496 | 4.225.864 | 0,11 | 31,68 | 142.442 | 133.883.823 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59.492 | 36.367.808 | 0,16 | 32,24 | 1.918.022 | 1.172.498.130 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6.508 | 4.221.368 | 0,15 | 32,24 | 209.818 | 136.096.904 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 301.066 | 36.308.316 | 0,84 | 32,76 | 9.862.139 | 1.189.366.031 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32.934 | 4.214.860 | 0,79 | 32,76 | 1.078.832 | 138.067.855 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21.814 | 36.007.250 | 0,06 | 31,24 | 681.563 | 1.125.021.321 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.386 | 4.181.926 | 0,06 | 31,24 | 74.549 | 130.661.351 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 172.462 | 35.985.436 | 0,48 | 30,34 | 5.232.928 | 1.091.888.092 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18.866 | 4.179.540 | 0,45 | 30,34 | 572.442 | 126.817.692 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 54.439 | 35.812.974 | 0,15 | 30,55 | 1.663.024 | 1.094.029.055 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.955 | 4.160.674 | 0,14 | 30,55 | 181.916 | 127.101.934 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6.022 | 19.015.852 | 0,03 | 74,00 | 445.628 | 1.407.173.048 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 678 | 3.260.384 | 0,02 | 74,00 | 50.172 | 241.268.416 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 20.492 | 19.009.830 | 0,11 | 69,70 | 1.428.282 | 1.324.975.646 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2.308 | 3.259.706 | 0,07 | 69,70 | 160.866 | 227.199.878 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 23.157 | 18.989.338 | 0,12 | 70,50 | 1.632.684 | 1.338.843.276 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2.608 | 3.257.398 | 0,08 | 70,50 | 183.877 | 229.662.846 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8.111 | 18.966.181 | 0,04 | 71,96 | 583.702 | 1.364.886.043 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 914 | 3.254.790 | 0,03 | 71,96 | 65.775 | 234.228.359 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39.815 | 35.758.535 | 0,11 | 30,13 | 1.199.793 | 1.077.554.845 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.485 | 4.154.719 | 0,11 | 30,13 | 135.152 | 125.199.133 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 128.255 | 35.718.720 | 0,36 | 29,86 | 3.830.118 | 1.066.678.851 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14.447 | 4.150.234 | 0,35 | 29,86 | 431.435 | 123.939.683 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 67.407 | 35.590.465 | 0,19 | 28,52 | 1.922.670 | 1.015.157.510 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7.593 | 4.135.787 | 0,18 | 28,52 | 216.577 | 117.966.293 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.134 | 35.523.058 | 0,01 | 28,46 | 117.674 | 1.011.163.846 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 466 | 4.128.194 | 0,01 | 28,46 | 13.265 | 117.509.042 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43.056 | 35.518.924 | 0,12 | 29,77 | 1.281.975 | 1.057.561.755 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.850 | 4.127.728 | 0,12 | 29,77 | 144.407 | 122.901.450 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 218.768 | 35.475.868 | 0,62 | 30,21 | 6.610.053 | 1.071.899.804 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24.643 | 4.122.878 | 0,60 | 30,21 | 744.586 | 124.572.346 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 456.849 | 35.257.100 | 1,31 | 29,20 | 13.339.991 | 1.029.507.320 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49.677 | 4.098.235 | 1,23 | 29,20 | 1.450.568 | 119.668.462 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 226.865 | 34.800.251 | 0,66 | 29,94 | 6.791.816 | 1.041.839.474 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24.669 | 4.048.558 | 0,61 | 29,94 | 738.533 | 121.204.515 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 726.291 | 34.573.386 | 2,15 | 31,25 | 22.694.197 | 1.080.304.220 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 78.976 | 4.023.889 | 2,00 | 31,25 | 2.467.739 | 125.733.252 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 902 | 33.847.095 | 0,00 | 29,50 | 26.609 | 998.489.302 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98 | 3.944.913 | 0,00 | 29,50 | 2.891 | 116.374.934 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 106.444 | 33.846.193 | 0,32 | 29,19 | 3.107.590 | 988.126.066 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11.575 | 3.944.815 | 0,29 | 29,19 | 337.927 | 115.167.296 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 151.144 | 33.739.749 | 0,45 | 30,27 | 4.574.645 | 1.021.194.235 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16.435 | 3.933.240 | 0,42 | 30,27 | 497.435 | 119.046.588 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 631 | 33.588.605 | 0,00 | 27,93 | 17.626 | 938.227.145 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 69 | 3.916.805 | 0,00 | 27,93 | 1.927 | 109.407.722 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72.073 | 33.587.974 | 0,22 | 27,28 | 1.966.043 | 916.229.549 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7.909 | 3.916.736 | 0,20 | 27,28 | 215.746 | 106.842.683 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 87.049 | 33.515.901 | 0,26 | 28,07 | 2.443.831 | 940.932.108 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.551 | 3.908.827 | 0,24 | 28,07 | 268.137 | 109.737.191 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 15.187 | 18.958.070 | 0,08 | 69,45 | 1.054.742 | 1.316.643.649 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1.651 | 3.253.876 | 0,05 | 69,45 | 114.662 | 225.982.664 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8.250 | 18.942.883 | 0,04 | 70,86 | 584.597 | 1.342.296.478 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 897 | 3.252.225 | 0,03 | 70,86 | 63.562 | 230.453.314 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 67.373 | 18.934.633 | 0,36 | 69,54 | 4.684.923 | 1.316.659.468 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7.326 | 3.251.328 | 0,23 | 69,54 | 509.429 | 226.087.920 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 124.057 | 18.867.260 | 0,66 | 70,21 | 8.710.228 | 1.324.698.625 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 13.490 | 3.244.002 | 0,42 | 70,21 | 947.153 | 227.766.246 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 397.079 | 18.743.203 | 2,16 | 71,10 | 28.233.945 | 1.332.718.580 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 43.178 | 3.230.512 | 1,35 | 71,10 | 3.070.133 | 229.702.648 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 149.927 | 18.346.124 | 0,82 | 67,94 | 10.186.595 | 1.246.503.545 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 16.450 | 3.187.334 | 0,52 | 67,94 | 1.117.674 | 216.559.265 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 38.117 | 18.196.197 | 0,21 | 63,98 | 2.438.547 | 1.164.107.162 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 4.183 | 3.170.884 | 0,13 | 63,98 | 267.609 | 202.858.255 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 168.055 | 18.158.080 | 0,93 | 64,87 | 10.902.350 | 1.177.981.834 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 18.441 | 3.166.701 | 0,59 | 64,87 | 1.196.336 | 205.435.611 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 541.340 | 17.990.025 | 3,10 | 65,80 | 35.621.958 | 1.183.803.012 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 59.401 | 3.148.260 | 1,92 | 65,80 | 3.908.782 | 207.165.897 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 49.021 | 17.448.685 | 0,28 | 66,68 | 3.268.823 | 1.163.514.958 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5.379 | 3.088.859 | 0,17 | 66,68 | 358.683 | 205.971.605 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 72.894 | 17.399.664 | 0,42 | 67,68 | 4.933.706 | 1.177.666.678 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7.999 | 3.083.480 | 0,26 | 67,68 | 541.399 | 208.700.102 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6.939 | 17.326.770 | 0,04 | 60,85 | 422.220 | 1.054.288.905 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 761 | 3.075.481 | 0,02 | 60,85 | 46.305 | 187.135.023 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 57.865 | 17.319.831 | 0,34 | 61,73 | 3.572.047 | 1.069.165.292 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6.349 | 3.074.720 | 0,21 | 61,73 | 391.928 | 189.804.618 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 136.793 | 17.261.966 | 0,80 | 58,13 | 7.952.133 | 1.003.482.965 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 15.010 | 3.068.371 | 0,49 | 58,13 | 872.570 | 178.372.384 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 114.908 | 17.125.173 | 0,68 | 59,01 | 6.780.526 | 1.010.527.346 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12.609 | 3.053.361 | 0,41 | 59,01 | 744.036 | 180.173.642 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 65.309 | 17.010.265 | 0,39 | 60,40 | 3.944.513 | 1.027.380.882 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7.166 | 3.040.752 | 0,24 | 60,40 | 432.810 | 183.654.427 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 113.546 | 16.944.956 | 0,67 | 61,40 | 6.971.475 | 1.040.383.019 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12.459 | 3.033.586 | 0,41 | 61,40 | 764.955 | 186.255.507 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 289.755 | 16.831.410 | 1,75 | 62,56 | 18.126.986 | 1.052.967.960 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 31.795 | 3.021.127 | 1,06 | 62,56 | 1.989.086 | 189.000.799 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 176.647 | 16.541.655 | 1,08 | 63,37 | 11.194.368 | 1.048.267.836 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19.383 | 2.989.332 | 0,65 | 63,37 | 1.228.328 | 189.438.154 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 235.734 | 16.365.008 | 1,46 | 64,46 | 15.195.814 | 1.054.916.236 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 25.869 | 2.969.949 | 0,88 | 64,46 | 1.667.560 | 191.447.961 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -56.853 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -2.296.890 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -238.850 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A-2 Preferred shares |
C - Conversion | -26.292.961 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A-2 Preferred shares |
C - Conversion | -1.912.167 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -582.747 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -44.572.171 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -4.382.118 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1.723.306 | 1.723.306 | 24,00 | 41.359.344 | 41.359.344 | ||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 189.374 | 189.374 | 24,00 | 4.544.976 | 4.544.976 | ||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 56.853 | 639.600 | 9,76 | 0,68 | 38.376 | 431.730 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 2.296.890 | 73.162.022 | 3,24 | 0,68 | 1.550.401 | 49.384.365 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 238.850 | 6.533.135 | 3,79 | 0,68 | 161.224 | 4.409.866 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 26.292.961 | 70.865.132 | 58,99 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 1.912.167 | 6.294.285 | 43,64 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 582.747 | 582.747 | |||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 44.572.171 | 44.572.171 | |||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 4.382.118 | 4.382.118 | |||||
| 2016-01-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.801.161 | 20.278.008 | 9,75 | 29,00 | 52.233.669 | 588.062.232 | |
| 2016-01-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 785.045 | 2.337.100 | 50,58 | 29,00 | 22.766.305 | 67.775.900 | |
| 2016-01-08 |
|
4/A | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.801.161 | 20.278.008 | 9,75 | 29,00 | 52.233.669 | 588.062.232 | |
| 2016-01-08 |
|
4/A | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 785.045 | 2.337.100 | 50,58 | 29,00 | 22.766.305 | 67.775.900 | |
| 2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7.082 | 78.885 | 9,86 | 3,00 | 21.246 | 236.655 | |
| 2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7.082 | 78.885 | 9,86 | 3,00 | 21.246 | 236.655 | |
| 2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7.082 | 6.348.612 | 0,11 | 3,00 | 21.246 | 19.045.836 | |
| 2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 513.020 | 0,03 | 108,45 | 18.979 | 55.637.019 | |
| 2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 513.020 | 0,03 | 108,45 | 18.979 | 55.637.019 | |
| 2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 666.111 | 0,03 | 108,45 | 18.979 | 72.239.738 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 308.843 | 0,18 | 35,20 | 19.994 | 10.871.274 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 308.843 | 0,18 | 35,20 | 19.994 | 10.871.274 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 482.740 | 0,12 | 35,20 | 19.994 | 16.992.448 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 11.423.179 | 0,00 | 35,20 | 19.994 | 402.095.901 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 196.132 | 0,29 | 35,20 | 19.994 | 6.903.846 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 356.791 | 0,16 | 35,20 | 19.994 | 12.559.043 | |
| 2015-12-15 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 150.000 | 33.428.852 | 0,45 | 44,00 | 6.600.000 | 1.470.869.488 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31.647 | 33.278.852 | 0,10 | 43,87 | 1.388.259 | 1.459.843.401 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57.461 | 33.247.205 | 0,17 | 43,93 | 2.524.015 | 1.460.406.753 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 75.612 | 33.189.744 | 0,23 | 43,93 | 3.321.363 | 1.457.905.971 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.000 | 33.114.132 | 0,01 | 43,00 | 172.000 | 1.423.907.676 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.638 | 33.110.132 | 0,03 | 43,84 | 466.321 | 1.451.395.880 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.400 | 33.099.494 | 0,03 | 44,00 | 413.600 | 1.456.377.736 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 800 | 33.090.094 | 0,00 | 43,00 | 34.400 | 1.422.874.042 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 407.800 | 33.089.294 | 1,25 | 43,71 | 17.823.388 | 1.446.207.301 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98.700 | 32.681.494 | 0,30 | 44,00 | 4.342.800 | 1.437.985.736 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 196.490 | 32.582.794 | 0,61 | 41,31 | 8.117.179 | 1.346.024.545 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 221.434 | 32.386.304 | 0,69 | 42,51 | 9.412.318 | 1.376.618.715 | |
| 2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6.945 | 71.803 | 10,71 | 3,06 | 21.252 | 219.717 | |
| 2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6.945 | 71.803 | 10,71 | 3,06 | 21.252 | 219.717 | |
| 2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6.945 | 71.803 | 10,71 | 3,06 | 21.252 | 219.717 | |
| 2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 512.845 | 0,03 | 110,33 | 18.977 | 56.582.189 | |
| 2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 972.118 | 0,02 | 110,33 | 18.977 | 107.253.779 | |
| 2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 16.282.190 | 0,00 | 110,33 | 18.977 | 1.796.414.023 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 308.275 | 0,30 | 21,34 | 19.974 | 6.578.588 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 308.275 | 0,30 | 21,34 | 19.974 | 6.578.588 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 11.422.611 | 0,01 | 21,34 | 19.974 | 243.758.519 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 1.911.734 | 0,05 | 21,34 | 19.974 | 40.796.404 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 195.564 | 0,48 | 21,34 | 19.974 | 4.173.336 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 356.223 | 0,26 | 21,34 | 19.974 | 7.601.799 | |
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -892.000 | 0 | -100,00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -31.967.000 | 0 | -100,00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -7.587.000 | 0 | -100,00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -65.000 | 0 | -100,00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -64.000 | 0 | -100,00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 101.652 | 512.673 | 24,73 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 3.642.962 | 16.128.927 | 29,18 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 864.614 | 2.943.733 | 41,59 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 7.406 | 61.049 | 13,81 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 7.292 | 58.632 | 14,20 | ||||
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 346.000 | 32.164.870 | 1,09 | 48,44 | 16.761.728 | 1.558.204.612 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50.000 | 31.818.870 | 0,16 | 47,40 | 2.370.000 | 1.508.214.438 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 160.453 | 31.768.870 | 0,51 | 48,60 | 7.798.690 | 1.544.100.511 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33.320 | 31.608.417 | 0,11 | 47,98 | 1.598.614 | 1.516.495.987 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14.386 | 31.575.097 | 0,05 | 47,54 | 683.847 | 1.500.941.181 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.600 | 31.560.711 | 0,01 | 47,24 | 75.577 | 1.490.798.589 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20.500 | 31.559.111 | 0,06 | 46,31 | 949.351 | 1.461.496.119 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.950 | 31.538.611 | 0,01 | 44,68 | 87.130 | 1.409.201.909 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 89.843 | 31.536.661 | 0,29 | 45,28 | 4.067.696 | 1.427.841.249 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 212.983 | 31.446.818 | 0,68 | 46,81 | 9.969.500 | 1.471.990.959 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.818 | 31.233.835 | 0,03 | 46,74 | 458.905 | 1.459.906.929 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.331 | 31.224.017 | 0,01 | 45,63 | 106.368 | 1.424.814.344 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.513 | 31.221.686 | 0,01 | 45,43 | 159.601 | 1.418.448.028 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13.897 | 31.218.173 | 0,04 | 45,00 | 625.359 | 1.404.805.298 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40.649 | 31.204.276 | 0,13 | 42,14 | 1.713.148 | 1.315.101.092 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8.063 | 31.163.627 | 0,03 | 44,40 | 357.971 | 1.383.565.315 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15.391 | 31.155.564 | 0,05 | 40,67 | 625.950 | 1.267.093.672 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 191.321 | 31.140.173 | 0,62 | 41,06 | 7.856.214 | 1.278.708.924 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 88.640 | 30.948.852 | 0,29 | 42,44 | 3.761.802 | 1.313.441.425 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 183.073 | 30.860.212 | 0,60 | 43,28 | 7.923.253 | 1.335.605.287 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 274.814 | 30.677.139 | 0,90 | 44,63 | 12.265.553 | 1.369.188.203 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.100 | 30.402.325 | 0,01 | 40,55 | 125.706 | 1.232.823.399 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11.300 | 30.399.225 | 0,04 | 41,13 | 464.823 | 1.250.466.041 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43.612 | 30.387.925 | 0,14 | 43,60 | 1.901.322 | 1.324.801.095 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.338.927 | 30.344.313 | 12,36 | 41,00 | 136.896.007 | 1.244.116.833 | |
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4.725.965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8.075.935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4.725.965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8.075.935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4.725.965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8.075.935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4.725.965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8.075.935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4.725.965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8.075.935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4.725.965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8.075.935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4.725.965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8.075.935 | ||||||||
| 2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 2.329 | 2.329 | |||||
| 2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 696 | 6.103.727 | 0,01 | ||||
| 2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 696 | 6.103.727 | 0,01 | ||||
| 2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -229.436 | 90.538 | -71,70 | 1,09 | -250.659 | 98.913 | |
| 2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -9.411.311 | 3.153.539 | -74,90 | 1,09 | -10.281.857 | 3.445.241 | |
| 2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -1.359.253 | 467.436 | -74,41 | 1,09 | -1.484.984 | 510.674 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 307.339 | 0,24 | 27,34 | 19.958 | 8.402.648 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 1.350.721 | 0,05 | 27,34 | 19.958 | 36.928.712 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 481.236 | 0,15 | 27,34 | 19.958 | 13.156.992 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 11.421.675 | 0,01 | 27,34 | 19.958 | 312.268.594 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 194.628 | 0,38 | 27,34 | 19.958 | 5.321.130 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 355.287 | 0,21 | 27,34 | 19.958 | 9.713.547 | |
| 2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 826.200 | 0,02 | 104,21 | 18.966 | 86.098.302 | |
| 2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 411.021 | 0,04 | 104,21 | 18.966 | 42.832.498 | |
| 2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 549.414 | 0,03 | 104,21 | 18.966 | 57.254.433 | |
| 2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5.260 | 64.858 | 8,83 | 3,66 | 19.252 | 237.380 | |
| 2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5.260 | 64.858 | 8,83 | 3,66 | 19.252 | 237.380 | |
| 2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5.260 | 64.858 | 8,83 | 3,66 | 19.252 | 237.380 | |
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 6.103.033 | 6.103.033 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 506.166 | 506.166 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 94.412 | 94.412 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 66.154 | 66.154 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 65.811 | 65.811 | |||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -3.000 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -3.000 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -15.000 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.750 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.750 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.750 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -9.184.771 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -680.187 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -143.462 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -200.526 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -15.000 | 0 | -100,00 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 21.196 | 100.523 | 26,72 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -211.614 | 12.250 | -94,53 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 497 | 79.327 | 0,63 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -100.490 | 12.250 | -89,13 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 40.449 | 78.830 | 105,39 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -1.068.128 | 680.187 | -61,09 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 5.543 | 38.381 | 16,88 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -55.479 | 12.250 | -81,91 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 12.500 | 32.838 | 61,46 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -165.213 | 12.250 | -93,10 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 19.318 | 20.338 | 1.893,92 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -206.800 | 12.250 | -94,41 | ||||
| 2015-06-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12.500 | 12.500 | |||||
| 2015-06-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20.000 | 20.000 | |||||
| 2015-06-10 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70.000 | 70.000 | |||||
| 2015-05-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 198.802 | 27.005.386 | 0,74 | 43,27 | 8.602.242 | 1.168.533.854 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57.202 | 26.816.266 | 0,21 | 43,29 | 2.476.343 | 1.160.908.335 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16.300 | 26.759.064 | 0,06 | 43,67 | 711.775 | 1.168.493.400 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90.155 | 26.742.764 | 0,34 | 43,62 | 3.932.723 | 1.166.567.503 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 150.000 | 26.652.609 | 0,57 | 42,93 | 6.439.500 | 1.144.196.504 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.200 | 26.492.927 | 0,03 | 40,95 | 376.718 | 1.084.821.778 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 52.381 | 26.483.727 | 0,20 | 41,54 | 2.176.038 | 1.100.200.229 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 139.683 | 26.431.346 | 0,53 | 42,68 | 5.961.908 | 1.128.134.781 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 13.352 | 26.291.663 | 0,05 | 42,97 | 573.749 | 1.129.779.051 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 2.300 | 26.278.311 | 0,01 | 42,15 | 96.949 | 1.107.675.482 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7.382 | 26.276.011 | 0,03 | 41,24 | 304.410 | 1.083.538.610 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.500 | 26.268.629 | 0,02 | 41,07 | 184.815 | 1.078.852.593 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 89.100 | 26.264.129 | 0,34 | 40,57 | 3.614.475 | 1.065.443.789 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 120.529 | 26.175.029 | 0,46 | 41,09 | 4.951.958 | 1.075.406.301 | |
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 26.054.500 | 0,01 | 39,94 | 147.778 | 1.040.616.730 | |
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 26.054.500 | 0,01 | 39,94 | 147.778 | 1.040.616.730 | |
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 410.839 | 5,12 | 7,68 | 153.600 | 3.155.244 | |
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 410.839 | 5,12 | 7,68 | 153.600 | 3.155.244 | |
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 410.839 | 5,12 | 7,68 | 153.600 | 3.155.244 | |
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 26.050.800 | 0,04 | 5,11 | 51.100 | 133.119.588 | |
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 26.050.800 | 0,04 | 5,11 | 51.100 | 133.119.588 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.100 | 26.040.800 | 0,00 | 37,07 | 40.777 | 965.332.456 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46.617 | 26.039.700 | 0,18 | 37,15 | 1.732.013 | 967.481.618 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8.334 | 25.993.083 | 0,03 | 35,85 | 298.745 | 931.761.050 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 129.118 | 25.984.749 | 0,50 | 36,40 | 4.700.515 | 945.969.590 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 137.800 | 25.855.631 | 0,54 | 36,25 | 4.995.250 | 937.266.624 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 155.731 | 25.717.831 | 0,61 | 36,67 | 5.710.048 | 942.972.563 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 23.012 | 25.562.100 | 0,09 | 35,91 | 826.437 | 918.019.366 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 354.300 | 25.539.088 | 1,41 | 34,76 | 12.315.078 | 887.710.606 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59.973 | 25.184.788 | 0,24 | 34,61 | 2.075.833 | 871.716.030 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.330 | 25.124.815 | 0,02 | 33,99 | 147.177 | 853.992.462 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90.397 | 25.120.485 | 0,36 | 34,56 | 3.123.949 | 868.116.233 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21.952 | 25.030.088 | 0,09 | 34,52 | 757.888 | 864.158.782 | |
| 2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5.470 | 59.598 | 10,11 | 3,52 | 19.254 | 209.785 | |
| 2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5.470 | 59.598 | 10,11 | 3,52 | 19.254 | 209.785 | |
| 2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5.470 | 59.598 | 10,11 | 3,52 | 19.254 | 209.785 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 306.609 | 0,21 | 30,43 | 19.962 | 9.330.112 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1.349.991 | 0,05 | 30,43 | 19.962 | 41.080.226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1.349.991 | 0,05 | 30,43 | 19.962 | 41.080.226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1.349.991 | 0,05 | 30,43 | 19.962 | 41.080.226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1.349.991 | 0,05 | 30,43 | 19.962 | 41.080.226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 306.609 | 0,21 | 30,43 | 19.962 | 9.330.112 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.880 | 25.008.136 | 0,01 | 34,72 | 99.986 | 868.217.461 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6.439 | 25.005.256 | 0,03 | 34,47 | 221.935 | 861.863.660 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 158.771 | 24.998.817 | 0,64 | 34,69 | 5.507.401 | 867.151.464 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 116.946 | 24.840.046 | 0,47 | 34,62 | 4.049.208 | 860.076.657 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19.600 | 24.723.100 | 0,08 | 34,82 | 682.537 | 860.939.928 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.021 | 24.703.500 | 0,02 | 34,79 | 139.882 | 859.380.417 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 213.820 | 24.699.479 | 0,87 | 34,76 | 7.432.169 | 858.529.191 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 211.400 | 24.485.659 | 0,87 | 34,92 | 7.382.532 | 855.090.632 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.000 | 24.274.259 | 0,00 | 35,60 | 35.595 | 864.042.249 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 62.650 | 24.273.259 | 0,26 | 34,46 | 2.159.163 | 836.551.171 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 163.054 | 24.210.609 | 0,68 | 33,80 | 5.510.818 | 818.258.058 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.995 | 24.047.555 | 0,02 | 33,60 | 167.830 | 807.985.824 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49.416 | 24.042.560 | 0,21 | 33,65 | 1.662.843 | 809.029.740 | |
| 2015-02-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.898.409 | 6.323.855 | 343,64 | 3,75 | 18.369.034 | 23.714.456 | |
| 2015-02-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 434.924 | 625.495 | 228,22 | 3,75 | 1.630.965 | 2.345.606 | |
| 2015-02-02 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 390.935 | 2.604.832 | 17,66 | 20,00 | 7.818.700 | 52.096.640 | |
| 2015-02-02 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 34.065 | 159.934 | 27,06 | 20,00 | 681.300 | 3.198.680 | |
| 2015-01-09 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 1.000.000 | 9.184.771 | 12,22 | 94,19 | 94.190.000 | 865.113.580 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -21.441 | 345.074 | -5,85 | 3,86 | -82.762 | 1.331.986 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -859.988 | 12.589.950 | -6,39 | 3,86 | -3.319.554 | 48.597.207 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -118.571 | 1.851.789 | -6,02 | 3,86 | -457.684 | 7.147.906 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -21.548 | 366.515 | -5,55 | 3,81 | -82.130 | 1.396.972 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -863.100 | 13.449.938 | -6,03 | 3,81 | -3.289.706 | 51.264.439 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -118.652 | 1.970.360 | -5,68 | 3,81 | -452.242 | 7.510.027 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -4.554 | 388.063 | -1,16 | 3,55 | -16.184 | 1.379.059 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -182.454 | 14.313.038 | -1,26 | 3,55 | -648.387 | 50.864.243 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -25.092 | 2.089.012 | -1,19 | 3,55 | -89.169 | 7.423.722 | |
| 2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.927 | 54.128 | 7,82 | 4,90 | 19.242 | 265.227 | |
| 2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.927 | 54.128 | 7,82 | 4,90 | 19.242 | 265.227 | |
| 2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.927 | 1.425.446 | 0,28 | 4,90 | 19.242 | 6.984.685 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 305.953 | 0,20 | 31,97 | 19.949 | 9.781.317 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 1.349.335 | 0,05 | 31,97 | 19.949 | 43.138.240 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 11.420.289 | 0,01 | 31,97 | 19.949 | 365.106.639 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 1.909.412 | 0,03 | 31,97 | 19.949 | 61.043.902 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 193.242 | 0,32 | 31,97 | 19.949 | 6.177.947 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 353.901 | 0,18 | 31,97 | 19.949 | 11.314.215 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -8.415 | 392.617 | -2,10 | 3,65 | -30.711 | 1.432.856 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -337.123 | 14.495.492 | -2,27 | 3,65 | -1.230.330 | 52.901.298 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -46.362 | 2.114.104 | -2,15 | 3,65 | -169.198 | 7.715.423 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -4.746 | 401.032 | -1,17 | 3,68 | -17.447 | 1.474.274 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -190.117 | 14.832.615 | -1,27 | 3,68 | -698.908 | 54.527.659 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -26.137 | 2.160.466 | -1,20 | 3,68 | -96.085 | 7.942.305 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -2.825 | 405.778 | -0,69 | 3,71 | -10.482 | 1.505.680 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -112.855 | 15.022.732 | -0,75 | 3,71 | -418.760 | 55.743.349 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -15.420 | 2.186.603 | -0,70 | 3,71 | -57.217 | 8.113.609 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -16.182 | 408.603 | -3,81 | 4,21 | -68.102 | 1.719.606 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -647.781 | 15.135.587 | -4,10 | 4,21 | -2.726.186 | 63.698.118 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -88.937 | 2.202.023 | -3,88 | 4,21 | -374.291 | 9.267.214 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -3.558 | 424.785 | -0,83 | 4,29 | -15.260 | 1.821.903 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -142.543 | 15.783.368 | -0,90 | 4,29 | -611.367 | 67.694.865 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -19.599 | 2.290.960 | -0,85 | 4,29 | -84.060 | 9.825.927 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -14.753 | 428.343 | -3,33 | 4,31 | -63.571 | 1.845.730 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -590.638 | 15.925.911 | -3,58 | 4,31 | -2.545.059 | 68.624.750 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -81.109 | 2.310.559 | -3,39 | 4,31 | -349.499 | 9.956.199 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.900 | 23.993.144 | 0,02 | 31,97 | 124.679 | 767.036.821 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 500 | 23.989.244 | 0,00 | 30,80 | 15.400 | 738.868.715 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49.685 | 23.988.744 | 0,21 | 31,82 | 1.581.096 | 763.379.407 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.855.894 | 23.939.059 | 8,40 | 31,94 | 59.276.698 | 764.606.363 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 597.000 | 22.083.165 | 2,78 | 31,75 | 18.954.631 | 701.136.072 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 305.532 | 21.486.165 | 1,44 | 31,68 | 9.680.415 | 680.763.355 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 70.867 | 21.180.633 | 0,34 | 31,41 | 2.226.244 | 665.376.877 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -6.874 | 443.096 | -1,53 | 4,27 | -29.358 | 1.892.419 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -274.734 | 16.516.549 | -1,64 | 4,27 | -1.173.361 | 70.540.529 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -37.592 | 2.391.668 | -1,55 | 4,27 | -160.552 | 10.214.575 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -9.908 | 449.970 | -2,15 | 4,45 | -44.093 | 2.002.456 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -396.496 | 16.791.283 | -2,31 | 4,45 | -1.764.486 | 74.724.568 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -54.396 | 2.429.260 | -2,19 | 4,45 | -242.073 | 10.810.693 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -5.457 | 459.878 | -1,17 | 4,71 | -25.724 | 2.167.865 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -218.383 | 17.187.779 | -1,25 | 4,71 | -1.029.457 | 81.023.190 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -29.960 | 2.483.656 | -1,19 | 4,71 | -141.231 | 11.707.954 | |
| 2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -8.429 | 465.335 | -1,78 | 4,62 | -38.907 | 2.147.940 | |
| 2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -337.541 | 17.406.162 | -1,90 | 4,62 | -1.558.056 | 80.345.103 | |
| 2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -46.383 | 2.513.616 | -1,81 | 4,62 | -214.099 | 11.602.600 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100.000 | 21.109.766 | 0,48 | 34,95 | 3.495.000 | 737.786.322 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 354.000 | 21.009.766 | 1,71 | 34,27 | 12.131.651 | 720.008.883 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14.772 | 20.655.766 | 0,07 | 34,53 | 510.114 | 713.295.239 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 185.378 | 20.640.994 | 0,91 | 34,33 | 6.364.935 | 708.706.465 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 30.507 | 107.504 | 39,62 | ||||
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 30.507 | 3.993.087 | 0,77 | ||||
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -399.208 | 0 | -100,00 | ||||
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.500 | 20.455.616 | 0,03 | 33,90 | 186.438 | 693.400.380 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 80.430 | 20.450.116 | 0,39 | 34,64 | 2.786.393 | 708.467.684 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42.500 | 20.369.686 | 0,21 | 33,28 | 1.414.515 | 677.958.148 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 185.528 | 20.327.186 | 0,92 | 33,31 | 6.180.420 | 677.151.416 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 216.284 | 20.141.658 | 1,09 | 32,56 | 7.043.267 | 655.911.079 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 38.614 | 19.925.374 | 0,19 | 33,00 | 1.274.254 | 657.533.357 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24.890 | 19.886.760 | 0,13 | 33,06 | 822.744 | 657.360.829 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -28.086 | 473.764 | -5,60 | 4,55 | -127.671 | 2.153.589 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -1.122.584 | 17.743.703 | -5,95 | 4,55 | -5.102.930 | 80.657.551 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -153.618 | 2.559.999 | -5,66 | 4,55 | -698.301 | 11.636.987 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -11.965 | 501.850 | -2,33 | 4,84 | -57.913 | 2.429.054 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -486.800 | 18.866.287 | -2,52 | 4,84 | -2.356.209 | 91.316.602 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -69.153 | 2.713.617 | -2,49 | 4,84 | -334.714 | 13.134.449 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -10.534 | 513.815 | -2,01 | 5,36 | -56.453 | 2.753.586 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -428.583 | 19.353.087 | -2,17 | 5,36 | -2.296.819 | 103.715.129 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -60.883 | 2.782.770 | -2,14 | 5,36 | -326.278 | 14.913.143 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98.076 | 19.861.870 | 0,50 | 36,57 | 3.586.737 | 726.368.448 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.639 | 19.763.794 | 0,05 | 36,75 | 390.999 | 726.349.075 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 69.397 | 19.753.155 | 0,35 | 35,88 | 2.490.291 | 708.836.041 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 63.137 | 19.683.758 | 0,32 | 36,74 | 2.319.502 | 723.134.028 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25.505 | 19.620.621 | 0,13 | 35,91 | 915.851 | 704.550.993 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22.839 | 19.595.116 | 0,12 | 35,55 | 811.963 | 696.637.726 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13.116 | 19.572.277 | 0,07 | 35,56 | 466.413 | 696.001.913 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 17.098 | 19.559.161 | 0,09 | 34,91 | 596.816 | 682.724.250 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 104.140 | 19.542.063 | 0,54 | 35,98 | 3.746.947 | 703.121.473 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29.006 | 19.437.923 | 0,15 | 35,28 | 1.023.471 | 685.863.225 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13.500 | 19.408.917 | 0,07 | 34,26 | 462.530 | 664.978.610 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25.769 | 19.395.417 | 0,13 | 34,58 | 890.989 | 670.615.938 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 866.669 | 19.369.648 | 4,68 | 33,79 | 29.287.172 | 654.554.641 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.394 | 18.502.979 | 0,02 | 33,71 | 148.139 | 623.807.584 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 38.166 | 18.498.585 | 0,21 | 34,83 | 1.329.390 | 644.339.013 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 252.474 | 18.460.419 | 1,39 | 34,41 | 8.686.949 | 635.173.175 | |
| 2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.914 | 50.201 | 21,59 | 2,16 | 19.254 | 108.434 | |
| 2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.914 | 50.201 | 21,59 | 2,16 | 19.254 | 108.434 | |
| 2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.914 | 1.421.519 | 0,63 | 2,16 | 19.254 | 3.070.481 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 305.329 | 0,23 | 28,54 | 19.978 | 8.714.090 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 305.329 | 0,23 | 28,54 | 19.978 | 8.714.090 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 1.348.711 | 0,05 | 28,54 | 19.978 | 38.492.212 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 11.419.665 | 0,01 | 28,54 | 19.978 | 325.917.239 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 192.618 | 0,36 | 28,54 | 19.978 | 5.497.318 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 353.277 | 0,20 | 28,54 | 19.978 | 10.082.526 | |
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 7.000 | 7.000 | |||||
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5.500 | 524.349 | 1,06 | ||||
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5.500 | 524.349 | 1,06 | ||||
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5.500 | 524.349 | 1,06 | ||||
| 2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6.182 | 41.287 | 17,61 | 2,83 | 17.495 | 116.842 | |
| 2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6.182 | 41.287 | 17,61 | 2,83 | 17.495 | 116.842 | |
| 2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6.182 | 1.412.605 | 0,44 | 2,83 | 17.495 | 3.997.672 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 304.629 | 0,24 | 27,86 | 19.948 | 8.486.964 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 1.348.011 | 0,05 | 27,86 | 19.948 | 37.555.586 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 11.418.965 | 0,01 | 27,86 | 19.948 | 318.132.365 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 1.908.088 | 0,04 | 27,86 | 19.948 | 53.159.332 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 191.918 | 0,37 | 27,86 | 19.948 | 5.346.835 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 352.577 | 0,20 | 27,86 | 19.948 | 9.822.795 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4.250 | 0 | -100,00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4.250 | 0 | -100,00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4.250 | 0 | -100,00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4.250 | 0 | -100,00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4.250 | 0 | -100,00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4.250 | 0 | -100,00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4.250 | 0 | -100,00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4.250 | 223.864 | 1,94 | 60,45 | 256.912 | 13.532.579 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4.250 | 223.864 | 1,94 | 60,45 | 256.912 | 13.532.579 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4.250 | 223.864 | 1,94 | 60,45 | 256.912 | 13.532.579 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4.250 | 257.722 | 1,68 | 60,45 | 256.912 | 15.579.295 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4.250 | 1.893.297 | 0,22 | 60,45 | 256.912 | 114.449.804 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4.250 | 212.711 | 2,04 | 60,45 | 256.912 | 12.858.380 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4.250 | 322.445 | 1,34 | 60,45 | 256.912 | 19.491.800 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 670 | 416.208 | 0,16 | 39,80 | 26.668 | 16.566.494 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 27.046 | 18.207.945 | 0,15 | 39,80 | 1.076.523 | 724.738.118 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.471 | 415.538 | 0,36 | 39,93 | 58.731 | 16.590.770 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59.400 | 18.180.899 | 0,33 | 39,93 | 2.371.604 | 725.890.573 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.938 | 414.067 | 0,47 | 39,99 | 77.503 | 16.559.036 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 78.262 | 18.121.499 | 0,43 | 39,99 | 3.129.791 | 724.700.491 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.155 | 412.129 | 0,28 | 39,84 | 46.021 | 16.421.239 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46.653 | 18.043.237 | 0,26 | 39,84 | 1.858.884 | 718.930.974 | |
| 2014-06-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70.000 | 70.000 | |||||
| 2014-06-10 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12.500 | 12.500 | |||||
| 2014-06-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20.000 | 20.000 | |||||
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.534 | 410.974 | 1,36 | 38,96 | 215.578 | 16.009.574 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 223.466 | 17.996.584 | 1,26 | 38,96 | 8.705.163 | 701.060.529 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 534 | 405.440 | 0,13 | 38,56 | 20.591 | 15.633.847 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21.559 | 17.773.118 | 0,12 | 38,56 | 831.319 | 685.334.985 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 477 | 404.906 | 0,12 | 37,52 | 17.895 | 15.190.413 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19.223 | 17.751.559 | 0,11 | 37,52 | 721.168 | 665.965.712 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.757 | 404.429 | 0,94 | 37,40 | 140.504 | 15.124.795 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 151.530 | 17.732.336 | 0,86 | 37,40 | 5.666.904 | 663.152.128 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.411 | 400.672 | 0,61 | 37,67 | 90.826 | 15.093.995 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 97.254 | 17.580.806 | 0,56 | 37,67 | 3.663.724 | 662.298.849 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 496 | 398.261 | 0,12 | 37,63 | 18.667 | 14.988.274 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20.011 | 17.483.552 | 0,11 | 37,63 | 753.100 | 657.981.241 | |
| 2014-06-06 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.534 | 397.765 | 0,39 | 36,04 | 55.281 | 14.334.377 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61.878 | 17.463.541 | 0,36 | 36,04 | 2.229.916 | 629.338.866 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 572 | 396.231 | 0,14 | 36,39 | 20.817 | 14.419.995 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23.058 | 17.401.663 | 0,13 | 36,39 | 839.147 | 633.296.981 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19 | 395.659 | 0,00 | 35,27 | 670 | 13.956.001 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 781 | 17.378.605 | 0,00 | 35,27 | 27.548 | 612.992.058 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.137 | 395.640 | 0,54 | 34,38 | 73.479 | 13.603.725 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 86.201 | 17.377.824 | 0,50 | 34,38 | 2.963.944 | 597.520.838 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 270 | 393.503 | 0,07 | 35,11 | 9.481 | 13.817.386 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.896 | 17.291.623 | 0,06 | 35,11 | 382.600 | 607.174.592 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.809 | 393.233 | 0,46 | 34,05 | 61.604 | 13.391.196 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72.980 | 17.280.727 | 0,42 | 34,05 | 2.485.268 | 588.479.605 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 480 | 391.424 | 0,12 | 34,21 | 16.421 | 13.391.046 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19.348 | 17.207.747 | 0,11 | 34,21 | 661.916 | 588.695.953 | |
| 2014-05-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11.600 | 11.600 | |||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8.400 | 518.849 | 1,65 | ||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8.400 | 518.849 | 1,65 | ||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8.400 | 518.849 | 1,65 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10.000 | 390.839 | 2,63 | 7,02 | 70.200 | 2.743.690 | |
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10.000 | 390.839 | 2,63 | 7,02 | 70.200 | 2.743.690 | |
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10.000 | 390.839 | 2,63 | 7,02 | 70.200 | 2.743.690 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8.750 | 8.750 | |||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8.750 | 8.750 | |||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8.750 | 8.750 | |||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.151 | 390.944 | 0,30 | 34,08 | 39.232 | 13.325.287 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46.460 | 17.188.399 | 0,27 | 34,08 | 1.583.584 | 585.864.861 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.921 | 389.793 | 0,76 | 34,03 | 99.415 | 13.266.449 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 117.879 | 17.141.939 | 0,69 | 34,03 | 4.011.965 | 583.419.037 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.500 | 386.872 | 0,91 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.500 | 386.872 | 0,91 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.500 | 17.178.061 | 0,02 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 505 | 383.372 | 0,13 | 34,26 | 17.304 | 13.136.012 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20.395 | 17.020.560 | 0,12 | 34,26 | 698.822 | 583.199.276 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7 | 382.867 | 0,00 | 34,10 | 239 | 13.055.765 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 293 | 17.000.165 | 0,00 | 34,10 | 9.991 | 579.705.626 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 382.860 | 2,68 | 7,26 | 72.600 | 2.779.564 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 382.860 | 2,68 | 7,26 | 72.600 | 2.779.564 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 382.860 | 2,68 | 7,26 | 72.600 | 2.779.564 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 746 | 372.860 | 0,20 | 34,60 | 25.815 | 12.902.522 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 30.122 | 16.989.872 | 0,18 | 34,60 | 1.042.348 | 587.920.929 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 740 | 372.114 | 0,20 | 33,73 | 24.964 | 12.553.191 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29.865 | 16.959.750 | 0,18 | 33,73 | 1.007.490 | 572.133.774 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.069 | 371.374 | 0,29 | 34,31 | 36.673 | 12.740.319 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43.131 | 16.929.885 | 0,26 | 34,31 | 1.479.648 | 580.794.942 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 783 | 370.305 | 0,21 | 33,92 | 26.559 | 12.560.486 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31.617 | 16.886.754 | 0,19 | 33,92 | 1.072.427 | 572.786.875 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 329 | 369.522 | 0,09 | 34,74 | 11.430 | 12.837.564 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13.271 | 16.855.137 | 0,08 | 34,74 | 461.048 | 585.564.315 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.933 | 369.193 | 0,80 | 33,77 | 99.060 | 12.469.235 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 118.389 | 16.841.866 | 0,71 | 33,77 | 3.998.506 | 568.822.235 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 839 | 366.260 | 0,23 | 33,72 | 28.295 | 12.352.009 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33.868 | 16.723.477 | 0,20 | 34,72 | 1.176.056 | 580.717.722 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.534 | 365.421 | 0,42 | 33,98 | 52.118 | 12.415.252 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61.892 | 16.689.609 | 0,37 | 33,98 | 2.102.793 | 567.032.804 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 623 | 363.887 | 0,17 | 34,01 | 21.190 | 12.376.779 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25.156 | 16.627.717 | 0,15 | 34,01 | 855.623 | 565.553.550 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.228 | 363.264 | 0,34 | 33,40 | 41.020 | 12.134.580 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49.553 | 16.602.561 | 0,30 | 33,40 | 1.655.283 | 554.596.928 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 984 | 362.036 | 0,27 | 33,54 | 33.007 | 12.143.991 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39.710 | 16.553.008 | 0,24 | 33,54 | 1.332.016 | 555.247.479 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 746 | 372.860 | 0,20 | 34,60 | 25.815 | 12.902.522 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 30.122 | 16.989.872 | 0,18 | 34,60 | 1.042.348 | 587.920.929 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 740 | 372.114 | 0,20 | 33,73 | 24.964 | 12.553.191 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29.865 | 16.959.750 | 0,18 | 33,73 | 1.007.490 | 572.133.774 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.069 | 371.374 | 0,29 | 34,31 | 36.673 | 12.740.319 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43.131 | 16.929.885 | 0,26 | 34,31 | 1.479.648 | 580.794.942 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 783 | 370.305 | 0,21 | 33,92 | 26.559 | 12.560.486 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31.617 | 16.886.754 | 0,19 | 33,92 | 1.072.427 | 572.786.875 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 329 | 369.522 | 0,09 | 34,74 | 11.430 | 12.837.564 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13.271 | 16.855.137 | 0,08 | 34,74 | 461.048 | 585.564.315 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.933 | 369.193 | 0,80 | 33,77 | 99.060 | 12.469.235 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 118.389 | 16.841.866 | 0,71 | 33,77 | 3.998.506 | 568.822.235 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 839 | 366.260 | 0,23 | 33,72 | 28.295 | 12.352.009 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33.868 | 16.723.477 | 0,20 | 34,72 | 1.176.056 | 580.717.722 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.534 | 365.421 | 0,42 | 33,98 | 52.118 | 12.415.252 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61.892 | 16.689.609 | 0,37 | 33,98 | 2.102.793 | 567.032.804 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 623 | 363.887 | 0,17 | 34,01 | 21.190 | 12.376.779 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25.156 | 16.627.717 | 0,15 | 34,01 | 855.623 | 565.553.550 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.228 | 363.264 | 0,34 | 33,40 | 41.020 | 12.134.580 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49.553 | 16.602.561 | 0,30 | 33,40 | 1.655.283 | 554.596.928 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 984 | 362.036 | 0,27 | 33,54 | 33.007 | 12.143.991 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39.710 | 16.553.008 | 0,24 | 33,54 | 1.332.016 | 555.247.479 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8.000 | 0 | -100,00 | 65,10 | 520.800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8.000 | 0 | -100,00 | 65,10 | 520.800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8.000 | 0 | -100,00 | 65,10 | 520.800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8.000 | 0 | -100,00 | 65,10 | 520.800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8.000 | 0 | -100,00 | 65,10 | 520.800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8.000 | 0 | -100,00 | 65,10 | 520.800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8.000 | 0 | -100,00 | 65,10 | 520.800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8.000 | 219.614 | 3,78 | 65,10 | 520.800 | 14.296.871 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8.000 | 219.614 | 3,78 | 65,10 | 520.800 | 14.296.871 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8.000 | 219.614 | 3,78 | 65,10 | 520.800 | 14.296.871 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8.000 | 253.472 | 3,26 | 65,10 | 520.800 | 16.501.027 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8.000 | 1.889.047 | 0,43 | 65,10 | 520.800 | 122.976.960 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8.000 | 208.461 | 3,99 | 65,10 | 520.800 | 13.570.811 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8.000 | 318.195 | 2,58 | 65,10 | 520.800 | 20.714.494 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 303.913 | 0,25 | 26,57 | 19.981 | 8.074.968 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 303.913 | 0,25 | 26,57 | 19.981 | 8.074.968 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 1.347.295 | 0,06 | 26,57 | 19.981 | 35.797.628 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 11.418.249 | 0,01 | 26,57 | 19.981 | 303.382.876 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 1.907.372 | 0,04 | 26,57 | 19.981 | 50.678.874 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 191.202 | 0,39 | 26,57 | 19.981 | 5.080.237 | |
| 2014-03-19 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 80.000 | 80.000 | |||||
| 2014-03-12 |
|
4 | IDP |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 60.000 | 60.000 | |||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-07 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 9.031 | 211.614 | 4,46 | 105,75 | 955.028 | 22.378.180 | |
| 2014-03-07 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 365.969 | 8.172.521 | 4,69 | 105,75 | 38.701.222 | 864.244.096 | |
| 2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11.738 | 452.540 | 2,66 | 28,50 | 334.533 | 12.897.390 | |
| 2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 475.644 | 18.476.847 | 2,64 | 28,50 | 13.555.854 | 526.590.140 | |
| 2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 38.934 | 1.552.055 | 2,57 | 28,50 | 1.109.619 | 44.233.568 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 303.161 | 0,23 | 29,27 | 19.962 | 8.873.522 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 303.161 | 0,23 | 29,27 | 19.962 | 8.873.522 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 11.243.600 | 0,01 | 29,27 | 19.962 | 329.100.172 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 1.732.723 | 0,04 | 29,27 | 19.962 | 50.716.802 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 16.553 | 4,30 | 29,27 | 19.962 | 484.506 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 177.212 | 0,39 | 29,27 | 19.962 | 5.186.995 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 639 | 361.052 | 0,18 | 39,91 | 25.504 | 14.410.344 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25.596 | 16.513.298 | 0,16 | 39,91 | 1.021.590 | 659.080.401 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.280 | 360.413 | 0,36 | 39,92 | 51.100 | 14.388.372 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 51.244 | 16.487.702 | 0,31 | 39,92 | 2.045.758 | 658.220.390 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.063 | 359.133 | 0,30 | 39,65 | 42.153 | 14.241.383 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42.646 | 16.436.458 | 0,26 | 39,65 | 1.691.123 | 651.786.098 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.486 | 358.070 | 0,70 | 39,70 | 98.694 | 14.215.379 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 99.775 | 16.393.812 | 0,61 | 39,70 | 3.961.068 | 650.834.336 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.377 | 355.584 | 0,39 | 39,54 | 54.442 | 14.058.725 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 55.256 | 16.294.037 | 0,34 | 39,54 | 2.184.656 | 644.217.341 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.056 | 354.207 | 0,87 | 39,53 | 120.798 | 14.001.201 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 122.660 | 16.238.781 | 0,76 | 39,53 | 4.848.541 | 641.891.407 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.492 | 351.151 | 1,59 | 43,98 | 241.512 | 15.441.935 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 219.958 | 16.116.121 | 1,38 | 43,98 | 9.672.697 | 708.709.644 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 553 | 345.659 | 0,16 | 44,00 | 24.332 | 15.208.823 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22.147 | 15.896.163 | 0,14 | 44,00 | 974.457 | 699.423.224 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.863 | 345.106 | 0,84 | 44,05 | 126.102 | 15.200.366 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 114.663 | 15.874.016 | 0,73 | 44,05 | 5.050.389 | 699.178.972 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 170 | 342.243 | 0,05 | 43,42 | 7.382 | 14.861.800 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6.814 | 15.759.353 | 0,04 | 43,42 | 295.896 | 684.345.176 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.512 | 342.073 | 0,74 | 42,95 | 107.883 | 14.691.043 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100.626 | 15.752.539 | 0,64 | 42,95 | 4.321.595 | 676.525.868 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 340 | 339.561 | 0,10 | 43,72 | 14.864 | 14.845.233 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13.632 | 15.651.913 | 0,09 | 43,72 | 595.976 | 684.284.419 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.011 | 339.221 | 0,30 | 43,01 | 43.479 | 14.588.403 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40.471 | 15.638.281 | 0,26 | 43,01 | 1.740.480 | 672.533.657 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.818 | 338.210 | 0,54 | 43,20 | 78.547 | 14.612.329 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72.807 | 15.597.810 | 0,47 | 43,20 | 3.145.619 | 673.901.821 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 455 | 336.392 | 0,14 | 43,64 | 19.858 | 14.681.829 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18.232 | 15.525.003 | 0,12 | 43,64 | 795.736 | 677.588.756 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 290 | 335.937 | 0,09 | 42,65 | 12.369 | 14.328.721 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11.617 | 15.506.771 | 0,07 | 42,65 | 495.500 | 661.410.303 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.551 | 335.647 | 1,07 | 42,56 | 151.129 | 14.284.968 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 142.220 | 15.495.154 | 0,93 | 42,56 | 6.052.812 | 659.466.007 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.632 | 332.096 | 0,80 | 42,41 | 111.631 | 14.085.188 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 105.414 | 15.352.934 | 0,69 | 42,41 | 4.470.924 | 651.163.990 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.816 | 329.464 | 0,86 | 42,31 | 119.144 | 13.939.556 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 112.797 | 15.247.520 | 0,75 | 42,31 | 4.772.419 | 645.119.522 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -127.000 | 892.000 | -12,46 | 432,60 | -54.940.390 | 385.880.538 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -4.567.000 | 31.967.000 | -12,50 | 432,60 | -1.975.691.050 | 13.828.972.150 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -1.084.000 | 7.587.000 | -12,50 | 432,60 | -468.940.026 | 3.282.147.580 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -2.459.000 | 1.019.000 | -70,70 | 425,88 | -1.047.233.756 | 433.969.580 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -88.153.000 | 36.534.000 | -70,70 | 425,88 | -37.542.414.519 | 15.559.023.199 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -20.922.000 | 8.671.000 | -70,70 | 425,88 | -8.910.217.424 | 3.692.787.271 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 170.000 | 6.050.000 | 2,89 | 104,52 | 17.768.043 | 632.333.295 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 6.830.000 | 243.450.000 | 2,89 | 104,52 | 713.857.257 | 25.444.882.755 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 242.000 | 5.880.000 | 4,29 | 104,25 | 25.228.500 | 612.990.000 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 9.758.000 | 236.620.000 | 4,30 | 104,25 | 1.017.271.500 | 24.667.635.000 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 61.000 | 5.638.000 | 1,09 | 103,75 | 6.328.750 | 584.942.500 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 2.439.000 | 226.862.000 | 1,09 | 103,75 | 253.046.250 | 23.536.932.500 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 121.000 | 5.577.000 | 2,22 | 104,75 | 12.674.750 | 584.190.750 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 4.879.000 | 224.423.000 | 2,22 | 104,75 | 511.075.250 | 23.508.309.250 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 5.456.000 | 5.456.000 | 100,00 | 545.600.000 | 545.600.000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 5.456.000 | 5.456.000 | 100,00 | 545.600.000 | 545.600.000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 219.544.000 | 219.544.000 | 100,00 | 21.954.400.000 | 21.954.400.000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 219.544.000 | 219.544.000 | 100,00 | 21.954.400.000 | 21.954.400.000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 25.000.000 | 25.000.000 | 100,00 | 2.500.000.000 | 2.500.000.000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 25.000.000 | 25.000.000 | 100,00 | 2.500.000.000 | 2.500.000.000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 133.000 | 5.674.000 | 2,40 | 104,09 | 13.844.090 | 590.611.767 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 5.367.000 | 228.326.000 | 2,41 | 104,09 | 558.655.860 | 23.766.658.833 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 85.000 | 5.541.000 | 1,56 | 104,12 | 8.850.625 | 576.956.625 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 3.415.000 | 222.959.000 | 1,56 | 104,12 | 355.586.875 | 23.215.605.875 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 302.479 | 0,22 | 30,33 | 19.957 | 9.174.188 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 11.242.918 | 0,01 | 30,33 | 19.957 | 340.997.703 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 1.732.041 | 0,04 | 30,33 | 19.957 | 52.532.804 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 15.871 | 4,33 | 30,33 | 19.957 | 481.367 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 176.530 | 0,37 | 30,33 | 19.957 | 5.354.155 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 196.794 | 0,34 | 30,33 | 19.957 | 5.968.762 | |
| 2013-09-27 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 25.663 | 202.583 | 14,51 | 56,63 | 1.453.296 | 11.472.275 | |
| 2013-09-27 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 1.024.337 | 7.806.552 | 15,10 | 56,63 | 58.008.204 | 442.085.040 | |
| 2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 21.410 | 510.449 | 4,38 | 3,62 | 77.504 | 1.847.825 | |
| 2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 1.854.058 | 19.767.770 | 10,35 | 3,62 | 6.711.690 | 71.559.327 | |
| 2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 882.323 | 2.829.753 | 45,31 | 3,62 | 3.194.009 | 10.243.706 | |
| 2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 21.410 | 510.449 | 4,38 | 3,62 | 77.504 | 1.847.825 | |
| 2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 1.854.058 | 19.767.770 | 10,35 | 3,62 | 6.711.690 | 71.559.327 | |
| 2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 882.323 | 2.829.753 | 45,31 | 3,62 | 3.194.009 | 10.243.706 | |
| 2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24.705 | 145.533 | 20,45 | 4,40 | 108.702 | 640.345 | |
| 2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 991.161 | 4.832.285 | 25,80 | 4,40 | 4.361.108 | 21.262.054 | |
| 2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 120.498 | 1.642.513 | 7,92 | 4,40 | 530.191 | 7.227.057 | |
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3.030 | 3.030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3.030 | 3.030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3.030 | 3.030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3.030 | 3.030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3.030 | 3.030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3.030 | 3.030 | |||||
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301.821 | 0,20 | 32,85 | 19.907 | 9.914.820 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301.821 | 0,20 | 32,85 | 19.907 | 9.914.820 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301.821 | 0,20 | 32,85 | 19.907 | 9.914.820 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 1.731.383 | 0,04 | 32,85 | 19.907 | 56.875.932 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 15.213 | 4,15 | 32,85 | 19.907 | 499.747 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 175.872 | 0,35 | 32,85 | 19.907 | 5.777.395 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 10.000 | -50,00 | 4,44 | -44.400 | 44.400 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 10.000 | -50,00 | 4,44 | -44.400 | 44.400 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 10.000 | -50,00 | 4,44 | -44.400 | 44.400 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10.000 | 380.839 | 2,70 | 4,44 | 44.400 | 1.690.925 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10.000 | 380.839 | 2,70 | 4,44 | 44.400 | 1.690.925 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10.000 | 12.455.783 | 0,08 | 4,44 | 44.400 | 55.303.677 | |
| 2013-06-13 | 3 | INCY |
INCYTE CORP
Common Stock |
12.430.783 | ||||||||
| 2013-06-13 | 3 | INCY |
INCYTE CORP
Common Stock |
15.000 | ||||||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16.500 | 16.500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16.500 | 16.500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16.500 | 16.500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16.500 | 16.500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16.500 | 16.500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16.500 | 16.500 | |||||
| 2013-06-11 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12.500 | 12.500 | |||||
| 2013-06-11 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12.500 | 12.500 | |||||
| 2013-06-11 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12.500 | 12.500 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 5.437 | 440.802 | 1,25 | 14,46 | 78.641 | 6.375.804 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 217.986 | 18.001.203 | 1,23 | 14,46 | 3.152.971 | 260.371.200 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 26.577 | 1.513.121 | 1,79 | 14,46 | 384.412 | 21.885.933 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 3.790 | 435.365 | 0,88 | 14,55 | 55.145 | 6.334.648 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 151.980 | 17.783.217 | 0,86 | 14,55 | 2.211.339 | 258.749.364 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 18.530 | 1.486.544 | 1,26 | 14,55 | 269.615 | 21.629.513 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 4.312 | 431.575 | 1,01 | 14,58 | 62.885 | 6.294.003 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 172.893 | 17.631.237 | 0,99 | 14,58 | 2.521.437 | 257.130.434 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 21.080 | 1.468.014 | 1,46 | 14,58 | 307.427 | 21.409.223 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 5.437 | 427.263 | 1,29 | 14,46 | 78.600 | 6.176.728 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 217.986 | 17.458.344 | 1,26 | 14,46 | 3.151.315 | 252.386.550 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 26.577 | 1.446.934 | 1,87 | 14,46 | 384.210 | 20.917.601 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2.775 | 421.826 | 0,66 | 14,42 | 40.004 | 6.081.001 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 111.266 | 17.240.358 | 0,65 | 14,42 | 1.604.000 | 248.535.277 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 13.566 | 1.420.357 | 0,96 | 14,42 | 195.566 | 20.475.724 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11.552 | 419.051 | 2,83 | 14,45 | 166.955 | 6.056.335 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 463.197 | 17.129.092 | 2,78 | 14,45 | 6.694.355 | 247.558.202 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 56.475 | 1.406.791 | 4,18 | 14,45 | 816.205 | 20.331.647 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 890 | 407.499 | 0,22 | 14,50 | 12.903 | 5.907.798 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 35.702 | 16.665.895 | 0,21 | 14,50 | 517.597 | 241.617.146 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4.353 | 1.350.316 | 0,32 | 14,50 | 63.108 | 19.576.476 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5.189 | 406.609 | 1,29 | 14,00 | 72.641 | 5.692.119 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 208.063 | 16.630.193 | 1,27 | 14,00 | 2.912.674 | 232.806.072 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25.368 | 1.345.963 | 1,92 | 14,00 | 355.127 | 18.842.136 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11.511 | 401.420 | 2,95 | 14,08 | 162.100 | 5.652.877 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 461.548 | 16.422.130 | 2,89 | 14,08 | 6.499.611 | 231.259.719 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 56.274 | 1.320.595 | 4,45 | 14,08 | 792.462 | 18.596.883 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4.735 | 301.215 | 1,60 | 35,82 | 169.584 | 10.788.015 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 189.886 | 11.241.654 | 1,72 | 35,82 | 6.800.767 | 402.619.838 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 23.152 | 1.730.777 | 1,36 | 35,82 | 829.189 | 61.987.778 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3.558 | 296.480 | 1,21 | 36,62 | 130.294 | 10.857.098 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 142.702 | 11.051.768 | 1,31 | 36,62 | 5.225.747 | 404.715.744 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 17.399 | 1.707.625 | 1,03 | 36,62 | 637.151 | 62.533.228 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.790 | 292.922 | 0,96 | 36,69 | 102.356 | 10.746.400 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 111.907 | 10.909.066 | 1,04 | 36,69 | 4.105.521 | 400.219.813 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 13.644 | 1.690.226 | 0,81 | 36,69 | 500.556 | 62.009.152 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.114 | 290.132 | 0,39 | 36,75 | 40.942 | 10.662.989 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 44.627 | 10.797.159 | 0,42 | 36,75 | 1.640.140 | 396.819.347 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5.501 | 1.676.582 | 0,33 | 36,75 | 202.174 | 61.618.077 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.021 | 289.018 | 0,35 | 36,82 | 37.595 | 10.642.105 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 40.933 | 10.752.532 | 0,38 | 36,82 | 1.507.219 | 395.925.432 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5.046 | 1.671.081 | 0,30 | 36,82 | 185.802 | 61.531.876 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.613 | 287.997 | 0,56 | 36,93 | 59.574 | 10.636.852 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 64.679 | 10.711.599 | 0,61 | 36,93 | 2.388.848 | 395.621.126 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7.974 | 1.666.035 | 0,48 | 36,93 | 294.511 | 61.533.170 | |
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11.600 | 11.600 | |||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11.600 | 11.600 | |||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11.600 | 11.600 | |||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8.400 | 489.039 | 1,75 | ||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8.400 | 489.039 | 1,75 | ||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8.400 | 1.947.430 | 0,43 | ||||
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.358 | 286.384 | 0,48 | 36,93 | 50.154 | 10.576.877 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 54.399 | 10.646.920 | 0,51 | 36,93 | 2.009.091 | 393.217.373 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 6.760 | 1.658.061 | 0,41 | 36,93 | 249.664 | 61.236.338 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 332 | 285.026 | 0,12 | 36,99 | 12.280 | 10.542.371 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 13.313 | 10.592.521 | 0,13 | 36,99 | 492.413 | 391.789.811 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.655 | 1.651.301 | 0,10 | 36,99 | 61.214 | 61.077.331 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 35 | 284.694 | 0,01 | 36,18 | 1.266 | 10.300.969 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.392 | 10.579.208 | 0,01 | 36,18 | 50.366 | 382.783.251 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 173 | 1.649.646 | 0,01 | 36,18 | 6.260 | 59.688.481 | |
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 8.750 | 8.750 | |||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 8.750 | 8.750 | |||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 8.750 | 8.750 | |||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.500 | 326.648 | 1,08 | ||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.500 | 326.648 | 1,08 | ||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.500 | 326.648 | 1,08 | ||||
| 2013-05-21 | 3 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
15.131.223 | ||||||||
| 2013-05-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 43.184 | 389.909 | 12,45 | 12,50 | 539.800 | 4.873.862 | |
| 2013-05-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.730.970 | 15.960.582 | 12,16 | 12,50 | 21.637.125 | 199.507.275 | |
| 2013-05-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 218.846 | 1.264.321 | 20,93 | 12,50 | 2.735.575 | 15.804.012 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 418 | 284.659 | 0,15 | 36,54 | 15.273 | 10.401.212 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 16.768 | 10.577.816 | 0,16 | 36,54 | 612.689 | 386.504.934 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.120 | 1.649.473 | 0,13 | 36,54 | 77.463 | 60.270.424 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.129 | 284.241 | 0,40 | 36,41 | 41.111 | 10.350.295 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 45.279 | 10.561.048 | 0,43 | 36,41 | 1.648.780 | 384.567.890 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5.725 | 1.647.353 | 0,35 | 36,41 | 208.469 | 59.986.383 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 589 | 283.112 | 0,21 | 35,53 | 20.928 | 10.059.507 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 23.610 | 10.515.769 | 0,23 | 35,53 | 838.908 | 373.645.253 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.985 | 1.641.628 | 0,18 | 35,53 | 106.063 | 58.330.162 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3.516 | 282.523 | 1,26 | 34,02 | 119.609 | 9.610.980 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 140.962 | 10.492.159 | 1,36 | 34,02 | 4.795.302 | 356.926.462 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 17.822 | 1.638.643 | 1,10 | 34,02 | 606.276 | 55.744.013 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.104 | 279.007 | 0,40 | 34,74 | 38.358 | 9.694.098 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 44.244 | 10.351.197 | 0,43 | 34,74 | 1.537.258 | 359.652.340 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5.594 | 1.620.821 | 0,35 | 34,74 | 194.364 | 56.315.426 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 277.903 | 0,26 | 27,99 | 19.985 | 7.778.505 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 277.903 | 0,26 | 27,99 | 19.985 | 7.778.505 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 10.306.953 | 0,01 | 27,99 | 19.985 | 288.491.614 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 1.615.227 | 0,04 | 27,99 | 19.985 | 45.210.204 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 14.607 | 5,14 | 27,99 | 19.985 | 408.850 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 175.266 | 0,41 | 27,99 | 19.985 | 4.905.695 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 612 | 277.189 | 0,22 | 27,63 | 16.912 | 7.659.813 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24.508 | 10.306.239 | 0,24 | 27,64 | 677.325 | 284.832.497 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3.080 | 1.614.513 | 0,19 | 27,64 | 85.122 | 44.620.134 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 453 | 276.577 | 0,16 | 27,97 | 12.672 | 7.736.744 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 18.151 | 10.281.731 | 0,18 | 27,97 | 507.742 | 287.612.918 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.281 | 1.611.433 | 0,14 | 27,97 | 63.807 | 45.076.938 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 758 | 276.124 | 0,28 | 28,43 | 21.551 | 7.850.509 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 30.102 | 10.263.580 | 0,29 | 28,43 | 855.833 | 291.804.869 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3.940 | 1.609.152 | 0,25 | 28,43 | 112.019 | 45.749.961 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 375 | 275.366 | 0,14 | 28,58 | 10.718 | 7.870.098 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 14.878 | 10.233.478 | 0,15 | 28,58 | 425.221 | 292.477.918 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.947 | 1.605.212 | 0,12 | 28,58 | 55.646 | 45.877.762 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.742 | 274.991 | 0,64 | 28,23 | 49.180 | 7.763.463 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 69.187 | 10.218.600 | 0,68 | 28,23 | 1.953.267 | 288.488.450 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 9.055 | 1.603.265 | 0,57 | 28,23 | 255.638 | 45.262.897 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 788 | 273.249 | 0,29 | 27,96 | 22.033 | 7.640.288 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 31.584 | 10.149.413 | 0,31 | 27,96 | 883.117 | 283.786.722 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4.004 | 1.594.210 | 0,25 | 27,96 | 111.955 | 44.575.546 | |
| 2013-01-23 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Stock Options (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-01-23 | 3 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
14.229.612 | ||||||||
| 2013-01-08 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 20.099 | 176.920 | 12,82 | 47,53 | 955.305 | 8.409.008 | |
| 2013-01-08 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 839.621 | 6.782.215 | 14,13 | 47,53 | 39.907.186 | 322.358.679 | |
| 2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 272.461 | 0,13 | 27,24 | 9.997 | 7.421.838 | |
| 2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 272.461 | 0,13 | 27,24 | 9.997 | 7.421.838 | |
| 2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 10.117.829 | 0,00 | 27,24 | 9.997 | 275.609.662 | |
| 2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 1.590.206 | 0,02 | 27,24 | 9.997 | 43.317.211 | |
| 2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 13.893 | 2,71 | 27,24 | 9.997 | 378.445 | |
| 2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 174.552 | 0,21 | 27,24 | 9.997 | 4.754.796 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 6 | 271.806 | 0,00 | 27,54 | 165 | 7.485.537 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 268 | 10.117.174 | 0,00 | 27,54 | 7.381 | 278.626.972 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 26 | 1.589.551 | 0,00 | 27,54 | 716 | 43.776.235 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4.859 | 271.800 | 1,82 | 26,83 | 130.352 | 7.291.551 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 202.311 | 10.116.906 | 2,04 | 26,83 | 5.427.377 | 271.405.226 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 21.830 | 1.589.525 | 1,39 | 26,83 | 585.631 | 42.642.028 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.223 | 266.941 | 0,84 | 27,32 | 60.725 | 7.291.894 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 92.592 | 9.914.595 | 0,94 | 27,32 | 2.529.289 | 270.832.034 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 8.352 | 1.567.695 | 0,54 | 27,32 | 228.147 | 42.823.940 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.231 | 264.718 | 0,85 | 27,99 | 62.450 | 7.409.960 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 92.917 | 9.822.003 | 0,96 | 27,99 | 2.600.923 | 274.936.526 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 8.691 | 1.559.343 | 0,56 | 27,99 | 243.278 | 43.648.973 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4.298 | 262.487 | 1,66 | 27,94 | 120.075 | 7.333.204 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 178.978 | 9.729.086 | 1,87 | 27,94 | 5.000.180 | 271.805.367 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 16.724 | 1.550.652 | 1,09 | 27,94 | 467.225 | 43.321.185 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 143 | 258.189 | 0,06 | 27,86 | 3.983 | 7.192.010 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24 | 258.046 | 0,01 | 26,68 | 640 | 6.884.693 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 79 | 258.022 | 0,03 | 27,16 | 2.146 | 7.008.187 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 9.905 | 257.943 | 3,99 | 27,84 | 275.793 | 7.182.113 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 651 | 248.038 | 0,26 | 26,91 | 17.516 | 6.673.735 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 324 | 247.387 | 0,13 | 25,83 | 8.367 | 6.388.868 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5.972 | 9.550.108 | 0,06 | 27,86 | 166.354 | 266.023.988 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 980 | 9.544.136 | 0,01 | 26,68 | 26.146 | 254.638.503 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3.298 | 9.543.156 | 0,03 | 27,16 | 89.578 | 259.203.569 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 412.596 | 9.539.858 | 4,52 | 27,84 | 11.488.241 | 265.625.898 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 27.125 | 9.127.262 | 0,30 | 26,91 | 729.828 | 245.579.024 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 13.447 | 9.100.137 | 0,15 | 25,83 | 347.274 | 235.014.678 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 585 | 1.533.928 | 0,04 | 27,86 | 16.296 | 42.728.485 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 96 | 1.533.343 | 0,01 | 26,68 | 2.561 | 40.909.745 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 323 | 1.533.247 | 0,02 | 27,16 | 8.773 | 41.644.828 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 40.412 | 1.532.924 | 2,71 | 27,84 | 1.125.224 | 42.682.429 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.657 | 1.492.512 | 0,18 | 26,91 | 71.490 | 40.157.677 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.316 | 1.489.855 | 0,09 | 25,83 | 33.986 | 38.476.101 | |
| 2012-10-31 |
|
4 | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 103.608 | 463.839 | 28,76 | 3,00 | 310.824 | 1.391.517 | |
| 2012-10-31 |
|
4 | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 4.282.419 | 17.888.512 | 31,47 | 3,00 | 12.847.257 | 53.665.536 | |
| 2012-10-31 |
|
4 | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 336.639 | 1.922.230 | 21,23 | 3,00 | 1.009.917 | 5.766.690 | |
| 2012-07-31 | 3 | GHDX |
GENOMIC HEALTH INC
Common Stock |
9.086.690 | ||||||||
| 2012-07-23 | 3 | XOMA |
XOMA Corp
Common Stock |
13.606.093 | ||||||||
| 2012-07-13 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 21.082 | 156.821 | 15,53 | 41,20 | 868.578 | 6.461.025 | |
| 2012-07-13 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 864.918 | 5.942.594 | 17,03 | 41,20 | 35.634.622 | 244.834.873 | |
| 2012-07-13 | 3 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
5.077.676 |
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)
